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Abstract: This PhD dissertation arises from a research project investigating the suitability of palliative
care approaches in the treatment of patients with severe and persistent mental illness. Specifically, the
project was designed to initiate the discussion of alternative avenues of care for patients with a severe
and persistent mental illness and an unlikely chance of ever recovering significantly. At the heart of this
dissertation and as a basis for subsequent considerations lies a survey among German speaking psychi-
atrists in Switzerland. The original research conducted throughout the PhD is organized by thematic
focus, resulting in two paper series (sections). The first section is concerned with the acceptability and
suitability of palliative care approaches for severely and persistently mentally ill patients. In the above-
mentioned survey study, psychiatrists working in Switzerland were questioned regarding their attitudes
towards palliative care approaches for and general concepts of severe and persistent mental illness. A
number of 457 psychiatrists completed the survey (response rate 34.9 percent). Our findings revealed that
the responding psychiatrists regard certain forms of severe and persistent mental illness as terminal, and
believe that interventions with curative intent may in some cases be futile. Furthermore, a vast majority
of the respondents believed that palliative care approaches can be suitable in the care of patients with
severe and persistent mental illness. Drawing upon these findings, two subsequent papers conceptually
examine the role of palliative care approaches in general, and palliative sedation specifically. Concerning
the latter, it is argued that if one a) accepts that closeness to death is an unsuitable criterion for the initia-
tion of palliative sedation and that b) intolerable suffering can result from both physical and non-physical
symptoms, there is a weighty argument in favor of palliative sedation for the relief of intolerable suffering
from non-physical symptoms. Such symptoms may potentially result from severe forms of treatment
refractory mental disorders. In the second section, the focus lies on the practice of (medical) assistance in
dying in the context of severe and persistent mental illness. The first paper reports on items concerning
(medical) assistance in dying (‘Sterbehilfe’) from the survey study. Psychiatrists were asked about their
agreement with the practice and their willingness to actively support patients in their requests. A major-
ity of respondents (about 50 percent) oppose (medical) aid in dying requests based on the suffering from
a severe and persistent ROLE OF PALLIATIVE CARE IN SPMI 2 mental illness. However, there was
great variability between respondents, with a third of all respondents supporting the practice to some
degree, and about a fifth of respondents remaining neutral. Willingness to support specific patients was
higher in the specific case vignettes, whereas support was highest for the patient suffering from severe
and enduring anorexia nervosa. Notable is the large variance in response patterns, impressively reflect-
ing the lack of consensus regarding the controversial practice of (medical) assistance in dying despite
Switzerland’s liberal legal framework. In the final chapter of this dissertation, the implications of these
findings are discussed and integrated into a broader ethical debate. The dissertation concludes with an
elaboration of potential underlying reasons for psychiatry’s hesitancy in discussing end- of-life options in
the context of severe and persistent mental illness, most notably preconceptions regarding the autonomy
of (chronically) mentally ill patients and clashing professional obligations of psychiatrists with regard to
patients who refuse further medical treatment.
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Abstract 
This PhD dissertation arises from a research project investigating the suitability of 
palliative care approaches in the treatment of patients with severe and persistent mental 
illness. Specifically, the project was designed to initiate the discussion of alternative 
avenues of care for patients with a severe and persistent mental illness and an unlikely 
chance of ever recovering significantly. At the heart of this dissertation and as a basis for 
subsequent considerations lies a survey among German speaking psychiatrists in 
Switzerland. 
 The original research conducted throughout the PhD is organized by thematic 
focus, resulting in two paper series (sections). The first section is concerned with the 
acceptability and suitability of palliative care approaches for severely and persistently 
mentally ill patients. In the above-mentioned survey study, psychiatrists working in 
Switzerland were questioned regarding their attitudes towards palliative care approaches 
for and general concepts of severe and persistent mental illness. A number of 457 
psychiatrists completed the survey (response rate 34.9 percent). Our findings revealed 
that the responding psychiatrists regard certain forms of severe and persistent mental 
illness as terminal, and believe that interventions with curative intent may in some cases 
be futile. Furthermore, a vast majority of the respondents believed that palliative care 
approaches can be suitable in the care of patients with severe and persistent mental illness. 
Drawing upon these findings, two subsequent papers conceptually examine the role of 
palliative care approaches in general, and palliative sedation specifically. Concerning the 
latter, it is argued that if one a) accepts that closeness to death is an unsuitable criterion 
for the initiation of palliative sedation and that b) intolerable suffering can result from 
both physical and non-physical symptoms, there is a weighty argument in favor of 
palliative sedation for the relief of intolerable suffering from non-physical symptoms. 
Such symptoms may potentially result from severe forms of treatment refractory mental 
disorders. 
In the second section, the focus lies on the practice of (medical) assistance in dying 
in the context of severe and persistent mental illness. The first paper reports on items 
concerning (medical) assistance in dying (‘Sterbehilfe’) from the survey study. 
Psychiatrists were asked about their agreement with the practice and their willingness to 
actively support patients in their requests. A majority of respondents (about 50 percent) 
oppose (medical) aid in dying requests based on the suffering from a severe and persistent 
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mental illness. However, there was great variability between respondents, with a third of 
all respondents supporting the practice to some degree, and about a fifth of respondents 
remaining neutral. Willingness to support specific patients was higher in the specific case 
vignettes, whereas support was highest for the patient suffering from severe and enduring 
anorexia nervosa. Notable is the large variance in response patterns, impressively 
reflecting the lack of consensus regarding the controversial practice of (medical) 
assistance in dying despite Switzerland’s liberal legal framework. 
In the final chapter of this dissertation, the implications of these findings are 
discussed and integrated into a broader ethical debate. The dissertation concludes with an 
elaboration of potential underlying reasons for psychiatry’s hesitancy in discussing end-
of-life options in the context of severe and persistent mental illness, most notably 
preconceptions regarding the autonomy of (chronically) mentally ill patients and clashing 
professional obligations of psychiatrists with regard to patients who refuse further 
medical treatment. 
  
ROLE OF PALLIATIVE CARE IN SPMI 3 
Acknowledgments 
I can think only of a few major crossroads throughout my life that are – looking 
back – easy to pinpoint. Having said this, I precisely remember when I decided to apply 
for this PhD position. Dating back to 2015, I was about to graduate as a clinical 
psychologist, knowing little about psychiatric ethics and the fundamental questions that 
have been on critical thinkers’ minds since the times when the first psychiatric institutions 
were built. Yet, I have always been fascinated by the numerous particularities of 
psychiatry and am unbelievably grateful for being given time to explore them. Getting 
involved with this PhD project and simultaneously enrolling in the PhD program 
Biomedical Ethics and Law, was certainly one of my wiser “adult life decisions”.  
The past three years have been full of highly personal challenges and I will always 
remember my PhD as a time of conquering fears through simply doing things, without 
necessarily (always) being certain about them. Be it by presenting my controversial (read: 
contentious) work to a smart and critical audience of experienced physicians or by simply 
finding again and again this intrinsic motivation that kept me going at fast pace despite 
the infamous struggles virtually every PhD student encounters.  
I must say, I am proud of myself! Yet, this wouldn’t have been possible without 
the help of so many of you! First of all, I would like to thank my supervisors Manuel, 
Florian, Paul, and Nikola. I am thankful for having had competent scholars and clinicians 
by my side who were always right there to help me out when I was stuck and needed 
support. A big “thank you” goes to all the other amazing people who have been supporting 
me professionally in the past three years: Holger for lending me his tidy brain while 
putting together this thesis, as well as Valerie and Sam, and many others who have been 
sporadically involved in improving my work. To my great buddies at work and beyond – 
Daniel, Manya, Mirriam, Dominik, Ana, Matthias, Michelle and Daniela: Thanks for 
making my empty office so much more bearable. 
Most importantly though, I am privileged to call a number of amazing humans 
(and non-humans) my friends. My dear friend Julia who is herself soon to finish a PhD: 
Thanks for all the support (and distraction, when needed), let’s always be friends! My 
dear Caro, thank you for countless distracting hours, don’t move to Paris please! To my 
brother Gian and my beautiful friends, Patricia, Nela, Ana, Matthias, Ghislaine, Sira, 
Maggie, Eva, Maria, and Gavin; thank you for existing and making this endeavor a 
ROLE OF PALLIATIVE CARE IN SPMI 4 
smooth and joyful one! And of course, a big shout out to my love and partner in crime! 
Malte, thank you for always being down to earth and showing me how good life can be. 
Last but not least, I am eternally indebted to my mum and dad who have been 
beyond supportive over all the years. Thank you for always protecting me. And: YES! 
IT’S DONE! I WILL FINALLY GRADUATE!  
 





ROLE OF PALLIATIVE CARE IN SPMI 5 
Funding 
This PhD project was funded by a grant from the Swiss Academy of Medical Sciences 
(SAMS), in cooperation with the Gottfried and Julia Bangerter-Rhyner Foundation; and 
the Stanley Thomas Johnson Foundation. 
  
ROLE OF PALLIATIVE CARE IN SPMI 6 
(Page intentionally left blank) 
  
ROLE OF PALLIATIVE CARE IN SPMI 7 
Table of Contents 
Abbreviations ........................................................................................................................................ 9 
| INTRODUCTION ................................................................................................... 10 
Setting the Scene ................................................................................................................................. 11 
Outline ............................................................................................................................................. 11 
Why Palliative Care? ........................................................................................................................ 12 
Palliative Care within Mental Health ................................................................................................ 13 
Identifying the Cohort ...................................................................................................................... 15 
Introduction to the Case Vignettes ..................................................................................................... 18 
Case 1: Anorexia Nervosa ................................................................................................................ 18 
Case 2: Schizophrenia ...................................................................................................................... 19 
Case 3: Major Depressive Disorder................................................................................................... 20 
Ethical Challenges in Caring for SPMI Patients ................................................................................ 21 
Autonomy and Beneficence: A Special Area of Tension in Psychiatry .............................................. 22 
Terminating Care based on Futility Judgment ................................................................................... 23 
(Medical) Assistance in Dying .......................................................................................................... 24 
Research Objectives ............................................................................................................................ 25 
| SECTION I: SUITABILITY OF PALLIATIVE CARE APPROACHES ............ 26 
Acceptability of Palliative Care Approaches for Patients with Severe and Persistent Mental Illness: 
A Survey of Psychiatrists in Switzerland ........................................................................................... 27 
Abstract ........................................................................................................................................... 27 
Introduction ..................................................................................................................................... 29 
Methods ........................................................................................................................................... 30 
Results ............................................................................................................................................. 35 
Discussion ....................................................................................................................................... 40 
Palliative Care in der Behandlung von schweren chronischen psychischen Störungen .................... 46 
Palliative Sedation on the Grounds of Intolerable Psychological Suffering and its Implications for 
Refractory Mental Disorders .............................................................................................................. 52 
Summary of Main Findings: Suitability of Palliative Care Approaches ........................................... 61 
Paper 1............................................................................................................................................. 61 
Paper 2............................................................................................................................................. 62 
Paper 3............................................................................................................................................. 62 
ROLE OF PALLIATIVE CARE IN SPMI 8 
| SECTION II: (MEDICAL) ASSISTANCE IN DYING ......................................... 64 
Attitudes towards Assisted Suicide Requests in the Context of Severe and Persistent Mental Illness: 
A Survey of Psychiatrists in Switzerland ........................................................................................... 65 
Abstract ........................................................................................................................................... 65 
Introduction ..................................................................................................................................... 66 
Methods ........................................................................................................................................... 69 
Results ............................................................................................................................................. 70 
Discussion ....................................................................................................................................... 73 
Letter to the Editor ............................................................................................................................. 77 
Summary of Main Findings: (Medical) Assistance in Dying.............................................................. 79 
Paper 4............................................................................................................................................. 79 
Paper 5............................................................................................................................................. 79 
| GENERAL DISCUSSION....................................................................................... 81 
Structure and Aim .............................................................................................................................. 82 
Critical Appraisal of the Survey Conducted Within This PhD Project ............................................. 82 
Survey: Limited Generalizability ...................................................................................................... 82 
Lack of Specificity of the Conceptual Framework ............................................................................. 83 
A Broader Perspective on the Findings .............................................................................................. 84 
Death and Dying and Psychiatry ....................................................................................................... 84 
Personal Autonomy and Responsibility to Treat ................................................................................ 86 
Severe and Persistent Mental Illness and Autonomy.......................................................................... 88 
A Brief Note on Professional Fallibility ............................................................................................ 89 
Professional Obligations Justifying Overriding Autonomy ................................................................ 89 
Implications in Practice and Future Research Areas ......................................................................... 91 
Summary of Ethical Considerations .................................................................................................. 91 
Future Research Topics .................................................................................................................... 92 
Final Conclusion .............................................................................................................................. 93 
REFERENCES .......................................................................................................... 94 
CURRICULUM VITAE.......................................................................................... 116 
  
ROLE OF PALLIATIVE CARE IN SPMI 9 
Abbreviations 
 
CEBES Checklist for the Ethical Evaluation of Empirical Studies that 
Don’t Need Mandatory Authorization 
FMH Swiss Medical Association (Foederatio Medicorum 
Helveticorum) 
HRA   Human Research Act 
IRB Institutional Review Board 
(M)AID (Medical) aid in dying 
PC Palliative care 
PS Palliative sedation 
SAMS Swiss Academy of Medical Sciences 
SEAN Severe and enduring anorexia nervosa 
SPMI Severe and persistent mental illness 
SSPP   Swiss Society for Psychiatry and Psychotherapy 
TRD   Treatment-resistant depression 
WHO   World Health Organization 
  
ROLE OF PALLIATIVE CARE IN SPMI 10 
| INTRODUCTION 
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Setting the Scene 
Outline 
In 2010, the Swiss Federal Office of Public Health (FOPH) implemented the 
“National Strategy for Palliative Care 2010-2012.” The FOPH has thus responded to the 
large gap in availability of and research on palliative care (PC) in Switzerland. Within 
the broader context of the National Strategy, the Swiss Academy of Medical Sciences 
(SAMS) issued medical-ethical guidelines and recommendations on PC, and 
implemented a funding program aiming at promoting the development and expansion of 
palliative care research in Switzerland. In its guidelines, the SAMS envisions an explicit 
role for PC in the context of mental health care. It states:  
Many psychiatric conditions can be chronic or are characterized by frequent 
relapses. In such cases palliative care, which is not aimed primarily at fighting the 
disease but aims at the best possible way of dealing with the symptoms or the 
disability, is all the more important. Often, this approach can enhance the quality 
of life and diminish the risk of suicide. 
The guidelines go on to suggest that some patients with severe and persistent 
mental illness (SPMI) may benefit from PC approaches. Specifically, the patients who 
may benefit from PC approaches include those suffering from treatment refractory 
depression with repeated suicide attempts, severe schizophrenia, and poor quality of life 
(in the opinion of the patient); severest anorexia; and drug addiction. By broaching the 
issue of PC in the context of SPMI, the SAMS, perhaps unwittingly, made a progressive 
proposal. The lack (and relevance) of end-of-life options in mental health care, and for 
patients with SPMI specifically, is discussed fiercely in the medical-psychiatric 
community. Thus, this PhD project offered ideal conditions for systematically 
investigating how the complex needs of SPMI patients are perceived and addressed by 
contemporary psychiatric care.  
The empirical project initiated and performed at the very beginning of this PhD 
project, a survey among psychiatrists in Switzerland, served as a cornerstone for further 
addressing questions around autonomy and decision-making as well as the currently 
available care options for SPMI.  
The introduction provides the reader with necessary background information on 
SPMI patients, including concepts relevant to clinical decision-making for this patient 
group. It briefly touches upon the concept of medical futility and (medical) assistance in 
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dying ([M]AID) – two scenarios that have recently provoked an emotional and divisive 
debate within the medical and psychiatric community. The publications (section I with a 
focus on palliative care and section II with a focus on [M]AID) report on the findings 
from the above-mentioned survey among psychiatrists’ attitudes toward goals of care and 
decision-making for patients suffering from severe and persistent mental illness. Here, a 
focus lies on the acceptability of palliative care approaches and the attitudes toward the 
practice of (M)AID for patients with severe and persistent mental illness. The subsequent 
papers conceptually approach the potential role PC may have in mental health care. In the 
third part of this thesis, I aim at integrating the original research into a broader ethical 
debate. I present my observations regarding the understanding of autonomy in the context 
of SPMI and the professional obligations guiding clinicians concerned with the care of 
SPMI. Finally, I discuss potential clinical implications of my work, and possible future 
research domains.  
Why Palliative Care? 
It is an inconvenient truth that available treatments in mental healthcare have 
limited efficacy, and the management of patients with persisting symptoms despite 
adequate treatment trials remains a major public health challenge. For example, more than 
a fifth of all patients diagnosed with major depressive disorder fail to respond to several 
steps of adequate treatment trials (Rush et al., 2006). For schizophrenic disorders, the 
outcome is equally poor: as many as 10 to 30 percent (depending on definition of 
treatment resistance) of all patients have little or no response to antipsychotic treatment 
and another third of all patients continue to experience positive and/or negative symptoms 
that effect their lives profoundly (Hasan et al., 2012). Mortality rates for patients with 
anorexia nervosa are dramatically elevated, with crude mortality rates of 5 to 6 percent 
(Arcelus, Mitchell, Wales, & Nielsen, 2011). Furthermore, a substantial number of SPMI 
patients die from suicide, sometimes after being invested in therapy for many years. The 
recognition that current psychiatric services still fail to significantly improve the lives of 
many of their patients, let alone cure them, has led some authors to the proposal of 
exploring alternative avenues of care that primarily focus on quality of life and relief of 
suffering. One of these proposed approaches is the expansion of palliative care 
approaches to mental health services (Berk et al., 2012; Trachsel, Irwin, Biller-Andorno, 
Hoff, & Riese, 2016b).  
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 The field of PC has undergone a major transformation in the past four decades. 
Originating from the hospice movement in the 1960s (Clark, 2007), PC for a long time 
focused on cancer patients. This narrow scope is prominently represented in the first 
WHO definition of PC in 1990: 
 The active total care of patients whose disease is not responsive to curative 
treatment. Control of pain, other symptoms, and of psychological, social, and 
spiritual problems is paramount. The goal of palliative care is achievement of the 
best possible quality of life for patients and their families. Many aspects of 
palliative care are also applicable earlier in the course of the illness, in conjunction 
with anticancer treatment.  
Since 1990, the WHO has continued to be essentially involved in the evolution of 
PC, and has revised its definition several times. According to the most recent WHO 
definition, PC is: 
An approach that improves the quality of life of patients and their families facing 
the problems associated with life-threatening illness, through the prevention and 
relief of suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial, and spiritual.  
Most importantly, the WHO has extended the clinical application of PC to life-
threatening illness, rather than limiting it to patients with a cancer diagnosis (World 
Health Organization (WHO) 2014., 2014). It has thus recognized the potential use of PC 
for diseases other than cancer. Nowadays, common medical conditions of people 
requiring palliative care include serious physical illness such as HIV/AIDS, motor neuron 
disease, muscular dystrophy, multiple sclerosis, liver failure, renal failure, Alzheimer’s 
disease and other dementias, spinal cord injuries, and, most recently, mental disorders 
(Berk et al., 2012; Pastrana, Jünger, Ostgathe, Elsner, & Radbruch, 2008). This expansion 
of palliative care approaches has not come without criticism, and the lack of common 
language and the heterogeneity of the PC population is argued to hinder research on PC 
as well as its implementation and best practices (Currow, Wheeler, Glare, Kaasa, & 
Abernethy, 2009). 
Palliative Care within Mental Health 
Palliative psychiatry is the term suggested by some authors to describe an 
approach within psychiatry that primarily aims at improving quality of life through harm 
reduction rather than questionable (either because highly burdensome or most likely 
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ineffective) psychiatric intervention (Trachsel et al., 2016b). However, the fuzziness 
regarding the definition of PC and disagreement regarding its clinical scope (Hanratty et 
al., 2006; Payne et al., 2002) have previously affected the acceptance of the term 
palliative within a psychiatric context (McGorry, Berk, Berk, & Goldstone, 2012; Trauer, 
2012). There is no consensus on when in the course of a disease PC should be 
implemented, whether it is compatible with curative treatment, or who should get it. In 
the psychiatric context, it has been suggested by various scholars that a palliative 
approach be implemented at later stages of the illness for patients with persistent mental 
illness severely affecting their quality of life and daily functioning (Berk, Singh, & 
Kapczinski, 2008; Trachsel et al., 2016b; Trachsel, Irwin, Biller-Andorno, Hoff, & Riese, 
2016a; Trauer, 2012).  
It has been argued that a palliative care approach within mental health essentially 
is about compassionate care and practice and that the provision of palliative mental health 
care will require a realignment of some fundamental ethical assumptions that have guided 
mental health care to date (Geppert, 2014; see Table 1 below). 
 
Table 1  
Comparison of Mental Health Care and Palliative Care Ethical Assumptions 
Assumption Mental health care 
(traditional sense) 
Palliative care 
Orientation Biobehavioral Humanistic 
Objectives Cure disease 
Control symptoms 
Improve quality of 
life 
Relieve suffering  
Focus Individual person  Person, family, 
community 
Autonomy Constraint and 
compulsion if needed to 
prevent harm 
Choice and flexibility 
even if reduces length 
of life 
Note. Adapted from Geppert, C. M. A. (2014). Overcoming ethical dilemmas. In D. B. Cooper 
& J. Cooper (Eds.), Palliative care within mental health (1st ed., pp. 19–29). London: Radcliffe. 
 
In the light of these considerations, the conceptual similarities between palliative 
care within mental health and the recovery model is evident. Indeed, reservations 
regarding the implementation of a palliative care approach were not infrequently based 
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on the fear that palliative care undermines or denies the importance and impact of the 
recovery model. Furthermore, it was argued that endorsing PC for SPMI is fundamentally 
incompatible with the principles of the recovery model, such as hope, empowerment, and 
personal growth. Subsequently, the potentially delicate and unwanted competitive 
situation between the recovery model and PC within mental health will be considered in 
more detail. 
A note on compatibility of palliative care and the recovery model. It is 
important to stress that PC as it is understood here, is not only compatible with a recovery-
oriented approach but also shares some of the core principles with the recovery model. 
The second basic assumption underlying all further reflections in this thesis is that starting 
a discussion about the reality of irremediableness/ongoing suffering and fatality in SPMI 
does not equal fueling hopelessness and/or campaigning for a pessimistic approach in the 
care of SPMI. It can be said with safe conscience that the (initially) user-driven recovery 
model is among the major positive transformation mental health care has undergone in 
the past few years, and probably the first time the lived experience of SPMI patients is 
put at the center of psychiatric care. It is not the intention of this work to deny these 
achievements or suggest replacing recovery-oriented services with PC. Instead, it is 
aimed at drawing attention to the small group of very severely mentally ill patients, who 
are potentially in need of additional layers of support. Furthermore, it is at least 
questionable whether really “everyone with mental illness can recover” and we believe 
that for a small number of patients, personal recovery in the sense of regaining “a way of 
living that is satisfying, hopeful, and contributing […] even with limitations caused by 
the illness” and developing “[…] new meaning and purpose in one’s life as one grows 
beyond the catastrophic effects of mental illness” (Roberts & Wolfson, 2004, p. 39) may 
not be possible. For this group of patients, an additional layer of support may be helpful. 
Identifying the Cohort 
The clinical staging model in psychiatry. Despite its great clinical importance, 
there is no universal agreement on the definition of treatment refractoriness for any of the 
major diagnostic classes of mental disorders (Kane & Correll, 2016), rendering scientific 
discussion and clinical translation of research particularly difficult (Conway, George, & 
Sackeim, 2016; Howes et al., 2016). A relatively new model of describing the progressive 
nature of mental disorders is the clinical staging model. In various medical specialties, 
clinical staging models are utilized to classify seriously ill patients in order to determine 
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adequate treatment regimens (Amin et al., 2017). In psychiatry, the clinical staging model 
is comparatively new, but is rapidly gaining momentum. A valid staging model is 
intended to allow classification of patients according to their resistance to treatment and 
inform treatment selection accordingly, and therefore improve clinical management of 
the patient (Ruhé, van Rooijen, Spijker, Peeters, & Schene, 2012). The model is thought 
to have the potential to overcome diagnostic boundaries and enhance practical value 
through high clinical utility (McGorry, Hickie, Yung, Pantelis, & Jackson, 2006; Scott et 
al., 2013). An example of suggested criteria for three major SPMIs is given in Table 2. 
Depending on the staging models, different variables are included in defining the stage. 
For example, many staging models for depression use the number of adequate 
antidepressant trials in their definitions, and some also include other treatment approaches 
such as psychotherapy or ECT (Ruhé et al., 2012). Because the clinical staging model is 
less rigid in its definition of stages and allows for heterologous clinicopathological 
scenarios, it has the potential to facilitate identification of patients with chronic and 
unremitting disease and an enhanced risk of dying prematurely. 
 
Table 2 
Proposals of Clinical Staging for Schizophrenia, Unipolar Depression, and Anorexia 
Nervosa 
Stage Schizophrenia Unipolar depression Anorexia nervosa 
1 prodromal phase 
with deterioration 
of functioning  
 
prodromal phase  




disorders) with mild 
functional change or 
decline  





fullness” after eating, 
reduction of food 











levels, complete denial 
of the illness, growing 
attention to body 
weight/shape/size, 
social impairment  
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3 residual phase residual phase 






b) mood symptoms 
(depressed mood, guilt, 
hopelessness) 
c) dysthymia 
residual phase  
 
4 chronic phase (in 
attenuated or 
persistent form)  
 
a) recurrent depression 
b) double depression (co-
existence of major 
depressive disorder and 
persistent depressive 
disorder/dysthymia) 
chronic (in attenuated 
or persistent form): 
extreme emaciation, 
laborious exercise and 
“general debility”; risk 
of co-occurrence of 
other psychiatric 
disorder (e.g., alcohol 
use disorder)  
5  chronic major depressive 
episode  
 
Note. Adapted from Cosci and Fava (2013) 
 
 Severe and persistent mental illness. Over the last two decades, considerable 
resources have been devoted toward identifying patients in the early stages (stages 1 and 
2 in Table 2) of mental disorders in order to develop effective strategies for prevention, 
and delayed or inadequate treatment is recognized as a major contributor to chronic and 
severe courses of mental illnesses. While early diagnosis is of great value for preventing 
potentially severe and persistent mental illnesses, the risk of neglecting patients with 
established illnesses has also been identified (McGorry, 2005). With a clear weight on 
the earlier stages and one-sided distribution of clinical and research resources, care 
options for patients in later stages remain limited (Berk et al., 2008). Patients who meet 
the criteria for stages 4 and 5 typically have well-established treatment resistance and 
present with persisting clinical symptoms that have a major impact on their quality of life 
and functioning (McGorry et al., 2012). Many of them have been ill for years, and have 
survived one or several suicide attempts. They have a very low probability of benefiting 
from additional pharmacological treatment (Rush et al., 2006) and are disproportionally 
prone to receiving care that is experimental, highly intrusive, burdensome, or in other 
ways not in line with their personal values (Berk et al., 2008). In addition, their ability to 
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decide for a certain treatment option is frequently questioned due to a persisting 
presumption of impaired decisional capacity and (acute or chronic) risk of death 
(Campbell & Aulisio, 2012). Unsurprisingly, providing care for patients with treatment-
refractory illness may prompt helplessness in providers and is therefore frustrating and 
unattractive (Lauber, Nordt, Braunschweig, & Rössler, 2006; Minkoff, 1987), especially 
among psychiatrists themselves (Lauber et al., 2006).  
 Recent development of social policy regarding the expansion of the practice of 
(M)AID to such patients with unremitting psychiatric illness has provoked a heated 
debate regarding differentiation between mental and physical illness, competency, and 
questions of irremediableness and futility in severely and persistently mentally ill patients 
with a death wish. Before further elaborations on the topic are presented, three case 
vignettes depicting stage 4/5 SPMI patients are presented in the following section. 
Introduction to the Case Vignettes 
The survey among psychiatrists in Switzerland consisted of both general 
conceptual questions surrounding the topic of SPMI and questions directly related to 
specific clinical situations presented in the form of case vignettes. All case vignettes were 
taken from previously published material and were minimally adapted to suit the format 
of the survey. In this section, the case vignettes are briefly discussed in order to allow a 
more comprehensive understanding of the target patient group relevant to this project. 
Case 1: Anorexia Nervosa  
Originally published in Trachsel, Wild, Biller-Andorno, & Krones (2015) 
37-year-old female with anorexia nervosa, onset at age 11 
Symptoms: general muscle weakness; loss of bone density; amenorrhea; current weight 24kg/52 
lbs; BMI 9.5 kg/m2; no recent weight gain or stabilization; no acute danger of dying, as her body 
is adapted to being underweight.  
The patient underwent 10 previous inpatient treatments (in both somatic and psychiatric 
hospitals), three of which were in specialized psychiatric institutions. Throughout the course of 
the disease, different intensive psychotherapies have been tried, without success. During 
hospitalizations, the patient underwent several artificial re-feedings, sometimes under sedation. 
The patient now refuses artificial re-feeding and treatment. She states that, for years, her life has 
been focused exclusively on trying to overcome her anorexia, leaving her without friends or 
hobbies. She suffers from the physical symptoms, including general muscle weakness and loss in 
bone density, saying that she would rather die than undergo further treatment, and wishes to be 
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left in peace. She does not want to be forced into eating anymore. Two experts have declared that 
the patient has decision-making capacity to refuse further treatment, with consequent risk of 
dying. 
 
 The patient presented in case one suffers from a very severe and enduring form of 
anorexia nervosa (SEAN). As mentioned above, patients diagnosed with anorexia nervosa 
have significantly elevated mortality rates (Arcelus et al., 2011) and full recovery is 
achieved in less than 50 percent of all patients (Steinhausen, 2002; Zipfel, Löwe, Reas, 
Deter, & Herzog, 2000). Lifetime variables predictive of mortality are previous suicide 
attempts and longer duration of the eating disorder (Huas et al., 2011; Keel et al., 2003). 
Patients who suffer from a lifetime of severe illness often pose a major challenge to their 
healthcare team (Strober, 2004), and many patients question the value of offered 
treatments at some point. Due to the life-threatening nature of their illness, patients with 
AN are particularly prone to non-consensual treatment scenarios (e.g., coercive measures 
such as forced tube-feeding). Additionally, their treatment refusal is said to be 
qualitatively different from treatment-resistance because available and efficacious 
treatment (nutrition) is refused rather than inefficient (Geppert, 2015). There has been an 
extensive discussion of decisional capacity in patients with severe and enduring AN, as 
starvation and malnutrition is known to cause structural abnormalities in the brain, likely 
negatively affecting cognitive abilities (Katzman, Christensen, Young, & Zipursky, 
2001).  
Case 2: Schizophrenia 
Originally published in Brenner et al. (1990) 
33-year-old male with schizophrenia, onset at age 17, no significant comorbidities  
Positive symptoms: auditory and visual hallucinations, persecutory delusions. Negative 
symptoms: apathy, social withdrawal, poverty of speech (all rated severe).  
Despite long-lasting, high-dose pharmacological treatment (several atypical neuroleptics, 
haloperidol, clozapine, and combinations of these), as well as electro-convulsive therapy, the 
patient has never been free from positive or negative symptoms. Multiple psychotherapies of 
various kinds have also failed to stabilize the patient or to improve his quality of life. He does not 
wish to continue assertive community treatment because he feels it is too intrusive. While the 
positive symptoms were more dominant in the first years following initial diagnosis, he went on 
to develop severe negative symptoms, as well as aggression and self-injurious behavior such as 
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burning himself with cigarettes. The negative symptoms and his strong functional deficits are 
exacerbated by chronic unemployment and inability to live independently, and the patient has no 
family system. His persisting illness has left him completely isolated, with no social contacts and 
no hobbies or interests. Two experts have declared that he possesses decision-making capacity in 
respect of his illness and its treatment.  
 
 The patient described in case two suffers from a severe and persistent form of 
schizophrenia. Although this patient does not have an immediate risk of dying, his life 
expectancy is likely negatively affected by his persisting mental disorder, and the 
development of comorbidities that affect his health in the future is likely. The patient’s 
(self-assessed) quality of life is very low and he feels overwhelmed by potentially 
beneficial but intrusive attempts at engaging him in treatment. The patients would like to 
“be left alone,” which would potentially lead to an aggravation of symptoms and repeated 
involuntary admissions (including phases of non-consensual treatment if the patient loses 
his decision-making capacity as a result of not engaging in treatment [e.g. not taking his 
antipsychotic medication]). People with schizophrenia are typically faced with difficulties 
in accessing health care, employment, and educational opportunities. Treatment is often 
focused on antipsychotics and there is a tendency for providers to convince patients to 
take antipsychotic medication despite recent doubts about the efficacy and effectiveness 
of clozapine in later stages of schizophrenia (Kane & Correll, 2016). 
Case 3: Major Depressive Disorder 
Originally published in Baweja & Singareddy (2013) 
40-year-old male with major depressive disorder, no significant comorbidities  
Symptoms: energy loss, insomnia, fatigue, persistent suicidal ideation over 20 years, current acute 
and concrete suicidal intent. 
The patient underwent different intensive, evidence-based, long-term psychotherapies, including 
specialized treatment approaches such as CBASP and IPT. His depression was not improved 
either by psychotherapy alone or in combination with adequate treatment trials of antidepressants 
(selective serotonin reuptake inhibitors, tricyclic antidepressants, venlafaxine, augmentation with 
lithium, and antipsychotic medications [quetiapine and aripiprazole]). The patient experienced 
significant adverse effects with several of the medications. Exhausted and as a last resort, he 
decided to undergo electro-convulsive therapy. However, maintenance electro- convulsive 
therapy proved equally ineffective in preventing the reappearance of suicidal ideation; indeed, the 
symptoms worsened. The patient experiences severe hopelessness and states that his quality of 
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life is very poor, that he doesn’t want to deal with his illness anymore, and that he plans to commit 
suicide in the near future. Two experts have declared that he possesses decision-making capacity 
regarding his illness and its treatment.  
 
 The patient described in case three suffers from what is commonly called treatment-
resistant depression (TRD). Ethical considerations regarding access to (medical) 
assistance in dying for psychiatric patients has been dominated by this patient group 
(Schuklenk & van de Vathorst, 2015a). This patient expresses a wish to die because the 
suffering from the depression has become unbearable. Although there is no imminent 
suicide risk, forms of such autonomous/rational suicide pose a major challenge to 
psychiatry, with its uncompromising focus on suicide prevention. Patients with TRD who 
refuse to undergo potentially helpful yet highly intrusive and possibly experimental 
treatment such as deep brain stimulation paradigmatically illustrate ethical conflicts 
frequently occurring in the treatment of patients with SPMI: the respect for patient 
autonomy and the principle of beneficence. 
 
Ethical Challenges in Caring for SPMI Patients 
 Although the patients presented in the case vignettes above present with different 
complex clinical pictures, they have a number of things in common: All three patients 
report very low quality of life because of their SPMI and wish (to different degrees) to 
stop further intrusive treatment because, up to this point, treatment has not only been 
unsuccessful for them, but also proved severely burdening at times. They have now 
arrived at an “enough is enough, already” state of mind (Yager, 2015). Moreover, all three 
patients have an elevated risk of death, either as a direct result of their disease (e.g., 
cardiac arrest); indirectly, as a result of severe comorbidities or adverse effects of 
psychopharmacological treatment they have undergone (e.g., cardiovascular disease); or 
through suicide. Despite the fact that most clinicians (and scholars) would acknowledge 
the clinical reality of SPMI patients such as the ones described in the vignettes, there is 
little guidance on how to best balance patient autonomy (an expressed desire “to be left 
alone,” to stop potentially helpful but intrusive treatment) with the principle of 
beneficence in such cases. The following section will briefly introduce core ethical 
concepts that are relevant when thinking about treatment decisions of SPMI patients. An 
in-depth ethical analysis, considering both the empirical results gathered in the survey as 
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well as conceptual deliberations during this PhD project, can be found later on in the 
general discussion.  
Autonomy and Beneficence: A Special Area of Tension in Psychiatry 
 The respect for personal autonomy is rooted in the liberal tradition of individual 
freedom and choice. Respecting an autonomous decision “is to recognize with due 
appreciation that person’s capacities and perspective, including his or her right to hold 
certain views, to make certain choices, and to take certain actions based on personal 
values and beliefs” (Beauchamp, 2009, p. 34) In contemporary medical ethics, patient 
autonomy has been a guiding principle. Many – if not most – ethical issues in psychiatry 
arise when a person’s (potentially) autonomous wish is overridden (Beauchamp, 2009). 
Such paternalistic inferences are justified on the grounds of beneficence or non-
maleficence. Examples of paternalism include involuntary commitment to institutions, 
compulsory psychiatric care, or interventions to stop a planned suicide (Beauchamp, 
2009). There is broad consensus in research and in clinical practice that in some 
circumstances, beneficent coercion is justified, namely when patients lack decisional 
capacity (Urteilsfähigkeit) and make choices that are likely to cause them harm. However, 
such coercive interventions are more frequent in psychiatry than in any other medical 
subspecialty. Several characteristics of SPMI patients may contribute to the high 
prevalence of coercive interventions.  
 Firstly, clinical decision-making may be challenged by fluctuating cognitive 
abilities of the patients and the clinicians’ personal values and attitudes (Hermann, 
Trachsel, & Biller-Andorno, 2015). Empirical evidence that SPMI patients are per se 
incapable of making decisions, however, is lacking. Nevertheless, an initial doubt about 
decisional capacity is more the rule than the exception to it. After all, decision-making 
capacity is a normative concept that should be free from personal values and norms of the 
assessors (Hermann, 2015). 
Several other aspects, though related to the concept of decision-making capacity, 
are relevant when thinking about treatment decisions for SPMI patients. To what extent, 
for example, can chronically mentally ill patients still be authentic? Specifically, how is 
an articulated wish of a patient to be evaluated if it is potentially affected by a cognitive 
distortion – but this distortion is immovable despite treatment? In other words, what if 
chronicity renders relying on a past authentic self impossible, and poor prognosis makes 
a future authentic self highly unlikely (Dembo, 2013)? In cases of prolonged mental 
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illness may the illness itself be a part of, or perceived to be a part of, the patient’s 
personality (Johansson et al., 2011)? 
 Secondly, despite danger to self and suicidal tendencies (Suizidalität) being one of 
psychiatry’s core topics, the ethical implications of chronic life-threatening mental illness 
are not systematically discussed outside the context of suicide prevention and (M)AID 
practices (see next section). Self-endangerment typically establishes a basis for 
involuntary admission (and treatment – depending on the legislation). Seemingly the only 
context in which the issue of a potentially fatal outcome in psychiatry by omission of 
further treatment has been discussed is in case of a medical futility and (M)AID. 
Terminating Care based on Futility Judgment 
 A prominent definition of medical futility distinguishes between a quantitative 
and a qualitative approach (Schneiderman, 1990). Quantitative futility, according to 
Schneiderman, occurs when “physicians conclude (either through personal experience, 
experiences shared with colleagues, or consideration of reported empiric data) that in the 
last 100 cases, a medical treatment has been useless.” Qualitatively futile, on the other 
hand, is any treatment that fails to be beneficial to the patient, e.g., by merely preserving 
unconsciousness (Schneiderman, 1990). Based on these definitions, so the argument goes, 
physicians have no obligation to continue treatment. In a pioneering paper, Lopez, Yager, 
and Feinstein (2015) have argued that medical futility might be equally applied to some 
very severe cases of mental illness. Opponents object that the concept of futility is 
unsuitable in the context of psychiatric disorders, pointing to high prognostic uncertainty. 
For example, a renowned clinician and bioethicist has argued that, “when writers refer to 
‘end stage’ AN, they cannot point to a well-established temporal gradient of 
psychopathology that would allow one to say confidently, ‘This is the end of the 
process.’” The expert further mentions the effects a futility judgment might have on 
attitudes and behaviors of caregivers (e.g., demoralization), and argues that futility 
judgments would mainly reflect the physician’s frustration and feeling of impotence when 
treating patients with refractory AN (Pies, 2015). Other authors point to the risk that lies 
in lumping together treatment refractoriness and treatment refusal, and the possibility that 
the latter might potentially be rooted in pathological denial of the illness (Geppert, 2015). 
Maybe partly as a result of a “terminology war,” consensus in this matter was never 
reached, despite its increasing relevance. In the wake of the global liberalization of the 
practice of (medical) aid in dying, questions surrounding futility of treatment for some 
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patients with a lifelong history of SPMI, however, have regained topicality: Under which 
circumstances (if ever) should patients with SPMI have a right to seek assistance in 
dying? 
(Medical) Assistance in Dying 
The question whether the practice of (medical) assistance in dying ([M]AID)1 
should ever be available for severely mentally ill patients is one of the most fiercely 
debated topics in contemporary psychiatry ethics. Switzerland is among the few countries 
where patients with SPMI can legally request assistance in dying. As a result, a small but 
increasing (Steck, Junker, & Zwahlen, 2018) number of SPMI patients die every year 
with the help of right-to-die organizations (RTDOs). Yet, as the empirical work within 
this PhD project and previous investigation have shown, only a minority of the psychiatric 
community in Switzerland is supportive of this practice (Brauer, Bolliger, & Strub, 2015). 
Psychiatry is an extraordinary area of tension when it comes to respecting autonomous 
wishes of patients potentially leading to their deaths. Indeed, there is a longstanding 
public health priority of preventing suicide rather than assisting it (WHO, 2000). This is 
not surprising, since evidence suggests that more than 85 percent of persons who die by 
suicide have a diagnosable mental illness (Arsenault-Lapierre, Kim, & Turecki, 2004; 
Nock, Hwang, Sampson, & Kessler, 2010). The predominant viewpoint in psychiatry is 
therefore that suicide is pathological and must be prevented. In contrast to severely 
physically ill patients, patients with severe mental illness are generally excluded from 
what has been called a rational suicide (Hewitt, 2013). Reservations over the capacity of 
SPMI patients with regard to (M)AID, as well as the high risk of false positives due to 
prognostic and diagnostic uncertainty, have led a majority of the psychiatrists to fiercely 
reject (M)AID based on the suffering from an SPMI. However, there seems to be an 
unspoken consensus that at least some patients suffering from SPMIs such as TRD may 
still be competent to make their own treatment decisions (Schuklenk & van de Vathorst, 
2015b). By acknowledging that such patients may sometimes suffer as unbearably as 
severely physically ill patients, a rather strong argument for allowing these patients to 
                                               
1 There is no consensus on terminology regarding assisted suicide. In this thesis, 
the term (medical) assistance in dying ([M]AID) is used, while in the published chapters, 
the originally chosen terms are left unchanged. 
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modify treatment in a life-limiting manner or request assisted suicide is made. Proponents 
therefore argue that excluding patients with mental illness from the rational suicide debate 
is unfairly discriminating (Schuklenk, 2015). But how, if at all, should psychiatrists 
interact with patients who wish to end their lives, even if death other than by suicide 
(unlike in, for example, some SEAN patients) is not imminent? 
 
Research Objectives 
In light of the considerations above, the original research performed during this 
PhD project aimed at exploring the attitudes of clinicians (psychiatrists) with regard to 
the treatment of SPMI patients with a very low chance of recovery, poor quality of life, 
and acute or latent risk of dying. The papers are arranged in two thematically differently 
oriented sections.  
Paper section I is concerned with the acceptability and suitability of PC 
approaches in the context of SPMI. The section contains three papers. The first paper 
reports on results from the survey on attitudes of psychiatrists practicing in Switzerland 
on the topic. Participating physicians were asked to respond to statements surrounding 
goals of care for SPMI patients, as well as questions regarding the conceptualization of 
SPMI, particularly in relation to fatality and futility. The goal of the survey was to get a 
sense of how palliative care and other controversial concepts such as death and futility 
are accepted by the respondents and to what degree they view them as suitable in order 
to improve care for SPMI patients. In the light of the absence of any clinical framework 
on how to value treatment goals for this group of patients or treatment guidelines, this 
seemed an important stepping stone before further pondering on the topic in papers two 
and three. Paper two is a book chapter summarizing the debate surrounding PC 
approaches and their suitability in the treatment of SPMI. Paper three is a theoretical 
contribution addressing ethical implications of palliative sedation in the context of SPMI.  
Paper section II is concerned with the practice of (M)AID in the context of SPMI. 
It was decided to clearly distinguish between PC approaches and (M)AID. The first paper 
reports on the results of the above-mentioned survey regarding acceptability and support 
for the practice of (M)AID at both a general level and for the case vignettes presented in 
the introduction specifically. The second paper of this section is a letter to the editor 
published as a response to a report on a study on Dutch data with regard to (M)AID and 
euthanasia.   
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| Section I: Suitability of Palliative Care 
Approaches  
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Abstract 
Background. Some patients develop severe and persistent mental illness (SPMI) 
which is therapy-refractory. The needs of these patients sometimes remain unmet by 
therapeutic interventions and they are at high risk of receiving care that is inconsistent 
with their life goals. Scholarly discourse has recently begun to address the suitability of 
palliative care approaches targeting at enhancing quality of life for these patients, but 
remains to be developed. 
Method. A cross-sectional survey asked 1311 German-speaking psychiatrists in 
Switzerland (the total number of German-speaking members of the Swiss Society for 
Psychiatry and Psychotherapy) about the care of SPMI patients in general, and about 
palliative care approaches in particular. 457 (34.9%) returned the completed survey. In 
addition, participants were asked to evaluate three case vignettes of patients with SPMI. 
Results. The reduction of suffering and maintaining daily life functioning of the 
patient were rated as considerably more important in the treatment of SPMI than impeding 
suicide and curing the underlying illness. There was broad agreement that SPMI can be 
terminal (93.7%), and that curative approaches may sometimes be futile (e.g. 72.4% for 
the anorexia nervosa case vignette). Furthermore, more than 75% of the participating 
psychiatrists were in favour of palliative care approaches for SPMI. 
Conclusions. The results of the present study suggest that the participating 
psychiatrists in Switzerland regard certain forms of SPMI as posing high risk of death. 
Additionally, a majority of respondents consider palliative care approaches appropriate 
for this vulnerable group of patients. However, the generalizability of the results to all 
psychiatrists in Switzerland or other mental health professionals involved in the care of 
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SPMI is limited. This limitation is important considering the reservations towards 
palliative care in the context of psychiatric illness, mainly because of the association with 
death and futility. Palliative care approaches, however, are applicable in conjunction with 
other therapies intended to prolong life. A next step could be to involve service users and 
develop a consensus of what palliative care might encompass in SPMI. A framework for 
identifying which patients might benefit from palliative care, should be explored for the 
future development of care for SPMI patients. 
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Introduction 
According to the World Health Organization: 
Palliative care is an approach that improves the quality of life of patients and their 
families facing the problem associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and 
spiritual. (WHO, 2014).  
Based on this broad definition, some psychiatric interventions may be considered 
palliative, as they aim primarily to enhance quality of life by means of adequate symptom 
control and by focusing on disability rather than on curing the illness (Trachsel et al., 
2016b). However, palliative care as a deliberate approach has not been widely 
implemented in mental healthcare, and its tools have not been deployed in psychiatric 
practice. Its relevance in the treatment of certain severe and persistent mental illness 
(SPMI) such as severe and persistent depression, schizophrenia and anorexia nervosa has 
only recently been suggested (Berk et al., 2012, 2008; Lopez, Yager, & Feinstein, 2009; 
Trachsel et al., 2016b; Trachsel, Wild, Biller-Andorno, & Krones, 2015). Studies have 
consistently shown higher mortality among patients with SPMI (Reininghaus et al., 2015; 
Walker, McGee, & Druss, 2015), who die 10 to 20 years earlier on average than persons 
in the general population (Colton & Manderscheid, 2006; Olfson, Gerhard, Huang, 
Crystal, & Stroup, 2015). At the same time, a large body of research has focused on ultra-
high risk and prodromal paradigms, representing a clear emphasis on early interventions 
at the cost of the development of adequate psychosocial care for patients in later stages 
of the disease (Appelbaum, 2017; Van Os & Guloksuz, 2017). Although full remission 
or recovery is the primary goal of acute psychiatric treatment, a substantial number of 
patients diagnosed with a major depressive disorder are resistant to evidence-based 
treatments, including treatments for chronic depression such as electro-convulsive 
therapy (Lima et al., 2013) or ketamine infusion (Andrade, 2017), and remission rates 
decrease with each additional treatment trial (Rush et al., 2006). In cases of schizophrenia, 
about one fifth of all patients show little or no therapeutic response and exhibit increased 
susceptibility to several life-threatening comorbidities (Kennedy, Altar, Taylor, Degtiar, 
& Hornberger, 2014). For these patients, evidence-based illness-modifying approaches 
are unavailable or remain ineffective, leading to low quality of life and frequent use of 
healthcare services (Berk et al., 2008). The contentious scholarly discourse surrounding 
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the application of palliative care approaches centres on the futility debate and is often 
linked to anecdotal reports, usually in the context of severe anorexia nervosa (Berk et al., 
2008; Bruni & Weijer, 2015; Geppert, 2015; Lopez et al., 2009; McKinney, 2015; 
Trachsel et al., 2015; Trauer, 2012; Yager, 2015). In these circumstances, there is a risk 
that palliative care approaches in psychiatry may be perceived as inevitably intertwined 
with ‘giving up’ and losing hope rather than as complementary to recovery-oriented 
models (Anthony, 1993) for specific cases of SPMI. However, it is important to 
acknowledge that additional experimental treatment trials (e.g. low yield, higher risk 
polypharmacy) can sometimes leave patients more demoralized as they are caught in a 
cycle of false hope (Berk et al., 2008). For patients with a low probability of a favourable 
treatment outcome, it is therefore important to develop a modern concept of supportive 
care that does not ignore or trivialise the catastrophic effect some mental illnesses can 
have. Such approaches should focus on a psychosocial support system that goes beyond 
the traditional mindset of psychiatric care. The acceptability of certain palliative care 
approaches for severe and persistent mentally ill patients whose needs cannot be met by 
contemporary therapeutic interventions, however, is unclear. Since psychiatrists are the 
main decision makers when it comes to SPMI patients, it is crucial to initially explore the 
extent of acceptance of palliative care approaches in treating SPMI patients. We therefore 
asked practicing physicians with a specialist training in psychiatry (hereinafter: 
psychiatrists) to evaluate the suitability of such approaches. The main research questions 
concerned whether psychiatrists in Switzerland considered palliative care approaches to 
be appropriate for SPMI in general and for certain diagnostic groups in particular, and 
how they evaluated futility in specific cases. Additionally, we were interested in the 
prioritization of common treatment goals in cases of SPMI, such as everyday functioning 
and the reduction of suffering. 
Methods 
A quantitative cross-sectional survey was conducted in cooperation with the Swiss 
Society for Psychiatry and Psychotherapy (SSPP), in accordance with the ethical review 
processes of the University of Zurich and the checklist for the ethical evaluation of 
empirical studies.  
Sample 
The sample comprised all German-speaking members of the SSPP who are 
practicing psychiatrists (n = 1311), corresponding to approximately 30 percent of 
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psychiatrists in Switzerland. About 70 percent of psychiatrists in Switzerland are either 
French- or Italian-speaking or are not SSPP members. The rationale for sampling solely 
from members of the SSPP lies in the fact that in Switzerland, reliable contact information 
of physicians is only available in cooperation with relevant professional organizations 
such as the SSPP in which membership is not mandatory for psychiatrists. The SSPP 
contacted all participants prior to the survey to inform them of its purpose. Data were 
collected in the period February–March 2017. 
Procedure 
All participants received a hard copy of the survey with an enclosed prepaid return 
envelope (paper-pencil format). There was no incentive for participation. Participants also 
received a reminder postcard four weeks later. 
Survey and Case Vignettes 
The cross-sectional survey was based on the research questions. The case 
vignettes drew on previously published material (Baweja & Singareddy, 2013; Brenner 
et al., 1990; Trachsel et al., 2015) and were adapted to suit the format and goal of the 
survey (see Table 3). The content of survey items and case vignettes was revised by an 
advisory group that included experts and trainees in psychiatric practice and/or research, 
as well as biostatisticians. Participants were asked to respond to 18 items on a 7-point 
Likert scale, ranging from completely disagree (-3) to completely agree (+3), with a 
neutral mid-point (0), or from unimportant (score: 0) to very important (6). (See Table 4 
for all survey items.) Items related to the three case vignettes (7 questions in each) adopted 
the same response format. The total number of items (including case vignettes) was 42. 
The WHO definition of palliative care (World Health Organization (WHO) 2014., 2014) 
was also provided. 
 
Table 3  
Case Vignettes Based on Modified Versions of Previously Published Cases (6,22,23) 
Case 1: 37-year-old female with anorexia nervosa, onset at age 11 
Symptoms: general muscle weakness; loss of bone density; amenorrhea; current weight 
24kg/52 lbs; BMI 9.5 kg/m2; no recent weight gain or stabilization; no acute danger of 
dying, as her body is adapted to being underweight.  
The patient underwent 10 previous inpatient treatments (in both somatic and psychiatric 
hospitals), three of which were in specialized psychiatric institutions. Throughout the 
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course of disease, different intensive psychotherapies have been tried, without success. 
During hospitalizations, the patient underwent several artificial re-feedings, sometimes 
under sedation. The patient now refuses artificial re-feeding and treatment. She states that, 
for years, her life has been focused exclusively on trying to overcome her anorexia, 
leaving her without friends or hobbies. She suffers from the physical symptoms, including 
general muscle weakness and loss in bone density, saying that she would rather die than 
undergo further treatment and wishes to be left in peace. She does not want to be forced 
into eating anymore. Two experts have declared that the patient has decision-making 
capacity to refuse further treatment, with consequent risk of dying. 
 
Case 2: 33-year-old male with schizophrenia, onset at age 17, no significant 
comorbidities  
Positive symptoms: auditory and visual hallucinations, persecutory delusions. Negative 
symptoms: apathy, social withdrawal, poverty of speech (all rated severe).  
Despite long-lasting, high-dose pharmacological treatment (several atypical neuroleptics, 
haloperidol, clozapine and combinations of these), as well as electro-convulsive therapy, 
the patient has never been free from positive or negative symptoms. Multiple 
psychotherapies of various kinds have also failed to stabilize the patient or to improve his 
quality of life. He does not wish to continue assertive community treatment because he 
feels it is too intrusive. While the positive symptoms were more dominant in the first 
years following initial diagnosis, he went on to develop severe negative symptoms, as 
well as aggression and self-injurious behavior such as burning himself with cigarettes. 
The negative symptoms and his strong functional deficits are exacerbated by chronic 
unemployment and inability to live independently, and the patient has no family system. 
His persisting illness has left him completely isolated, with no social contacts and no 
hobbies or interests. Two experts have declared that he possesses decision-making 
capacity in respect of his illness and its treatment.  
 
Case 3: 40-year-old male with major depressive disorder, no significant 
comorbidities  
Symptoms: energy loss, insomnia, fatigue, persistent suicidal ideation over 20 years, 
current acute and concrete suicidal intent. 
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The patient underwent different intensive, evidence-based, long-term psychotherapies, 
including specialized treatment approaches such as CBASP and IPT. His depression was 
not improved either by psychotherapy alone or in combination with adequate treatment 
trials of antidepressants (selective serotonin reuptake inhibitors, tricyclic antidepressants, 
venlafaxine, augmentation with lithium and antipsychotic medications (quetiapine and 
aripiprazole). The patient experienced significant adverse effects with several of the 
medications. Exhausted and as a last resort, he has decided to undergo electro-convulsive 
therapy. However, maintenance electro- convulsive therapy proved equally ineffective in 
preventing the reappearance of suicidal ideation; indeed, the symptoms worsened. The 
patient experiences severe hopelessness and states that his quality of life is very poor, that 
he doesn’t want to deal with his illness anymore, and that he plans to commit suicide in 
the near future. Two experts have declared that he possesses decision-making capacity 
regarding his illness and its treatment.  
 
To examine how psychiatrists would evaluate a patient’s life expectancy, the case 
vignettes included a ‘surprise question’ (‘I would not be surprised if this patient died 
within the next 6 months’; see item S in Table 4). In palliative care, variants of the surprise 
question are often used for patient prognosis near the end of life (White, Kupeli, 
Vickerstaff, & Stone, 2017). The survey included items concerning attitudes to palliative 
sedation and physician-assisted dying for SPMI patients (see items O, P, Q, R, X and Y 
in Table 4). These are reported in a separate article. 
 
Table 4  
Survey Items 
I: Questions on the treatment of patients with severe and persistent mental illness 
(SPMI) 
In the treatment of patients with severe and persistent mental illness (SPMI), how 
important is: 
 
A) curing the illness 
B) reduction of suffering 
C) the patient’s ability to function in daily life 
D) the patient remaining autonomous in their decision making 
E) impeding suicide 
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According to the World Health Organization (WHO), palliative care ‘is an approach 
that improves the quality of life of patients and their families facing the problem 
associated with life-threatening illness, through the prevention and relief of 
suffering by means of early identification and impeccable assessment and treatment 
of pain and other problems, physical, psychosocial and spiritual’. 
How strongly do you agree or disagree with the following. 
 
F) For me, the term ‘palliative’ relates directly to end of life. 
G) For some SPMI patients, palliative care is indicated. 
H) In psychiatry, applying a palliative care model is important in providing optimal 
support for certain patients without a life-limiting medical illness. 
I) In severe, chronic and therapy-refractory anorexia nervosa, a palliative approach 
would be suitable. 
J) In severe, chronic and therapy-refractory schizophrenia, a palliative approach 
would be suitable. 
K) In severe, chronic and therapy-refractory depression, a palliative approach would 
be suitable. 
L) In severe, chronic and therapy-refractory bipolar disorder, a palliative approach 
would be suitable. 
M) In severe, chronic and therapy-refractory substance disorder, a palliative approach 
would be suitable. 
 
How strongly do you agree or disagree with the following. 
 
N) SPMI can be a terminal illness. 
O) Sedation for the reduction of unbearable refractory psychological symptoms is 
justifiable in certain cases of SPMI. 
P) I would generally be willing to perform sedation as mentioned above in ‘O’. 
Q) I generally advocate access to assisted suicide for patients with SPMI. 
R) If physician-assisted suicide was legally permitted for SPMI, I would support my 
patients in seeking this intervention as the physician of record or by referring them 
to another physician. 
 
II: Questions about the three case vignettes 
Please evaluate the case vignettes as below. 
 
S) I would not be surprised if this patient died within the next 6 months. 
T) For this patient, further interventions to cure the anorexia would most likely be 
futile. 
U) In this case, I would be comfortable with a reduction of life expectancy in order 
to increase or maintain quality of life if consistent with the patient’s goals. 
V) In this case, I would accept a temporary decrease in quality of life due to coercive 
measures. 
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W) In this case, I would not proceed against the patient's wishes. 
X) In this case, sedation to reduce an unbearable refractory symptom is reasonable. 
Y) If physician-assisted suicide was legally permitted, I would support this patient if 
this was her explicit and enduring wish, referring her to appropriate care. 
 
Note. Questions S–Y applied to all three case vignettes in Table 3. 
 
Statistical Analysis 
Arithmetic means were calculated for age and work experience, and descriptive 
statistics (percentages) were calculated for gender, as well as for all Likert scale items. In 
order to facilitate readability of the results, Likert scale items were collapsed into three 
categories (1, 2, 3 = agree, 0=neutral, -1, -2, -3 =disagree) in the running text.  
We included 100% of participants and used available-case analysis, i.e., we indicated the 
number of missing cases separately for every question, because the low number of 
missing cases. 
Results 
The survey was mailed to 1311 active members of the SSPP, and 457 surveys 
(34.9%) were returned of which 85% were fully completed. Of the respondents, 58.8% 
were male, and 4.2% did not indicate their gender. This gender distribution reflected the 
total sample of active SSPP members (62.9% male vs. 37.1% female). Mean age was 57.8 
years (SD = .43; 95% confidence interval [CI] = 56.9, 58.6; range 35 - 88, missing n = 
20), and mean work experience was 27.7 years (SD = .44; CI = 26.8, 28.6; missing n = 
23).  
Views on the General Goals of Care in Severe and Persistent Mental Illness 
In relation to treatment goals for SPMI, respondents most frequently rated reduction of 
suffering as either important or very important (ratings of 5 or 6 in 94.1% of responses; 
CI = 91.5%, 95.9%; missing n = 1). This was followed by daily life functioning (ratings 
of 5 or 6 in 90.8% of responses; CI = 87.8%, 93.1%; missing n = 1), autonomy (ratings 
of 5 or 6 in 76.0% of responses; CI = 71.9%, 79.7%; missing n = 3), and impeding suicide 
(ratings of 5 or 6 in 66.1% of responses; CI = 61.6%, 70.3%; missing n = 3). Only 11.0% 
of respondents rated curing the illness as an important goal (ratings of 5 or 6; CI = 8.4%, 
14.2%); a further 49.4% considered this moderately important (ratings of 3 or 4; CI = 
44.8%, 54.1%; missing n = 10). 
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Views on Palliative Care and Its Use in Patients with Severe and Persistent Mental 
Illness 
For 45.4% of respondents, the term ‘palliative’ related directly to end of life (ratings of 
1, 2 or 3; CI = 40.8%, 50.0%); 21.2% remained neutral (rating 0; CI = 17.7%, 25.2%), 
and 33.4% did not relate the term to end of life (ratings of -1, -2 or -3; CI = 29.2%, 37.9%; 
missing n = 5). While 78.2% (CI = 74.1%, 81.8%) of respondents said that palliative care 
approaches were indicated for certain SPMI, 11.2% (CI = 86.3%, 14.5%) remained 
neutral (missing n = 12). Similarly, 75.8% (CI = 71.6%, 79.5%) of respondents thought 
that application of a palliative care model was important in providing optimal support for 
certain patients without a life-limiting illness, and 13.6% (CI = 10.7%, 17.0%) remained 
neutral (missing n = 7). However, 94.5% (CI = 92.0%, 96.2%) of all respondents believed 
that SPMI could be terminal while 4.4% (CI = 2.9%, 6.7%) remained neutral (missing n 
= 4). 
When asked about the application of palliative care approaches to different mental 
disorders, respondents found this most suitable for severe, chronic and therapy-refractory 
schizophrenia (76.28 rating 1, 2 or 3; CI = 72.8%, 80.5%; missing n = 4) and for substance 
disorders (75.3% rating 1, 2 or 3; CI = 71.1%, 79.0%; missing n = 4). Palliative care 
approaches were found almost equally suitable for chronic and therapy refractory 
depression (70.4.7% rating 1, 2 or 3; CI = 66.1%, 74.4%; missing n = 4); bipolar disorder 
(67.8% rating 1, 2 or 3; CI = 63.3%, 72.0%; missing n = 4); and anorexia nervosa (67.7% 
rating 1, 2 or 3; CI = 63.3%, 71.9%; missing n = 5).  
 
ROLE OF PALLIATIVE CARE IN SPMI 37 
 
Note. Psychiatrists’ attitudes to palliative care and severe and persistent mental illness. 
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Note. Psychiatrists’ attitudes to palliative care and severe and persistent mental illness. 
 
Responses to Vignettes  
Anorexia nervosa. A majority of respondents indicated that they would not be 
surprised if the anorexia nervosa patient died within the next 6 months (87.2% rating 1, 2 
or 3, where 3 designated strongly agree; CI = 83.8%, 90.0%; missing n = 3). (For all case 
vignettes, see Table 1). Most respondents agreed that further interventions to cure the 
anorexia nervosa would most likely be futile (73.1% rating 1, 2 or 3; CI = 68.8%, 77.0%; 
missing n = 4), and 82.3% (CI = 78.5%, 85.5%) indicated that they would be comfortable 
with a reduction in life expectancy in order to increase or maintain quality of life in such 
cases (missing n = 5).  
Schizophrenia. While almost half of respondents indicated that they would not 
be surprised if the patient diagnosed with schizophrenia died within the next 6 months 
(45.1%; CI = 40.9%, 49.3%), more than a quarter remained neutral (26.9% rating 0; CI = 
23.0%, 31.2%) with regard to this item (missing n = 7). A majority agreed that further 
interventions to cure the schizophrenia would most likely be futile (64.8% rating either 
1, 2 or 3; CI = 60.2%, 69.0%; missing n = 9), and 72.8% (CI = 68.5%, 76.7%) indicated 
that they would be comfortable with a reduction of life expectancy in order to increase or 
maintain quality of life (missing n = 9).  
Major depressive disorder. A sizeable majority of respondents indicated that 
they would not be surprised if the patient diagnosed with major depressive disorder died 
within the next 6 months (83.8% rating 1, 2 or 3, where 3 designated strongly agree; CI 
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= 80.1%, 86.9%; missing n = 7). Slightly more than half agreed that further interventions 
to cure the depression would most likely be futile (53.6% rating 1, 2 or 3; CI = 48.9%, 
58.1%; missing n = 7), and 69.3% (CI = 64.9%, 73.4%) indicated that they would be 
comfortable with a reduction of life expectancy in order to increase or maintain quality 
of life (missing n = 7). 
 
 
Note. Summary of psychiatrists’ attitudes to life expectancy, futility and quality of life 
with regard to the three clinical case vignettes. 
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Note. Summary of psychiatrists’ attitudes to life expectancy, futility and quality of life 
with regard to the three clinical case vignettes. 
Discussion 
Acceptability of palliative care approaches in mental health care. In this 
survey of psychiatrists in Switzerland, almost all respondents believed that SPMI can be 
a terminal illness, and that curing the illness has a lower priority than other care goals 
such as reduction of suffering and functioning in daily life. These findings align with 
previous conceptual work which suggested that some existing clinical approaches in 
contemporary psychiatry can be considered palliative because their primary aim is not 
remission or illness modification (Trachsel et al., 2016b). The broad consensus about the 
fatality of certain severe cases of mental illness is particularly noteworthy given the ‘loud 
silence’ with regard to death and dying (other than suicide and its prevention) in mental 
healthcare. Premature mortality is a neglected aspect in mental health care. Accepting it 
as an unchangeable outcome (Ivbijaro, 2017), or completely ignoring it in the 
development of new treatment approaches is harmful to the most vulnerable of all 
patients. It is hoped that by acknowledging that this group of patients is at greater risk of 
dying (Liu et al., 2017), additional resources can be freed up in order to improve the care 
of these patients. In summary, our findings suggest widespread agreement among the 
respondents on the suitability of general palliative care approaches in treating SPMI. One 
issue raised by several participants in the comment section of the survey was the concern 
expressed by some experts about the possible impact of characterising mental health 
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treatments as ‘palliative’, which might be seen to imply ‘giving up’ on patients (Bruni & 
Weijer, 2015; Geppert, 2015; McKinney, 2015; Trauer, 2012, 2012). Indeed, the term 
‘palliative’ may not be ideal, given its associations with terminal illness (Berk et al., 
2008); almost half of our respondents felt that it was closely related to end-of-life care, 
indicating a heterogeneous understanding of palliative care, even among health care 
professionals.  
It is important to stress that the use of palliative care in psychiatry (as in other 
areas of healthcare) need not exclude other treatment approaches. The features of 
palliative care approaches, such as the ongoing alliance with patients and their relatives 
(Berk et al., 2012), exquisite symptom management and pursuit of patient and family 
goals for care and for life in general are, for example, compatible and consistent with the 
principles of the recovery model (Berk et al., 2012). In this sense, palliative care 
approaches may offer psychiatrists additional tools in the care of SPMI, particularly 
where patient needs and goals cannot be met by current psychiatric interventions. 
However, the discomfort about introducing approaches that used to be reserved for a 
terminally ill population in psychiatric treatment of SPMI patients has to be taken 
seriously and has to be critically accompanied scientifically. Specifically, it has to be 
evaluated whether using a less loaded term such as supportive care can improve 
acceptance of the concept. 
With regard to the case vignettes, participants prioritized quality of life over 
patients’ remaining life expectancy, and in all three cases, the great majority doubted that 
further interventions to cure the illness would be successful. This finding aligns with 
conceptual questions concerning the importance of curing SPMI as compared to other 
goals of care such as reduction of suffering and functioning in daily life. The overall 
consensus that curative approaches would most likely be futile in certain specific cases 
of SPMI confirms the need to further explore the concept of medical futility in psychiatry. 
Objections to the applicability of this concept in cases of chronic psychiatric illness are 
multifaceted (Geppert, 2015; Yager, 2015). However, even if one accepts these 
arguments and concludes that the concept is not relevant in the context of mental illness, 
the question remains of how best to deal with the reality of unremitting or progressively 
declining mental illness. In summary, while it could be argued that the recovery-based 
model and the harm reduction approaches already seek to minimize symptoms in acute 
and maintenance phases, we believe that the considerations above have implications that 
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go beyond of what is currently available, especially with regard to futility and last resort 
therapeutic interventions. 
Lack of specificity of the conceptual framework. It seems clear that the 
concepts and framework underpinning palliative care approaches in a psychiatric context 
require further elucidation, including the issue of how specific palliative care 
interventions might be implemented. In particular, advocates need to elaborate how 
palliative care might be applied to psychiatric illness, including the prevention and relief 
of suffering, prevention of futile and burdensome interventions (Trauer, 2012) and 
improvement of quality of life. Any such investigation of the feasibility of specific 
palliative care interventions lies beyond the scope of the present study. It should also be 
noted that the WHO definition of palliative care provided in the survey (see Table 4) was 
described by several respondents as vague and applicable to many (if not all) forms of 
psychiatric treatment. The high variability in the results might be one indication for a lack 
of consensus on what palliative care approaches in this context would comprise. This 
aspect hast to be taken into consideration when interpreting the data, and it will be crucial 
to develop a minimum consensus regarding the definition of palliative care approaches in 
order to further develop this area. 
Strengths and Limitations 
The present study has a number of strengths. Previously, palliative care 
approaches in psychiatry have been discussed mainly at a conceptual level by ethicists 
and experienced clinicians. We are aware of only one other study that tackles the topic 
empirically through qualitative interviews (McGrath, Koilparampil, Koshy, & George, 
2009), focusing on commonalities between contemporary mental healthcare and 
palliative care philosophies. It is argued here that the similarities between mental health 
services and palliative care principles can serve as a foundation for integrating these 
approaches into mental health services. 
The present study is the first survey to use quantitative methods to explore mental 
health professionals’ attitudes to the treatment of SPMI patients in general, and to the use 
of certain palliative care approaches in particular. In light of the controversy surrounding 
that discussion, this insight is an important first step towards establishing the relevance 
of the palliative care concept in mental health care.  
The study also has several limitations. Although Likert scale items are an accepted 
means of conducting quantitative surveys, the options offered can only approximate 
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complex multidimensional concepts. In assembling the study’s advisory group, our 
rationale was to include on the one hand persons who were able to advise us with relevant 
knowledge on the research questions and the content of the survey including experts and 
trainees in psychiatry, psychology, and palliative care, and on the other hand, 
professionals with regard to survey design issues and statistics (psychologist and 
biostatistician). However, it’s a limitation that no other stakeholders such as patients, 
family, or policy makers have been part of the advisory board. The present evidence 
depends on only 457 completed surveys. This corresponds to about 10 percent of 
psychiatrists in Switzerland. In addition, the sample was confined to German-speaking 
members of the SSPP and may not be representative for all psychiatrists practicing in 
Switzerland. Furthermore, the results are not generalizable to other mental health care 
professionals who might be involved in the care of patients with SPMI such as nurses and 
psychologists. The nonresponse rate raises the possibility of response bias. It might be 
possible that psychiatrists with particular pre-existing normative beliefs were 
disproportionally represented. However, the demographics correspond to the total of all 
psychiatrists in Switzerland and the results have a high variability, suggesting a minor 
impact of the response bias on our data. Lastly, it is important to note that an available 
case analysis was used in order to minimize loss of data.  
Lastly, it is important to note that an available case analysis was used in order to 
minimize loss of data but that the known disadvantages of this, e.g., that the standard of 
errors computed by most software packages uses the average sample size across analyses, 
do not apply for our study because we haven’t used inferential statistics and used available 
cases for SD’s and confidence intervals as well. 
Implications for Clinical Practice 
The present findings indicate that many psychiatrists—at least in Switzerland—consider 
that palliative care approaches may be suitable for certain cases of SPMI. For clinical 
practice, this means that palliative care represents a possible option in the treatment of 
SPMI patients and the psychiatric profession’s readiness to introduce some of these tools 
to clinical care. To explore this option, the psychiatric profession must design a 
framework for use and a common language for the field, and must subsequently create an 
evidence base capturing the impact on clinical outcomes for SPMI patients. Most 
importantly, palliative approaches must be seen as an addition to rather than a 
replacement for other novel and promising person-centred approaches, such as the 
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recovery movement (Anthony, 1993; Berk et al., 2012). It remains open whether the term 
‘palliative’ will have majority appeal or whether palliative care principles will merely 
inform a modern concept of psychosocial support for SPMI patients. 
Future Research 
While this study offers some insight into how the surveyed psychiatrists appraise the 
implementation of palliative care approaches in mental healthcare, it is mainly to be 
interpreted as a starting point of the discussion. It remains unclear how the concept might 
be assessed by affected patients, and the specifics of palliative care interventions remain 
to be defined. The next step will be to develop a framework for differential indication—
that is, to identify which patients would qualify for or benefit from a palliative care 
approach. It will be crucial for further development to adequately involve patients and 
put their needs first. 
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Palliative Care in der Behandlung von schweren chronischen psychischen 
Störungen 
Book chapter in “Ethik in der psychiatrischen Praxis – Prinzipien – Werte – Tugenden”, 
Christian Prüter-Schwarte, Euphrosyne Gouzoulis-Mayfrank, Pabst: Köln. 
Manuel Trachsel & Martina A. Hodel 
Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, 
Switzerland 
Palliative Care - Reorientierung der Behandlungsziele mit Fokus auf die 
Lebensqualität 
Das Lindern von Leiden und der zentrale Fokus auf die Lebensqualität schwer 
kranker Menschen bilden zentrale Pfeiler der Palliative Care. Palliative Care hat ihren 
Ursprung zwar in der modernen Hospizbewegung (Saunders, 2001), umfasst aber heute 
wesentlich mehr als reine Sterbebegleitung. Laut der World Health Organization (WHO) 
entspricht "Palliative Care einer Haltung und Behandlung, welche die Lebensqualität von 
Patienten und ihren Angehörigen verbessern soll, wenn eine lebensbedrohliche Krankheit 
vorliegt. Sie erreicht dies, indem Schmerzen und andere physische, psychosoziale und 
spirituelle Probleme frühzeitig und aktiv identifiziert, immer wieder erfasst und 
angemessen behandelt werden" (World Health Organization (WHO) 2014., 2014). 
Palliative Care umfasst also sowohl medizinische als auch pflegerische und 
psychologische Interventionen sowie die Koordination und Kommunikation zwischen 
den verschiedenen involvierten Akteuren in der Fürsorge für Patientinnen mit 
lebensbedrohlichen Krankheiten (Morrison & Meier, 2004). Mit der oben zitierten 
neuesten Definition weitet die WHO das Konzept der Palliative Care im Vergleich zu 
früheren Definitionen auch auf Erkrankungen aus, die (noch) nicht im terminalen Stadium 
sind. Zeitgenössische Palliative Care versteht sich als heilungsorientierten Ansätzen nicht 
direkt gegenübergestellt, sondern wird auch parallel zu kurativen Interventionen 
angewandt. Dabei hat sie primär zum Ziel, Symptome zu lindern und die Lebensqualität 
der Patientinnen zu erhalten oder zu verbessern. Die zahlreichen positiven Effekte von 
Palliative Care für lebensbedrohlich erkrankte Patientinnen und deren Angehörige 
führten in den letzten Jahren zu einer stetigen Ausweitung ihres Anwendungsfeldes 
(Hughes & Smith, 2014). Der Bedarf nach Palliative Care wird auch in Zukunft, im 
Rahmen des demographischen Wandels und dem häufigeren Auftreten von chronischen 
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Krankheiten, zunehmen (Sachs, Shega, & Cox-Hayley, 2004). Längst wird Palliative 
Care nicht mehr nur im Rahmen onkologischer Erkrankungen angewandt, sondern auch 
in der Pflege und Fürsorge von Personen mit Demenz und anderen chronisch und 
lebensbedrohlich erkrankten Patientinnen als zentral angesehen (Baker, 2005). Auch 
psychiatrische Fachpersonen sind in der modernen Palliative Care zahlreich vertreten und 
leisten dort einen wichtigen Beitrag, um den komplexen und vielseitigen Bedürfnissen 
lebensbedrohlich kranker Patientinnen gerecht zu werde (Chochinov & Breitbart, 2009), 
z. B. in der Psychoonkologie. Obwohl von verschiedenen Seiten argumentiert wird, dass 
Palliative Care und die Psychiatrie eine ähnliche Grundhaltung teilen (Berk et al., 2012), 
gibt es in der Psychiatrie bis dato keine explizit als palliativ bezeichneten Ansätze. Der 
Diskurs, ob und wie Palliative Care auch bei schweren und chronischen psychischen 
Störungen positive Effekte auf Symptome und Lebensqualität haben könnte und ob einige 
psychiatrische Interventionen de facto palliativer Natur sind (Trachsel et al., 2016b), wird 
erst seit Kurzem geführt. 
Das Konzept der Medical Futility und dessen Rolle bei psychischen Störungen 
Die Relevanz von Palliative Care im psychiatrischen Kontext wurde erstmals im 
Zusammenhang mit der Debatte um die sogenannte Medical Futility (nachfolgend 
Futility) genannt (Lopez et al., 2009). Futility ist ein in der somatischen Medizin 
etabliertes Konzept und lässt sich sinngemäß mit medizinischer Aussichtslosigkeit 
übersetzen. Konkret wird der Begriff Futility dann verwendet, wenn eine bestimmte 
medizinische Intervention bei Patientinnen als potentiell ineffektiv angesehen wird, eine 
Verbesserung der medizinischen Situation herbeizuführen. In der Psychiatrie wurde 
Futility bisher primär im Zusammenhang mit an schwersten Anorexien erkrankten 
Patientinnen diskutiert, die sich aufgrund ihrer psychischen Störung in einer 
lebensbedrohlichen Situation befinden (Bruni & Weijer, 2015; Geppert, 2015; Lopez et 
al., 2009; McKinney, 2015; Trachsel et al., 2015; Yager, 2015). Lopez, Yager und 
Feinstein (2009) haben anhand einer klinischen Fallvignette Kriterien beschrieben, unter 
denen das Futility-Konzept und im weiteren Verlauf Palliative Care bei psychischen 
Störungen eine Rolle spielen könnte. 
Bei der beschriebenen 30-jährigen Patientin wurde im Alter von 19 Jahren eine 
Anorexia nervosa diagnostiziert. Zahlreiche Behandlungsversuche – unter anderem eine 
stationäre Behandlung über zwei Jahre und mehrere Jahre in einer ambulanten 
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Tagesklinik – scheiterten mit dem Ziel, den Zustand der Patientin zu verbessern oder 
zumindest zu stabilisieren. Zum beschriebenen Zeitpunkt hatte die Patientin einen Body 
Maß Index von 10.9 und wurde aufgrund eines lebensbedrohlichen Sturzes gegen ihren 
Willen hospitalisiert. Das staatliche Krankenhaus, in welchem sie hospitalisiert war, 
sowie eine spezialisierte Therapieeinrichtung für Langzeitpatientinnen mit Essstörungen 
weigerten sich jedoch, die Patientin nach Stabilisierung gegen ihren Willen aufzunehmen. 
Aufgrund der prekären, lebensbedrohlichen Situation in der sich die Patientin befand, 
wurden sämtliche Experten konsultiert, die sich über die letzten zehn Jahre intensiv mit 
der Patientin beschäftigt hatten. Die Anorexia nervosa der Patientin wurde unter den 
gegenwärtig zur Verfügung stehenden Behandlungsoptionen einstimmig als 
therapieresistent beurteilt. Die Patientin erfüllte zudem laut Rechtsexperten des 
Krankenhauses die zentralen Kriterien der Selbstbestimmungsfähigkeit2 und hatte somit 
grundsätzlich das Recht, eine weiterführende Behandlung abzulehnen. Vom 
behandelnden Team wurde anschließend entschieden, dass eine weiterführende kurative 
Therapie inklusive notwendiger unfreiwilliger Klinikeinweisung und Zwangsbehandlung 
mit höchster Wahrscheinlichkeit zu keiner Verbesserung des klinischen Zustandes der 
Patientin führen würde und somit aussichtslos (futile) wäre. Die Autoren sahen den 
Wechsel zu einer palliativ orientierten, primär symptomlindernden Behandlung in diesem 
Fall als einzige ethisch vertretbare und würdevolle Alternative zu einem intrusiven, 
paternalistischen Vorgehen. Eine solche Anwendung des Futility-Konzeptes bei Patienten 
mit schweren chronischen psychischen Störungen ist jedoch nicht unumstritten (Bruni & 
Weijer, 2015; Geppert, 2015; McKinney, 2015). Die Vorbehalte sind vielschichtig: 
Einerseits wird argumentiert, dass gerade im Falle von Patientinnen mit Anorexie nervosa 
nicht von einer Therapieresistenz im eigentlichen Sinne die Rede sein kann, sondern dass 
es sich in solchen Fällen um eine Ablehnung einer Intervention handelt, die für die 
Patientin lebensrettend wäre (Geppert, 2015). Diese Situation ist ethisch besonders 
anspruchsvoll, wenn zusätzlich noch Zweifel an der Selbstbestimmungsfähigkeit der 
Patientin bestehen, welche die lebensrettende Therapie ablehnt. So ist es gerade bei 
Patientinnen mit schweren Essstörungen, jedoch auch bei anderen psychischen 
Störungen, schwierig zu beurteilen, inwiefern eine Ablehnung der Therapie auf fehlender 
                                               
2 Die entsprechenden Rechtsbegriffe lauten Einwilligungsfähigkeit in 
Deutschland respektive Urteilsfähigkeit in der Schweiz. 
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Krankheitseinsicht oder anderen krankheitsbedingten Symptomen basiert; bei 
Essstörungen basiert die Therapieablehnung z. B. auch oft auf einer irrationalen Angst 
vor dem Zunehmen und der dahinter liegenden Körperschemastörung. Es bleibt aber auch 
hier zu beachten, dass Behandlungsentscheidungen grundsätzlich keineswegs vernünftig 
sein müssen, sondern lediglich den Willen der Patientin abbilden sollen. Im geschilderten 
Fallbeispiel war es der Patientin laut den Autoren nicht möglich, die Konsequenzen der 
Ablehnung einer lebenserhaltenden Therapie zu antizipieren. Sie glaubte bis zum Schluss 
nicht daran, dass sie bei einem Therapieverzicht (in diesem Fall einer Einweisung und 
Ernährung mit Magensonde) sterben würde (Geppert, 2015; Lopez et al., 2009). Es bleibt 
unklar, wie in einem solchen Fall die Ziele der Patientin zu würdigen sind, da diese 
offensichtlich auf falschen Grundannahmen in Bezug auf ihre Erkrankung basieren. 
Vorbehalte bezüglich der Selbstbestimmungsfähigkeit schwerst psychisch erkrankter 
Personen sind denn auch das Hauptargument gegen eine Anwendung des Futility-
Konzeptes und gegen die Initiierung von Palliative Care bei Patienten mit schweren 
chronischen psychischen Störungen, welche eine weitere kurative Behandlung ablehnen. 
Palliative Psychiatrie – ein sinnvolles neues Konzept? 
Der Diskurs rund um die Anwendung von Palliative Care in der Psychiatrie ist 
ähnlich kontrovers wie die Diskussion über das Futility-Konzept bei psychischen 
Störungen (Berk et al., 2012; Geppert, 2015; McGorry, 2005; Trauer, 2012). Es wurde 
argumentiert, dass Palliative Care in der Psychiatrie kein Anwendungsfeld habe, da der 
Begriff zu stark mit dem Lebensende verknüpft sei und dass den Patientinnen damit 
Hoffnungslosigkeit suggeriert werde (Trauer, 2012). Die Prinzipien der Palliative Care 
würden direkt mit anderen patientenzentrierten Ansätzen in der Psychiatrie wie 
beispielsweise der Recovery Bewegung konkurrieren (Trauer, 2012). 
Andererseits wurde hervorgehoben, dass Palliative Care und Psychiatrie von ähnlichen 
Grundannahmen und -haltungen ausgehen und darum eine gute Basis dafür bestehe, 
Palliative Care in der Psychiatrie anzuwenden (McGrath et al., 2009). Tatsächlich pflegen 
sowohl die Palliative Care als auch die Psychiatrie eine patientenzentrierte und 
systemorientierte Praxis, betonen die Wichtigkeit der therapeutischen Beziehung und 
arbeiten in multidisziplinären Teams. Trachsel, Irwin, Biller-Andorno, Hoff und Riese 
(2016) haben die mögliche Bandbreite eines palliativen Ansatzes in der Psychiatrie 
(Palliative Psychiatrie) konzeptuell ausgearbeitet: Obschon viele psychiatrische 
Interventionen keine primär kurative Absicht haben, sehen die Autoren die Rolle von 
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Palliative Care vor allem bei schwerst psychisch erkrankten Patientinnen wie 
beispielsweise schwersten Schizophrenien und Anorexien. Ausgehend von Fällen wie 
dem oben beschriebenen, könnte ein Fokuswechsel von aggressiv-kurativ hin zu 
stützend-palliativ eine sowohl aus klinischer als auch aus ethischer Sicht wertvolle Option 
in der Behandlung von schwerst psychisch erkrankten Patientinnen sein (Berk et al., 
2012; Lopez et al., 2009; McGorry, 2005; Trachsel et al., n.d., 2016b, 2015; Yager, 
2015).Dabei ist es nicht von Relevanz, ob gewisse Patientinnen mit psychischen 
Störungen als terminal krank bezeichnet werden, da palliative Ansätze per definitionem 
unabhängig von der verbleibenden Lebenszeit angewendet werden können (World Health 
Organization (WHO) 2014., 2014). Laut Trachsel und Kollegen (2016) würde sich eine 
Palliative Psychiatrie dadurch auszeichnen, dass sie Unterstützung im Coping und der 
Akzeptanz von Symptomen bietet, beispielsweise in Form von Akzeptanz- und 
Commitment-Therapie (Hayes, Luoma, Bond, Masuda, & Lillis, 2006). Zudem würden 
physiologische, psychologische, soziale und spirituelle Aspekte explizit in die 
Behandlung integriert und ein breites Supportsystem gewährleistet, das die Bedürfnisse 
der Patientinnen und ihrer Angehörigen so gut wie möglich aufnimmt und zufrieden stellt. 
Dabei hat ein palliativer Ansatz nicht primär eine Lebensverlängerung zum Ziel, sondern 
vielmehr die Lebensqualität der Patientinnen (Chochinov & Breitbart, 2009). Die 
Schweizerische Akademie der Medizinischen Wissenschaften sieht in einer Integration 
von palliativen Ansätzen in der Psychiatrie sogar das Potential, das Suizidrisiko bei der 
besonders vulnerablen Patientengruppe von chronisch psychisch erkrankten Patientinnen 
zu senken. Sie schreibt in ihren medizin-ethischen Richtlinien zu Palliative Care 
Folgendes:  
Viele psychiatrische Leiden können chronisch verlaufen oder sind durch häufige 
Rezidive charakterisiert. Umso wichtiger ist in solchen Fällen ein palliativer 
Ansatz, der nicht in erster Linie das Bekämpfen der Krankheit zum Ziel hat, 
sondern den bestmöglichen Umgang mit der Symptomatik oder Behinderung. Oft 
kann die Lebensqualität verbessert und das Suizidrisiko gesenkt werden, wenn 
zusätzlich zu kurativen bzw. störungsorientierten Behandlungen eine palliative 
Unterstützung und Zuwendung stattfindet. (SAMW, 2017). 
Schlussfolgerungen 
Nicht nur im Rahmen der allgemeinen Suizidprävention, sondern auch im Zuge 
der zunehmenden Liberalisierung der Gesetze zur Sterbehilfe und dem erleichterten 
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Zugang zu assistiertem Suizid auch für nicht terminal Kranke, stellt sich die Frage, welche 
Optionen psychiatrische Fachpersonen Menschen bieten können, die aufgrund einer 
schweren und chronischen psychischen Störung eine sehr geringe Lebensqualität haben 
und die ihr Leben aufgrund ihres großen Leidens als nicht mehr lebenswert erachten. 
Palliative Ansätze könnten gerade in solchen Fällen eine Alternative zu aggressiven und 
ineffektiven Interventionen mit kurativer Intention darstellen und Autonomie stärkend 
sowie Selbstwert und Würde erhaltend wirken. Ein klarer Fokus auf die Lebensqualität 
und ein individuell an die Werte und Ziele der Patienten angepasster Behandlungsplan 
könnte umgekehrt dazu führen, dass seitens der Patienten weniger Frustration und 
Hilflosigkeit entsteht. 
Es bleibt offen, inwiefern Palliative Care künftig Einzug in die psychiatrische 
Praxis findet. Eine schweizer Studie zeigt, dass sich eine Mehrheit der befragten 
Fachärztinnen für Psychiatrie und Psychotherapie offen gegenüber einer Integration von 
palliativen Ansätzen in die Psychiatrie und ebenfalls eine Mehrheit sieht bei gewissen 
schwerst psychisch erkrankten Patientinnen die Indikation für Palliative Care als gegeben 
an (Trachsel et al., n.d.). Wie genau solche Interventionen aussehen sollten und welche 
Patientengruppen mit welchen psychischen Störungen von Palliative Care besonders 
profitieren könnten, muss jedoch noch ausgearbeitet werden. Dabei wird es von 
besonderer Wichtigkeit sein, ein solches Konzept zusammen mit Patientinnen und 
Angehörigen zu entwickeln. Keinesfalls sollten palliative Ansätze in der Psychiatrie 
Hoffnungslosigkeit suggerieren oder stigmatisierend wirken. Prinzipien der Palliative 
Care sollten auch parallel zu kurativen Ansätzen berücksichtigt werden können und eine 
Alternative für diejenigen Patienten bieten, denen das traditionelle psychiatrische 
Versorgungssystem nicht gerecht werden kann. 
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Abstract 
Palliative sedation is a widely accepted medical practice in end-of-life care when goals 
shift from prolonging life toward primarily providing comfort care and quality of life. 
Although widespread, the practice remains controversial, particularly where non-physical 
symptoms are decisive for its application. The present article explores the problematic 
entanglement of closeness to death and intolerable suffering and the questionable 
distinction between physical and non-physical symptoms leading to intolerable suffering. 
Discussion has recently begun around the potential role of palliative approaches for 
treatment-refractory mental disorders, and euthanasia and physician-assisted dying on the 
basis of treatment-refractory mental disorders is now a reality in several European 
countries. In this context, if it is accepted that intolerable suffering can result from both 
physical and non-physical symptoms, there is a weighty argument in favor of palliative 
sedation for the relief of intolerable suffering from treatment-refractory mental disorders. 
 
Keywords. Palliative sedation, terminal sedation, treatment-refractory mental disorder, 
palliative care, intolerable suffering, decision-making capacity 
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Concept of Palliative Sedation and Traditional Indications 
Palliative sedation is a widely accepted medical procedure in end-of-life care 
when the goals of care shift from a focus on prolonging life toward primarily providing 
comfort care and quality of life (Gurschick, Mayer, & Hanson, 2015; Veterans Health 
Administration National Ethics Committee, 2007). Although palliative sedation is a far-
reaching intervention that not only reduces the patients’ suffering but may sometimes 
extend beyond that (depending on the depth of sedation) to every conscious experience, 
there is seemingly wide consensus that palliative sedation is an ethically acceptable 
intervention to relieve intolerable suffering in the dying patient that cannot be otherwise 
alleviated (Veterans Health Administration National Ethics Committee, 2007). Despite 
wide agreement on the justifiability of palliative sedation in terminally ill patients, 
however, palliative sedation remains a controversial practice, particularly where non-
physical symptoms are of decisive importance (Bruce & Boston, 2011). 
Additionally, there is a striking fuzziness of definition regarding terminology. 
Terms for palliative sedation sometimes (wrongly) used interchangeably include sedation 
to unconsciousness (Levine, 2008), continuous deep sedation (Levine, 2008), and 
terminal sedation (Battin, 2008; Levine, 2008). The term terminal sedation is misleading 
in that it suggests intentional life-shortening (Cassell & Rich, 2010), with connotations 
of inducing death. It seems important to counter that palliative sedation is primarily 
intended to relieve or palliate intolerable suffering that cannot be treated otherwise 
(Gurschick et al., 2015); fostering death is not a primary goal. Continuous deep sedation 
can therefore be justified ethically by the doctrine of double effect (McIntyre, 
2011)6/13/19 2:41:00 PM: following this reasoning, death as an unintended consequence 
remains ethically unproblematic (Boyle, 2004). Because hastening death is not the 
primary goal of palliative sedation other than in cases of misuse—what was sometimes 
called “slow euthanasia” (Broeckaert, 2011)—the term continuous deep palliative 
sedation is therefore more appropriate than terminal sedation. However, there is a risk 
that some physicians abuse palliative sedation to hasten death. This form of “hidden” 
intention for euthanasia is highly problematic from an ethical perspective, but is not a 
subject of this paper. Other risks of palliative sedation involve medical risks such as 
aspiration, pneumonia, problems related to prolonged bed rest, alterations in 
hemodynamic state, problems with artificial nutrition, paradoxical agitation, and of 
course, the loss of the ability to interact (Khader, 2015). 
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There is more or less consensus among experts of palliative sedation that the depth 
of sedation should be induced in proportion to the severity of suffering the patients 
experience, i.e. consciousness should only be reduced to the level necessary to control the 
suffering (Cherny & Radbruch, 2009; Graeff & Dean, 2007; Lo & Rubenfeld, 2005). De 
Graeff and Dean (2007) suggest three levels of palliative sedation: (1) mild: patients are 
awake but the level of consciousness is lowered to somnolence; (2) intermediate: patients 
are asleep but can be woken if needed; and (3) deep: patients are unconscious and in an 
unresponsive comatose state. 
In this article, we attempt to demonstrate that closeness to death is an unsuitable 
criterion for determining the appropriateness of palliative sedation, and that the 
distinction between physical and non-physical symptoms (hereinafter 
psychological/existential suffering) in the context of palliative sedation can be reasonably 
challenged. We further discuss the implications arising for non-terminal, non-somatic 
illnesses, including some treatment-refractory mental disorders, in light of the current 
debate surrounding palliative care approaches and euthanasia or assisted dying for those 
patients. Furthermore, if palliative sedation is justified on the basis of intolerable 
suffering, even if the suffering is primarily of existential or psychological nature, this 
constitutes an argument in favor of (mild and intermediate forms of) palliative sedation 
for patients with treatment refractory mental disorders. 
The Questionable Relevance of Closeness to Death with Regard to Palliative 
Sedation 
In 2008, the Council on Ethical and Judicial Affairs of the American Medical 
Association decided that palliative sedation should only be considered in the final stages 
of terminal illness when death can reasonably be expected within the next few hours or 
days or, at longest, within two weeks (Levine, 2008). Their report argued that palliative 
sedation is disproportionate for patients with a life expectancy of longer than two weeks 
because continued life without consciousness in a form of induced coma is purposeless 
and therefore ethically unacceptable (Levine, 2008). This proposal raises some problems: 
Aside from the reality of high prognostic uncertainty for even the most critically ill 
patients, the conflation of intolerable suffering and proximity to death is problematic. By 
narrowing down the concept of palliative sedation to continuous deep sedation (as implied 
by the report), the distinction between euthanasia and palliative sedation is blurred and 
the important concept of proportionality ultimately jeopardized (Claessens, Menten, 
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Schotsmans, & Broeckaert, 2008). We hold that palliative sedation should not be equated 
with continuous deep sedation and that there are different appropriate levels and durations 
of palliative sedation depending on the condition of the patient (see section on “The 
potential role of palliative sedation for treatment-refractory mental disorders” below). 
A further problematic issue is the definition of intolerable suffering. We hold that 
intolerable suffering is related but not necessarily bound to closeness to death. It follows 
that intolerable suffering as the main prerequisite in deciding for or against palliative 
sedation and simultaneously denying access to palliative sedation to anyone unlikely to 
die within the next 14 days (but suffering intolerably) discriminates unfairly against 
patients with an uncertain or non-terminal prognosis. As Delbeke has put it, “[…] it seems 
strange to allow access to adequate pain management only to dying patients. […] Every 
patient has a right to adequate pain and symptom management and it should not be 
restricted to those with a limited life expectation” (Delbeke, 2013, p. 11). 
Defining Intolerable Suffering 
While exact prognosis raises difficulties, attempts to define intolerable suffering 
are no easier; how the notion of intolerable suffering is to be defined and the patient’s 
role in its determination remains contested (Boston, Bruce, & Schreiber, 2011; 
Schildmann & Schildmann, 2014). These definitional issues are especially relevant 
because while palliative sedation for the alleviation of intolerable physical symptoms is 
widely accepted, it remains controversial whether treatment-refractory psychological or 
existential symptoms with no physical component are sufficient to legitimize palliative 
sedation. It has been argued that intersubjective elements should be taken into account 
when assessing whether a patient’s suffering is intolerable (e.g., what other individuals 
would deem intolerable in a similar situation) (Berghmans, Widdershoven, & 
Widdershoven-Heerding, 2013). However, suffering is ultimately a subjective and private 
experience that can only be appraised by the patient himself (Cassell, 1998), and 
individuals differ in what ‘intolerable suffering’ means to them (Dees et al., 2013; Weide, 
Onwuteaka-Philipsen, & Wal, 2005). It is undisputed, however, that some psychological 
or existential symptoms can be refractory, including anxiety, depression, and existential 
suffering (Cherny & Radbruch, 2009). Making palliative sedation unavailable to these 
patients is to underestimate psychological or existential suffering as less severe than 
physical suffering. If intolerable suffering is a key criterion, it should not matter what 
symptoms underlie that suffering—physical, psychological, or existential. As one of the 
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most influential contributors on the subject of suffering, Eric Cassell wrote that 
“[s]uffering is experienced by persons, not merely by bodies, and has its source in 
challenges that threaten the intactness of the person as a complex social and psychological 
entity. Suffering can include physical pain but is by no means limited to it“ (Cassell, 1998, 
p. 639). In the same way, it can be argued that in exceptional cases, palliative sedation 
may be appropriate not only in cases of physical suffering but also for treatment-
refractory psychological or existential suffering, including such states as anxiety and 
depression (Morita, 2004). A further distinction is sometimes drawn between 
psychological and existential suffering, as when the Council on Ethical and Judicial 
Affairs of the American Medical Association stated that “[s]evere psychological distress 
may also warrant palliative sedation to unconsciousness when potentially treatable mental 
health conditions have been excluded” (Levine, 2008, p. 4). However, the Council 
proposed to deny access to palliative sedation for treatment-refractory existential 
suffering “as the experience of agony and distress that results from living in an unbearable 
state of existence including […] death anxiety, isolation, and loss of control” (Levine, 
2008, p. 4). 
The above argument for distinguishing between psychological suffering and 
existential suffering in the context of palliative sedation is invalid for the same reason that 
it is unsustainable to differentiate between physical and psychological suffering. In this 
regard, it is appropriate to recall the following words from Cassell and Rich: 
When a source of distress, like pain, produces suffering, it is the suffering that 
becomes the central distress not the pain. It is not valid to make a distinction 
between suffering whose source may be physical, such as pain, and suffering 
coming from the threat to the integrity of the person from the very nature of the 
person’s existence. […] It is no longer valid to make a medical distinction between 
the body and the mind or the person and the mind. The mind-body dichotomy 
goes back to antiquity, but is perhaps best known in the form described by Rene 
Descartes, where the body is part of nature and the material world, and the mind 
is the place of the soul and part of the spiritual world of God. The dichotomy has 
been discredited for more than a century but is persistent. For medicine and 
science persons are of a piece, whatever happens to one part happens to all and 
whatever takes place in the whole person has an impact on every single part. There 
is no such thing as a pain or nausea, vomiting, or dyspnea that solely occurs in the 
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body without having an impact on the conscious person. (Cassell & Rich, 2010, 
p. 436) 
In other words, it is of no consequence what kind of symptom leads to the 
treatment-refractory suffering—physical, psychological, or existential—and conceptual 
delimitation is absent (Boston et al., 2011) or appears incidental. Accordingly, the 
American Academy of Hospice and Palliative Medicine and other organizations rightly 
draw no such distinction in their palliative sedation policies (American Academy of 
Hospice and Palliative Medicine. "Statement on palliative sedation," 2013). 
If we accept that psychological or existential suffering can be intolerable in certain cases, 
the question of palliative sedation on the sole basis of psychological or existential 
suffering and/or treatment-refractory mental disorders—that is, without additional 
physical suffering—is just a step away. There is evidence that palliative sedation for some 
non-physical symptoms is not uncommon (Morita, 2004; Muller-Busch, Andres, & 
Jehser, 2003; Van Deijck et al., 2015) but we know of no conceptual or empirical study 
addressing palliative sedation on the grounds of treatment-refractory mental disorders. 
However, discussion has recently begun around palliative care approaches in this context 
(Berk et al., 2012, 2008; Lopez et al., 2009; Trachsel et al., 2016b). 
Palliative Approaches in the Context of Treatment-Refractory Mental Disorders 
It is an inconvenient reality that some patients will, despite best efforts, develop 
treatment-refractory mental disorders such as treatment-refractory major depressive 
disorder, chronic schizophrenia, or severe and enduring anorexia nervosa. For some of 
these patients, no treatment has proved effective, including last-resort approaches such as 
electro-convulsive therapy or ketamine infusions (Andrade, 2017; Lima et al., 2013). 
Although hope is an important ingredient of mental health care, it sometimes reaches its 
limit and may result in demoralizing and frustrating cycles of ineffective treatment 
(Cassell & Rich, 2010). Patients with such treatment-refractory mental disorders are often 
exposed to aggressive or off-label treatments with unfavorable risk-benefit balances 
(Berk et al., 2008). Along with several other scholars, we have suggested that palliative 
care approaches might be considered in the context of exceptional cases of treatment-
refractory mental disorders (Berk et al., 2008; Lopez et al., 2009; Trachsel et al., 2016b). 
This arises when a person’s suffering cannot be otherwise alleviated and when all 
applicable and evidence-based psychopharmacological and psychotherapeutic treatment 
options with primarily curative intent are exhausted and have proved ineffective. We 
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believe that palliative care approaches may offer a complementary alternative when 
treating treatment-refractory mental disorders, improving quality of life for patients and 
their families by preventing or relieving suffering through harm reduction and 
circumvention of burdensome and ineffective interventions (Trachsel et al., 2016b). This 
alternative is driven by a palliative mindset that focuses on short-term quality of life, 
giving less weight to long-term consequences. So, for example, sedating drugs such as 
benzodiazepines may be considered less problematic because less emphasis is placed on 
long-term addiction risk. Besides such relatively mild forms of palliative sedation, there 
exist stronger forms like sedation to unconsciousness. The various forms of palliative 
sedation, their appropriateness and justifiability for patients with treatment-refractory 
mental disorders will be discussed in the next section. 
The Potential Role of Palliative Sedation for Treatment-Refractory Mental 
Disorders 
To our knowledge, palliative sedation in the context of treatment-refractory 
mental disorders has not been discussed in the literature to date. We are aware of only a 
few case studies discussing the justifiability of initiating palliative care for treatment-
refractory mental disorders at the patient’s request, possibly including (but not explicitly 
mentioning) palliative sedation (Lopez et al., 2009; Wang, 2015). Additionally, 
euthanasia and/or assisted suicide on the basis of mental disorder is now legal in several 
European countries and is likely to become more established in the near future. 
Hypothetically, it seems not too farfetched that this group of patients will request deep 
continuous sedation as an appropriate means of alleviating their suffering as a potential 
alternative to euthanasia or assisted dying. As elaborated earlier, it can be argued that 
intolerable suffering may arise from physical or psychological/existential symptoms, or 
both. While this line of reasoning potentially justifies a request for assisted dying 
(Schuklenk & van de Vathorst, 2015a), it can also be deployed when discussing palliative 
sedation for the alleviation of intolerable suffering from symptoms of an underlying 
treatment-refractory mental disorder without the intention to die. In addition, the 
prevailing presumption that certain mental disorders are indicative of a lack of decision-
making capacity – i.e. automatically render a person incompetent – is persistent but 
wrong; there is evidence that although impaired decision-making capacity is common, 
many patients with mental disorders retain capacity (Okai et al., 2007). As for other kinds 
of diseases, for persons with treatment-refractory mental disorders, the appropriate level 
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of sedation would have to be chosen and healthcare professionals need to make sure that 
“the patient is not sedated too lightly (the patient’s experience of suffering must be taken 
away), or too heavily (as warranted by the degree of severity of the symptoms)” (Sterckx, 
Raus, & Mortier, 2013, p. 35). This stepwise model was named proportionate palliative 
sedation (PPS) in contrast to palliative sedation to unconsciousness (PSU) (Holahan, 
Carroll, Gonzalez, & Quill, 2013).
Based on the different levels of sedation mentioned in the introduction section, 
palliative sedation must not always be permanent and deep but can be 
temporary/intermittent and in various depths. For treatment-refractory mental disorders, 
temporary/intermittent either mild (level 1) or intermediate sedation (level 2) seem 
appropriate. These levels would also allow to completely interrupt the palliative sedation 
when the patient improves (Materstvedt & Bosshard, 2009).  
Some authors argue that patients with psychological or existential suffering often get into 
a downward spiral of mutually reinforcing symptoms such as fear, sleeplessness, and 
fatigue which can sometimes be breached by intermittent palliative sedation allowing the 
patients to regain some energy (Cherny & Radbruch, 2009; Graeff & Dean, 2007). It is 
conceivable that similar effects occur in patients suffering from treatment-refractory 
mental disorders. Finally, if sedation is administered with the hope of some therapeutic 
effect, however, it remains questionable whether the term palliative is suitable to describe 
the intervention. 
Conclusion 
In the wake of recent discussion around the role of palliative care approaches for 
treatment-refractory mental disorders, the role of palliative sedation in this context must 
be critically evaluated. If it is acknowledged that (a) the term palliative sedation includes 
mild and intermediate forms of sedation; (b) that proximity to death is (at the least) a 
controversial criterion for determining the appropriateness of palliative sedation and (c) 
palliative sedation is justified on the basis of intolerable suffering, even if the suffering is 
primarily of existential or psychological nature, this constitutes an argument in favor of 
palliative sedation for patients with treatment refractory mental disorders. In the present 
article, we don’t argue for continuous deep sedation for patients with SPMI but only for 
intermittent palliative sedation on a mild or intermediate level. Also these forms of 
sedation can be palliative; palliative sedation must not always be permanent and deep but 
can be temporary/intermittent and in various depths. Nevertheless, continuous deep 
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sedation for patients with SPMI is a difficult ethical issue which should be further 
discussed in the future. 
The ambiguity of definitions surrounding psychological or existential suffering 
must therefore be acknowledged and addressed. Future empirical studies should 
investigate whether palliative sedation is a clinically relevant, feasible, and beneficent 
approach to alleviating intolerable suffering among those with treatment-refractory 
mental disorders that cannot be alleviated by other means. Equally, it seems crucial to 
develop adequate safeguards and validated guidelines to prevent misuse and to protect 
this vulnerable group of patients. 
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Summary of Main Findings: Suitability of Palliative Care Approaches 
Paper 1 
The goals of this paper were: 
• to describe which goals of care the responding psychiatrists view as more 
important than others; 
• to provide insight on the conceptualization and associations with SPMI; 
o Are these patients considered to be in a terminal stage of their disease? 
o Is a curative framework sometimes considered futile? 
• to explore the suitability of palliative care approaches in this context. 
o Do the respondents view palliative care approaches as suitable in the 
treatment of SPMI patients? 
The main finding of the survey among psychiatrists is that palliative care 
approaches are indicated for certain SPMI. The reduction of suffering was rated the most 
important goal in the treatment of this patient group. Impeding suicide, on the other hand, 
was considered an important or very important goal by about 65 percent of all 
respondents, while no more than 10 percent found curing the illness to be an important 
aim in the treatment of SPMI. These results clearly underline the parallels between 
palliative care approaches – where quality of life and reduction of suffering are guiding 
principles – and psychiatric care for chronically ill patients (Trachsel et al., n.d.). 
Furthermore, the results challenge the curative framework that frequently guides 
treatment decisions even in patients that have a very low chance of significant clinical 
improvement (Trachsel et al., n.d.), raising questions regarding the guiding normative 
frameworks in the care of SPMI patients. With regard to the case vignettes, respondents 
equally prioritized quality of life over life prolongation: A vast majority would be 
comfortable with reducing life expectancy in order to maintain or enhance quality of life. 
It is in line with these assumptions that most responding psychiatrists believe that in some 
cases, further curative interventions can be futile and that palliative care approaches might 
be indicated. At the same time, there are limited alternative possibilities for SPMI patients 
(Trachsel et al., n.d.). Accepting that some SPMI can be terminal and that additional 
treatment interventions may sometimes be futile, as well as that the main goal in these 
patients is the relief of suffering, constitutes an ethical argument for the development of 
palliative care approaches.  
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Paper 2 
The goal of this chapter was: 
• to describe the concept of palliative care approaches in the care for patients with 
SPMI. 
In this book chapter, we summarize the discourse surrounding palliative care (PC) 
approaches in the context of SPMI and discuss the concept of medical futility in 
psychiatry. We conclude that an integration of PC approaches is important. This is 
particularly the case in countries where (medical) aid in dying (M)AID is a legal option 
for psychiatric patients. PC approaches may be a feasible alternative option between 
aggressive but ineffective interventions on one hand, and (M)AID on the other hand. An 
important aspect will be to include the patients’ and families’ perspective. 
Paper 3 
The goals of this paper were: 
• to explore the role of palliative sedation in the context of intolerable suffering 
based on non-physical symptoms; 
• to discuss possible ethical implications for SPMI. 
The findings from the survey study discussed above provided a good starting point 
for the theoretical discussion of specific palliative care interventions and their possible 
use in the context of SPMI. In the light of a special issue of Bioethica Forum – Swiss 
Journal of Biomedical Ethics on the topic of palliative sedation (PS), we have explored 
how closeness to death and unbearable suffering present suitable decisive criteria for the 
initiation of PS. We have argued that proximity to death as a criterion for initiation of PS 
is problematic. On the one hand, there is high prognostic uncertainty regarding remaining 
life expectancy even for the most critically ill patients. On the other hand, intolerable 
suffering is not necessarily bound to closeness to death. 
Although the considerations remain on a largely theoretical level, it can be argued 
that if it is accepted that intolerable suffering can result from non-physical symptoms and 
that closeness to death is a problematic criterion for initiation of palliative sedation, there 
is a weighty argument in favor of palliative sedation in the context of SPMI. It should be 
noted that these considerations remain on a largely theoretical level, and may have limited 
clinical relevance. Yet, it seems worthwhile to critically evaluate the role of palliative 
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interventions such as palliative sedation, particularly in the light of increasing access of 
SPMI patients to (M)AID. 
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| Section II: (Medical) Assistance in Dying 
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Attitudes towards Assisted Suicide Requests in the Context of Severe and 
Persistent Mental Illness: A Survey of Psychiatrists in Switzerland 
Article accepted for publication in Palliative & Supportive Care 
Martina A. Hodel1, Paul Hoff, Scott A. Irwin3, Nikola Biller-Andorno,1 Florian Riese4, 
Manuel Trachsel1 
1 Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, 
Switzerland; 2 Psychiatric Hospital Zurich, Zurich, Switzerland; 3 Cedars-Sinai Medical 
Center, Los Angeles, CA; 4 Psychiatric University Zurich, Division of Psychiatry 
Research and Psychogeriatric Medicine, Zurich, Switzerland Hospital. 
Abstract 
Objective. Switzerland is among the few countries worldwide where a request for 
assisted suicide (AS) can be granted on the basis of a primary psychiatric diagnosis. 
Psychiatrists play an increasingly important role in this regard, especially when the 
request for AS arises in the context of suffering caused by severe and persistent mental 
illness (SPMI). The objective of the survey was to assess general attitudes among 
psychiatrists in Switzerland regarding AS requests from patients with SPMI. 
Methods. In a cross-sectional survey of 1311 German-speaking psychiatrists in 
Switzerland, participants were asked about their attitude to AS for patients with SPMI, 
based on three case vignettes of patients diagnosed with anorexia nervosa, treatment-
refractory depression, or severe persistent schizophrenia.  
Results. From a final sample of 457 psychiatrists (a response rate of 34.9%) 
whose mean age was 57.8 years, 48.6% of respondents did not support access to AS for 
persons diagnosed with SPMI; 21.2% were neutral, and 29.3% indicated some degree of 
support for access. In relation to the case vignettes, a slightly higher percentage of 
respondents supported the patient’s wish to seek AS: 35.4% for those diagnosed with 
anorexia nervosa; 32.1% for those diagnosed with depression, and 31.4% for those 
diagnosed with schizophrenia. 
Significance of results. While a majority of the responding psychiatrists did not 
support AS for SPMI patients, about a third would have supported the wishes of patients 
in the case vignettes. In light of the increasing number of psychiatric patients seeking AS 
and the continuing liberalization of AS practices, it is important to understand and take 
account of psychiatrists’ perspectives. 
ROLE OF PALLIATIVE CARE IN SPMI 66 
Introduction 
Assisted suicide3 (AS) is now legal in some countries in Europe, in certain U.S. 
states, in Canada and Colombia, and, from 2019, in the Australian state of Victoria (Dyer, 
White, & Rada, 2015; Emanuel, Onwuteaka-Philipsen, Urwin, & Cohen, 2016). 
Traditionally, AS has evolved as a medical intervention, performed by physicians and 
confined to the terminally ill as a means of preventing unnecessary suffering and to 
respect patient autonomy. In Western societies, there is wide support for AS among both 
the public and medical professionals (Emanuel et al., 2016), but the degree of support is 
strongly dependent on the patient group. Specifically, surveys have shown that 
physicians, including psychiatrists, are generally more reluctant if the request for AS is 
based on suffering that relates to mental illness as compared to suffering as a consequence 
of physical illness (Rousseau, Turner, Chochinov, Enns, & Sareen, 2017; Bolt, 
Snijdewind, Willems, Heide, & Onwuteaka-Philipsen, 2015; Brauer et al., 2015; 
Kouwenhoven et al., 2013). AS on the basis of a mental illness is legal in only a few 
jurisdictions and remains highly controversial (Miller & Appelbaum, 2018; 
Vandenberghe, 2018; Appelbaum, 2016; S. Kim & Lemmens, 2016; Schuklenk & van de 
Vathorst, 2015b). However, the number of persons granted access to AS for a psychiatric 
disorder is increasing. In the Netherlands, 13 cases were reported in 2011, increasing to 
60 in 2016 and 83 in 2017 (Regional euthanasia review committees, 2017). In the absence 
of a reporting system in Switzerland, there is a lack of information about cases of 
psychiatric AS. However, cases of AS are known to have increased since 2008, with an 
absolute increase in non-terminal patients seeking AS (Steck et al., 2018). The Swiss 
model differs significantly from other approaches in a number of ways (see Box 1). 
Internationally, Switzerland is the only country whose legal framework requires neither 
a terminal (somatic) condition for patients requesting AS nor a specific role for physicians 
in the request process. Instead, the physician’s involvement is confined to assessing 
decision-making capacity (DMC) and prescribing the lethal drug, with no further legal 
                                               
3 In the course of legalization and depending on prevailing concepts, established 
terms differ; these include assisted suicide and (medically) assisted dying. While aware 
of the controversy surrounding these different terms, the term assisted suicide is used 
here because it is commonplace in Switzerland. 
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regulations governing access and procedure (Gamondi, Borasio, Oliver, Preston, & Sheila 
Payne, 2017; Ziegler & Bosshard, 2007). In practice, non-governmental “right-to-die” 
organizations (RTDOs) evaluate, coordinate, and respond to AS requests (Ziegler, 2009; 
Ziegler & Bosshard, 2007). RTDOs define internal guidelines that specify necessary 
preconditions and procedural requirements, including whether requests can be made on 
the basis of suffering related to mental illness (Ziegler & Bosshard, 2007). Criticism 
notwithstanding, the Swiss model has been described as de-medicalizing AS and 
resolving some ethical dilemmas commonly faced by medical professionals (Ziegler, 
2009). Until now, AS in Switzerland has ostensibly been treated as a political and public 
concern rather than a medical one. Nevertheless, many of Switzerland’s hospitals, nursing 
homes, hospices, and other institutions involved in the care of seriously ill patients 
encounter AS requests. Some institutions have begun to develop their own internal 
guidelines for refusing or allowing AS in their wards (Harding, 2005; Tuffs, 2007). In 
cases where suffering caused by mental illness is the primary reason for requesting AS, 
psychiatrists and other mental health care staff are likely to be involved. In Switzerland, 
only one study to date has explored physicians’ support for AS in different medical 
scenarios, including dementia and mental illness that is refractory, chronic and severe 
(Brauer et al., 2015). That study was commissioned by the Swiss Academy of Medical 
Sciences (SAMS) to obtain an overview of physicians’ views on AS and to inform new 
medical-ethical guidelines for “Management of dying and death” (Swiss Academy of 
Medical Sciences (SAMS), 2018). In the survey, 28% of all responding physicians 
supported the principle of AS while 22% were clearly opposed. About 40% of 
respondents believed that physicians should be allowed to perform AS (Brauer et al., 
2015). While the survey sheds some light on the attitudes of physicians practicing in 
Switzerland, the low response rate of 34.9% and the wide variation of respondents from 
different professional specialties serve to limit the generalizability of the results. In 
addition, SAMS has recently revised its guidelines on physician-assisted suicide. The 
new guidelines propose circumstances in which physician-assisted suicide may be 
ethically justifiable but notably refrain from including terminal illness as a criterion for 
AS (Swiss Academy of Medical Sciences (SAMS), 2018). The present study explores 
psychiatrists’ general attitudes to AS in the context of SPMI, with reference to three 
clinical scenarios presented as case vignettes. 
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Table 5  
The Swiss Model  
  
Research Questions 
To determine the attitudes of physicians with specialist training in psychiatry to 
AS requests from patients with SPMI and, specifically, their willingness to support a 
patient’s decision to make such a request, two research questions were asked: (1) whether 
German-speaking psychiatrists in Switzerland support the possibility of AS in patients 
with SPMI in general, and (2) whether they would be willing to play an active role in AS. 
Additionally, the participants were asked to evaluate three case vignettes: a patient with 
severe and enduring anorexia (vignette 1); a patient diagnosed with treatment-resistant 
depression (vignette 2); and a patient suffering from severe persistent schizophrenia 
(vignette 3). The third research question asked (3) whether their support would differ for 
the patients in the three case vignettes. 
Regulated by the Swiss Criminal Code, Article 115 on “Inciting and assisting suicide” 
“Any person who for selfish motives incites or assists another to commit or attempt to commit 
suicide is, if that other person thereafter commits or attempts to commit suicide, liable to a 
custodial sentence not exceeding five years or to a monetary penalty” 
Features 
• no further regulations regarding content (e.g. eligibility criteria for AS) or formalities 
(e.g. procedural measures) 
• no formal role for physicians 
Right-to-die organizations 
While everyone can legally assist someone in dying/suicide (unless guided by selfish 
motives), in practice, non-governmental right-to-die organizations evaluate, coordinate and 
respond to requests. They formulate their own guidelines and access to AS based on their 
personnel’s assessment of a specific case. 
Role of doctors  
• assessment of decision-making capacity (need not necessarily be psychiatrists) 
• prescription of the lethal drug 
• Medical-ethical guidelines (not binding until incorporated into the Code of the Swiss 
Medical Association FMH) of the Swiss Academy of Medical Sciences set out ethical 
principles and offer guidance for physicians and nurses 
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Methods 
The quantitative cross-sectional survey was conducted in cooperation with the 
Swiss Society for Psychiatry and Psychotherapy (SSPP), based on a previously reported 
protocol (Trachsel et al., n.d.). The study fell outside the scope of the Swiss Human 
Research Act (HRA) (Swiss Federal Council, 2014) because no personal data related to 
human diseases or the structure or function of the human body were collected. However, 
the study was assessed according to the Checklist for the ethical evaluation of empirical 
studies that do not need mandatory authorization (CEBES); No. CEBES-2016-04. 
Participants’ identities were anonymized, and the study was non-interventional in nature. 
All participants received a copy of the survey by mail with an enclosed prepaid return 
envelope, followed four weeks later by a postcard reminder.  
Sample 
The total sample (n = 1311) included all German-speaking members of the Swiss 
Society of Psychiatry and Psychotherapy (SSPP), corresponding to approximately 30% 
of psychiatrists in Switzerland. Data were collected during the period February–March 
2016. 
Survey and Case Vignettes 
This article reports 5 of 42 items targeting different aspects of care for SPMI patients, 
with particular reference to the suitability of palliative care approaches for this group of 
patients (Trachsel et al., n.d.). (See Table 4 for all survey items.) The two subsets of items 
(palliative care approaches and assisted suicide in the context of SPMI) are purposefully 
reported separately, as they relate to two distinct topics. Participants were asked to 
respond to the statements on a 7-point Likert scale, ranging from completely disagree (-
3) to completely agree (+3), with mid-point neutral (0). The case vignettes have 
previously been published in other contexts (Trachsel et al., 2015; Brenner et al., 1990; 
Baweja & Singareddy, 2013) and were adapted to suit the purpose and format of the 
survey. (See Table 3 for the case vignettes.) Participants also had the option to make 
additional comments in a ‘General Comments’ section; any such comments were 
translated into English. 
Statistical Analysis 
Arithmetic means were calculated for age and work experience, and descriptive 
statistics (percentages) were calculated for gender, as well as for the Likert scale items. 
IBM SPSS Statistics 24 was used to perform the analysis. 
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Patient and Public Involvement 
Because the goal of the study was to investigate the attitudes of psychiatrists, there 
was no direct patient involvement in the survey’s development. However, the survey 
design was informed by studies involving patients (as in the case vignettes). An advisory 
board of experts from psychiatry, psychology, and palliative care was involved in all steps 
of the study, and further research from the patient perspective is planned. 
Results 
Sample characteristics. The response rate was 34.9% (457 of 1311 recipients). 
Respondents’ mean age was 57.8 years; 37% were female, and 4.2% did not indicate their 
gender. The gender distribution reflected the total sample of active SSPP members 
(62.9% male vs. 37.1% female). Mean work experience was 27.7 years (missing n = 23).  
Attitudes towards assisted suicide on the basis of severe and persistent mental 
illness. 
 
Figures 3 and 4 
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Note. Psychiatrists’ attitudes on access to and support for assisted suicide on the basis of 
a mental disorder. 
 
Overall, 48.6% of respondents stated that they did not generally support access to 
AS for persons diagnosed with SPMI (-1, -2 or -3, where -3 designates strongly disagree). 
A further 29.3% stated that they supported access to AS to some degree (1, 2 or 3, where 
3 designates strongly agree) while 21.2% remained neutral (rating 0). (Missing n = 4 or 
0.9%.) There were no differences in age and work experience between those who 
remained neutral and the rest. For detailed results see Figures 3 and 4. 
In total, 55.6% of respondents would not support an AS request from a patient 
with SPMI by writing a psychiatric report or referring them to an RTDO (-1, -2, -3, where 
-3 designates strongly disagree). A further 27.4% would provide support (1, 2 or 3, where 
3 designates strongly agree) while 16.0% remained neutral. (Missing n = 5 or 1.1%.) 
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Responses to vignettes. 
Figure 5 
 
Note. Views of survey respondents by case vignette. 
 
In total, 45.8% of respondents would not support the explicit and enduring wish 
for AS of the patient described in case vignette 1 by referring her to a relevant 
organization (-1, -2 or -3, where -3 designates strongly disagree). In contrast, 35.4% 
would provide support (1, 2 or 3, where 3 designates strongly agree) while 17.5% 
remained neutral. (Missing n = 6 or 1.3%.) 
About half (50.3%) of respondents would not support the explicit and enduring 
wish for AS of the patient described in case vignette 2 by referring him to a relevant 
organization. A further 31.3% would provide support while 16.6% remained neutral. 
(Missing n = 8 or 1.8%). 
Finally, 48.6% of respondents would not support the explicit and enduring wish 
for AS of the patient described in case vignette 3 by referring him to a relevant 
organization. However, 32.1% would provide support, and 17.7% remained neutral. 
(Missing n = 7 or 1.5%). For detailed results see Figure 5.  
Comments section. Anecdotes recorded in the General Comments section of the 
survey indicated that psychiatrists may experience conflicts of interest when confronted 
with an AS request. One respondent wrote: “As a psychiatrist, I would help to abolish my 
own profession if I were to support suicide.” Another respondent stated:  
I would only dare to make an assessment if I had known the patient over a longer 
period of time but not on the basis of a single cross-sectional consultation. 
Generally, I do not support suicide in my position as a treating physician, 
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regardless of my personal stance. Reason: I believe that my own personal 
judgement is dangerous because the patient initially consulted me to improve his 
life. However, the patient has the possibility of being assisted to commit suicide 
independent of me. 
Discussion 
To our knowledge, this is the first study to systematically assess the attitudes of 
psychiatrists working in Switzerland to the practice of AS for psychiatric patients. In light 
of recent developments surrounding AS and psychiatry, this quantitative study makes an 
important contribution to current discourse. 
General support for AS in patients with SPMI. While almost half of the 
respondents opposed access to AS for patients with SPMI, more than a fifth were neutral, 
and 29.3% agreed that patients with SPMI should have access to AS. These results 
correspond to the findings of another study of Swiss physicians of all subspecialties, in 
which about 32% of respondents considered AS to be justifiable for SPMI (Brauer et al., 
2015). That study also revealed that acceptance of AS for psychiatric patients is no higher 
or lower among psychiatrists than among medical providers in general (Brauer et al., 
2015). Similarly, a survey of Canadian psychiatrists’ attitudes to AS in the context of a 
primary psychiatric diagnosis found that 29.4% were supportive, with general support for 
AS in some circumstances (e.g., terminal illness) at 72% (Rousseau et al., 2017). In light 
of current scholarly debate and the multiple objections raised by many experienced 
clinicians, the level of support reported here for AS in patients with SPMI is significant, 
as is the high percentage of neutrals (ranging from 16% to 21.2% for different items). 
Importantly, there were no differences in age and gender between neutrals and the rest. 
Although interpretation of a neutral rating is speculative, it may reflect the ambivalence 
and role conflict currently experienced by psychiatrists in relation to AS (Miller & 
Appelbaum, 2018); indeed, this ambivalence was stressed by some respondents in the 
General Comments section. As several of those comments noted, the practice of AS is 
often thought to conflict with the high priority psychiatry assigns to suicide prevention 
(Hewitt, 2013; Schuklenk & van de Vathorst, 2015a). This is curious, since AS and 
unassisted suicide have traditionally been viewed as distinct phenomena; only recently 
(and solely within psychiatry) have scholars begun to discuss a possible overlap. 
Specifically, it has been argued that psychiatric AS is difficult to distinguish from suicide 
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because of certain shared characteristics, and this may ultimately affect societal 
commitment to suicide prevention (S. Y. H. Kim, Conwell, & Caine, 2018). 
Willingness to provide active support for psychiatric patients seeking AS. Of 
the responding psychiatrists, 27.4% would actively support SPMI patients in the event of 
a concrete AS request—for instance, by writing a psychiatric evaluation or referring the 
patient to an RTDO. Willingness to provide support was even higher for the specific case 
vignettes (35.4% for the patient with anorexia nervosa; 31.4% for the patient with 
schizophrenia; and 32.1% for the patient with depression). These findings contrast with a 
previous qualitative study of palliative care physicians in Switzerland, which found that 
establishing contact with the RTDOs was clearly perceived to be the patient’s 
responsibility (Gamondi et al., 2017).  
Lack of variation within diagnoses. There is evidence that the source of a 
patient’s suffering can determine the physician’s willingness to grant an AS request, and 
that for a majority of physicians, physical symptoms are a prerequisite for “unbearable” 
suffering (Bolt et al., 2015; Van Tol, Rietjens, & van der Heide, 2010; Rietjens, van Tol, 
Schermer, & van der Heide, 2009). To our knowledge, no study to date has investigated 
the variation of physician support for different psychiatric diagnoses. In the present case, 
there was only a small degree of variation in support for the three different patients in the 
case vignettes. This is somewhat surprising, as their prognosis varied, especially in 
relation to fatal outcomes. While all three patients had an increased risk of death (Ivbijaro, 
2017; Laursen, Nordentoft, & Mortensen, 2014), those with anorexia nervosa are known 
to have the highest mortality rate of all mental illnesses (Arcelus et al., 2011). 
Additionally, the case patient suffering from major depressive disorder exhibited concrete 
suicidal intent, making a potential fatal outcome more likely. Interestingly, this did not 
significantly influence the participating psychiatrists’ willingness to support the 
depressed patient in seeking AS, with 32.1% supporting access to some degree. The lack 
of variation in diagnoses may be linked to general underlying attitudes to AS in 
psychiatric patients—that is, the participating psychiatrists either generally approved or 
generally disapproved of the practice as a whole.  
Strengths and Limitations 
The present study has several strengths. It is the first to specifically assess the 
largely unexplored attitudes of psychiatrists to AS in psychiatric patients in Switzerland 
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using quantitative methods. Additionally, the inclusion of distinct case vignettes provides 
a more differentiated picture of psychiatrists’ support for AS in patients with SPMI.  
The study also has several limitations. The non-response rate raises the possibility 
of non-response bias, although respondents’ age and gender correspond to the total 
population of SSPP members. We did not explore other possible confounding variables 
such as sector (e.g., private practice or hospital; adult or geriatric psychiatry) or personal 
experience of AS. As only about 50% of all psychiatrists are members of the SSPP, there 
is a risk of sampling bias; additionally, only German-speaking psychiatrists were 
recruited for this survey, and it is known that attitudes to end-of-life practices differ across 
language regions in Switzerland (Fischer et al., 2006). Nevertheless, our results 
correspond with those from a recent survey of Swiss physicians in all three language 
regions (Italian, French, and German), in which 33% of all respondents tended to support 
AS for patients with SPMI (Brauer et al., 2015). Finally, it is important to stress that 
Likert scale items shed no light on underlying concepts that may have influenced the 
psychiatrists’ responses. Additionally, the decision to include a “neutral” midpoint made 
interpretation more difficult. A neutral response might indicate indecision or 
ambivalence; on the other hand, respondents may have chosen the mid-point because they 
were not sufficiently concerned or engaged. The decision to offer this neutral option was 
deliberate, as we considered it important not to force respondents to take a side in order 
to avoid possible frustration, especially in relation to such a controversial subject. In any 
event, it seems unlikely that respondents would not be sufficiently concerned to adopt a 
clear position, given that AS is a reality of increasing importance in Switzerland. 
Future Directions and Implications for Clinical Practice 
In the few countries where AS on the basis of a primary psychiatric diagnosis is 
legal, the number of patients seeking AS continues to increase (Dierickx, Deliens, Cohen, 
& Chambaere, 2017; S. Kim & Lemmens, 2016). Given the ongoing global liberalization 
of AS practices and the likelihood of psychiatrists’ involvement—especially if the 
suffering relates to a mental illness—it is important to understand and take account of 
psychiatrists’ perspectives. More research (especially qualitative research) is needed in 
order to systematically assess the reasons underpinning psychiatrists’ views. That 
knowledge should in turn inform psychiatrists’ formal training in responding to requests 
and end-of-life issues in general, particularly where AS is a legal option for psychiatric 
patients.  
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In Switzerland, there is a particular urgency to develop a systematic approach to 
AS in order to adequately safeguard vulnerable patients with SPMI. The authors contend 
that psychiatrists who openly endorse the option of AS for some SPMI patients have an 
obligation to remain critical and to accept professional responsibility. To ensure adequate 
safeguards for SPMI patients, it is essential that psychiatrists are involved in the 
evaluation process (e.g., assessment of decision-making capacity and possible 
alternatives). Those psychiatrists who generally refuse access of AS for SPMI must 
remain committed to the care of any of their patients contemplating AS. To abandon any 
patient on the basis of divergent moral beliefs is unethical and ultimately harmful to 
chronically suicidal patients. Refusing to openly discuss the option of AS with SPMI 
patients in a value-neutral environment is clearly counterproductive in caring for suicidal 
SPMI patients. 
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Letter to the Editor 
Letter published in JAMA Psychiatry 
Martina A. Hodel & Manuel Trachsel 
Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, 
Switzerland 
In their recent article in JAMA Psychiatry, Olié and Courtet (2016) took the report 
by Kim and colleagues on euthanasia or assisted suicide (EAS) of psychiatric patients in 
the Netherlands as an occasion to highlight the challenges surrounding the legalization of 
EAS in patients with a psychiatric illness (Scott Kim, Vries, & Peteet, 2016). The present 
contribution comments on their propositions. 
First, Olié and Courtet mention the option of palliative care for terminally ill 
patients as a possible alternative to EAS (Olié E & Courtet P, 2016). We believe that the 
achievements of contemporary palliative care indicate relevance beyond the context of 
terminal somatic illness, for the significant group of people suffering from severe 
persistent mental illness (SPMI). For this group of patients, we advocate a shift towards 
patient-oriented palliative care, centered on the ethical principle of patient self-
determination. Given its focus on empowering people with mental illness, the recovery 
movement is already heading in this direction (Jacobson & Greenley, 2001). However, 
some of those with SPMI may have a long history of failed functional recovery. Their 
suffering may be unbearable and their therapeutic options exhausted. In such specific 
cases, a reorientation of care goals toward symptom relief as the main focus of care—
possibly without modifying the course of the disease—may be a legitimate option. 
Second, the authors mention the possibility of EAS evaluations in the interests of 
suicide prevention. Although suicide prevention has a long history in psychiatry, there 
are potential risks in focusing mainly or exclusively on impeding suicide without taking 
account of the risks of overly aggressive care or even coercion. The severe side effects 
and interactions of polypharmacy, as well as the patient’s (and doctor’s) possible sense 
of failure, may result in an even poorer quality of life for the patient (Berk et al., 2012). 
We agree with Yager5 that hyper-interventionism (especially against the patient’s wishes) 
and treatment excesses are not supportable; and that even patients with partially impaired 
decision-making capacity retain some capacity to make prudent decisions in respect of 
their long-term desires. 
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We are fully aware of the controversy surrounding futility and palliative care for 
patients suffering from SPMI (Berk et al., 2012; Yager, 2015). First and foremost, 
however, we would observe that a palliative approach in psychiatry does not mean giving 
up on a patient but rather involves redefining the goals of care. This entails accepting the 
reality that mental illness can be fatal. With improvements in the quality of care, there 
might be fewer requests for EAS. 
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Summary of Main Findings: (Medical) Assistance in Dying 
Paper 4 
The goals of this paper were: 
• to provide insight into the attitudes of the responding psychiatrists regarding the 
practice of (M)AID in the context of SPMI; 
• to explore their willingness to support patients in their wish to die in the specific 
case vignettes. 
Data from the survey indicate that only a minority (less than 30 percent) of the 
respondents advocate for access to (M)AID on the sole basis of suffering from a mental 
disorder. More than a fifth of all respondents remained neutral (rating ‘0’ on the Likert 
scale), and slightly less than half of the respondents do not generally advocate for access. 
The willingness to support patients in seeking (M)AID was even less strong: More than 
55 percent would not support a patient, e.g., by writing a psychiatric report. In the case 
vignettes, similar figures were obtained. Support was strongest for (M)AID for the patient 
suffering from severe and enduring anorexia nervosa (SEAN) and weakest for the patient 
with treatment-resistant depression (TRD) (35.4 percent and 32.1 percent respectively). 
Most notably, there was considerable variance in the answer pattern, with heavy use of 
the neutral middle-point (‘0’). Support for (M)AID in this sample corresponds with a 
study that questioned physicians of all subspecialties in Switzerland (Brauer et al., 2015), 
and a study of psychiatrists from Canada, where (M)AID is not a legal option (Rousseau 
et al., 2017). In view of the finding that most respondents in the same survey believed 
some forms of SPMI to be terminal and additional curative interventions as sometimes 
futile (Trachsel et al., n.d.), limited support of the concept of (M)AID raises some 
questions regarding remaining alternative options for this group of patients. 
Paper 5 
In this letter, we replied to a previously published article by Olié and Courtet 
(2016). In their comment, Olé and Courtet highlight current challenges surrounding the 
legalization of (M)AID in the context of mental disorders based on data regarding 
(M)AID from the Netherlands (Scott Kim et al., 2016). We argue that contemporary 
palliative care has relevance beyond the context of terminal somatic illness and advocate 
for a shift toward patient-oriented palliative care for SPMI patients whose therapeutic 
options are exhausted. We criticize hyper-interventionism in such patients and stress that 
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chronically mentally ill patients may remain some capacity to make decisions regarding 
their long-term wishes. To improve quality of care for the most severely ill, we argue, a 
redefinition of goals of care may be of great value. 
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| GENERAL DISCUSSION 
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Structure and Aim 
In this final chapter, I first critically evaluate the methodological approach used 
in the survey study. In a second step, I take up the findings from the papers and integrate 
them into a broader ethical debate. I conclude from my original research that the topic of 
death and dying is not sufficiently addressed within mental health care and subsequently 
reflect on the reasons why. 
A focus lies on the concept of autonomy and its special position within psychiatry 
and mental health. Specifically, I address the problem of overriding patient autonomy in 
the context of SPMI. I argue that autonomy in patients with severe and persistent mental 
illness (SPMI) is a more contested issue than in patients with physical illness, despite 
lacking evidence of significant differences regarding incapacity. Furthermore, I 
hypothesize that the professional identity of psychiatrists contributes to a paternalistic 
approach regarding SPMI patients, particularly if they refuse treatment and are at 
increased risk of dying. These factors, I suggest, contribute to the lack of discussion of 
end-of-life options such as palliative care (PC) and (M)AID in psychiatry. The thesis 
concludes with clinical implications resulting from my considerations. Furthermore, I 
present potential research domains suitable for deepening the understanding of patient 
needs in the context of life-threatening forms of SPMI. 
Critical Appraisal of the Survey Conducted Within This PhD Project 
The empirical part of this PhD project was concerned with the development and 
conducting of a survey distributed among German-speaking members of the Swiss 
Society of Psychiatry and Psychotherapy (SSPP). The results from this survey served as 
the basis of subsequent conceptual considerations. While the survey was a first step 
toward the understanding of psychiatrists’ attitudes regarding goals of care for SPMI 
patients, PC approaches, and (M)AID, it certainly had several limitations. 
Survey: Limited Generalizability  
The results from the survey are of descriptive nature. Their generalizability to the 
entire psychiatric community in Switzerland is further confined by several factors: 
First, the nonresponse was beyond 65%. While this nonresponse rate is not 
particularly low for physicians (Cunningham et al., 2015), it is still notable, particularly 
in the context of a rather sensitive and complex topic such as PC and (M)AID in the 
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context of SPMI. However, it is important to note here that no statistical calculations were 
performed, reducing the impact of a potential response bias. 
Second, the study did not include French- and Italian-speaking psychiatrists. The 
language region is known to be a strong determinant of differences in attitudes, 
particularly toward end-of-life decisions (Fischer et al., 2006) and medical end-of life 
practices (Hurst, Zellweger, Bosshard, & Bopp, 2018).  
Third, Likert scale items do not allow profound insights or assumptions as to why 
the respondents answered in a certain way. To gather insight into the diverse concepts 
and thought processes that have led to the detected answer patterns, a more differentiated 
quantitative or a qualitative approach is inevitable. The great utilization of the comments’ 
section further suggests the respondents’ need to further clarify their answers. 
Lack of Specificity of the Conceptual Framework 
As a consequence of the broad definition of palliative care, it has been argued by 
reviewers and respondents alike that almost every psychiatric intervention is: 
An approach that improves the quality of life of patients and their families facing 
the problem associated with life-threatening illness, through the prevention and 
relief of suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual. (WHO, 
2015) 
They further argue that the definitional fuzziness is hampering interpretation of 
the results from the survey. Therefore, critics have argued, what respondents have 
understood of PC approaches, remains unclear. While this certainly limits the conclusions 
that can be drawn from the survey results, it is unlikely that respondents have interpreted 
palliative care as including just any psychiatric intervention with no explicit curative 
intend (e.g. short time management of general distress in anorexia nervosa patients with 
benzodiazepines). Considering the still widespread view of palliative care as being 
applied mainly in an end-of-life context, a very broad interpretation of the term seems 
unlikely.  
Ultimately, the main aim of the empirical research project marking the onset of 
this PhD project was its stepping stone function. With the limited generalizability in mind, 
the goal of the original research from the previous sections was to better describe the 
normative framework psychiatrists use when thinking about SPMI and its treatment. With 
these limitations in mind, some results from the survey remain striking and give cause to 
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critically scrutinize the status quo in psychiatric practice, which is attempted in the 
following sections.  
A Broader Perspective on the Findings 
In the first paper section, the main finding is that the questioned psychiatrists 
believe that the focus for some SPMI patients should lie on relief of suffering and that 
sometimes, a curative framework is inappropriate in the care for SPMI. Additionally, a 
striking majority of respondents agree with describing the course of some SPMI as 
terminal. Based on this initial work, I argue in the theoretical contributions that PC 
inspired principles, focusing on relief of suffering without major therapeutic intent, 
should guide the care for SPMI patients with low chance of recovery and enhanced risk 
of dying prematurely, and that psychiatry faces a strong ethical argument for investing in 
the development of such approaches.  
In the second section, I report on the lacking consensus regarding (M)AID among 
survey respondents and stress the importance that the psychiatric community further 
engages with the topic of (M)AID. Accepting the social reality of (M)AID for SPMI 
patients and systematically addressing questions that arise with (M)AID is of paramount 
importance in order to adequately safeguard for SPMI patients.  
Subsequently, I now explore in more detail why topics such as death and dying, 
PC, and (M)AID are not explicitly subject of discussion within the psychiatric 
community. I thereby focus on issues surrounding the concept of autonomy and 
competency in the context of SPMI, as well as on the professional identity of psychiatrists 
potentially complicating the discourse. Based on the recognition that there is a blind spot 
in mental health care regarding end-of-life options, I begin with a brief reflection on the 
topic of death and dying within mental health care. 
Death and Dying and Psychiatry 
Terms with a connotation of death and dying, such as end-stage, terminal, or 
palliative are, with some exceptions (Campbell & Aulisio, 2012; O’Neill, Crowther, & 
Sampson, 1994; Sommer & Raj, 2017), rarely used in psychiatric language. Considering 
that mental disorders rank among the most substantial causes of death worldwide, with 
an estimate of 14.3 percent of all deaths being attributable to mental disorders (Walker et 
al., 2015), the lack of attention to end-of-life care is difficult to understand. Research 
usually focuses on the seriously physically ill patient with a comorbid psychiatric 
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disorder, rather than on the SPMI patient coping with serious physical illness (McGrath 
& Forrester, 2006). As a result, efforts to engage SPMI patients in end-of-life discussions 
and palliative care are only made in tertiary care, or on cancer and palliative units (Woods, 
Willison, Kington, & Gavin, 2008). There, SPMI patients are at high risk of receiving 
treatment not in line with their values and preferences (Shalev, Brewster, Arbuckle, & 
Levenson, 2017). Despite evidence that SPMI patients are willing and able to voice their 
end-of-life preferences (Elie et al., 2017), their potential end-of-life care needs on the side 
of mental health institutions are largely unknown. The field of palliative care for 
individuals is thus wide open and a call for collaboration between mental health 
institutions and palliative care has been made (Woods et al., 2008). 
 Survey respondents in this project, for their part, have not been averse to 
considering some forms of SPMI as terminal and a significant proportion of respondents 
indicated that they would not be surprised if the patients described in the case vignettes 
died within the next 6 months (more than 80 percent for the patients diagnosed with 
SEAN and TRD respectively, and still 45 percent of all respondents for the patient 
diagnosed with schizophrenia). The surprise question – “Would I be surprised if this 
patient died in the next 6/12 months?” – has been widely used in somatic medicine to 
identify patients who are at risk of death and would possibly benefit from end-of-life care 
and palliative care approaches (White et al., 2017). These answer patterns contrast with 
the predominant framework for treatment of mental disorders. They are also in sharp 
contrast with one of the core arguments against making (M)AID available to persons with 
mental disorders: Within this specific debate, there is general consensus that mental 
disorders are, in general, not terminal (Simpson, 2018).  
 Whether or not one conceptualizes some SPMI as terminal, the expansion of 
(M)AID to patients with mental disorders poses an unprecedented challenge to 
psychiatry. The topic has caused increasing disputes and divisions among professional 
organizations on both an international and national level. Recently, the Swiss Medical 
Association (FMH) has voted against incorporating the revised SAMS medical-ethical 
guidelines on death and dying into their own professional code of conduct (Vögeli, 2018). 
The only controversial issue in the said guidelines was a brief section on prerequisites for 
ethically acceptable physician involvement in assisted suicide (Swiss Academy of 
Medical Sciences (SAMS), 2018, p. 23). In the revised guidelines, the closeness to death 
criterion has been replaced with the criterion of unbearable suffering. The FMH considers 
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the criterion of unbearable suffering as too vague and expansive. This lack of consensus 
regarding the legal possibility and societal reality of psychiatric (M)AID is also reflected 
in our survey. About half of all respondents do not support access to (M)AID for SPMI 
patients, more than a fifth remain neutral and about a third supports access to (M)AID for 
SPMI patients to some degree.  
 In the light of these findings, I contend that the lack of a scientifically driven 
debate about (M)AID within psychiatry as a potential end-of-life option for SPMI patients 
is ultimately harming patients. One potential consequence of the refusal to address the 
(legal) reality of (M)AID is that right-to-die associations (RTDOs) may increasingly 
become a port of call for SPMI patients who encounter the taboo status of the practice of 
(M)AID in psychiatry. 
In the following section, I will look at potential obstacles that prevent mental 
health institutions in general, and clinicians in particular, from adopting end-of-life 
approaches and engaging in a discourse regarding (M)AID. 
Personal Autonomy and Responsibility to Treat 
As indicated in the introduction, one of the key ethical issues in caring for mentally 
ill patients lies in how to balance personal autonomy with the responsibility to treat. In 
contemporary medical care, patients usually direct their care and decide about the 
tolerable level of invasiveness of the care interventions offered to them. This premise of 
modern medicine has been proven to be more challenging in the context of mental illness. 
Frequently, societal interests in protecting others and the interest in the patients’ health 
interfere with the personal autonomy of patients (Sjöstrand & Helgesson, 2008), and a 
paternalist perspective is known to be prevalent in mental health institutions (e.g., Veikko 
Pelto-Piri, Engstörm, & Engström, 2013). Furthermore, many mentally ill patients’ 
autonomy may indeed be affected by their disorder, demanding careful evaluation and 
ethically challenging clinical decision-making. 
If there is little likelihood for the patients to ever improve significantly, as is the 
case for some SPMI patients, clinicians are faced with even more complex ethical 
dilemma. Overriding a patient’s wish becomes increasingly difficult to justify if the 
potential benefit of a forced treatment intervention is highly unlikely (for further 
elaboration, see section on professional fallibility on p. 93). Yet, as was reflected in our 
survey, proceeding against (competent) patients’ wishes by coercive measures is a clinical 
reality. (See Table 6.)  
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Table 6 
Coercive Measures and Patient Autonomy 
In this case, I would accept a temporary decrease in quality of life due to coercive 
measures 
 disagree (%) agree (%) 
Anorexia nervosa 62.1 25.6 
Major depression 47 39.4 
Schizophrenia 44.2 41.1 
 
In this case, I would not proceed against the patients’ wishes 
 disagree (%) agree (%) 
Anorexia nervosa 21.2 66.3 
Major depression 34.1 48.4 
Schizophrenia 36.8 44.2 
Note. From unpublished results by the author. 
 
Even though a majority of respondents would refrain from applying coercive measures, 
a significant percentage of respondents would act against the patients’ articulated wishes, 
despite the patients presumed competence (see case vignette 1 on p. 18: “Two experts have 
declared that the patient has decision-making capacity to refuse further treatment, with 
consequent risk of dying”). For the SEAN patient, for example, this would entail 
compulsory admission and, potentially, force-feeding, since the patient stated that she 
would “rather die than undergo further treatment” and “doesn’t want to be forced into 
eating anymore” (again, see case vignette 1). This unpublished result inevitably raises the 
question why a substantial number of respondents feel comfortable in disregarding the 
patients’ autonomy in such circumstances.  
One option is that they doubt the experts’ assessment that the patients in the case 
vignettes are truly competent in making a (potentially life-limiting) decision. Another 
option is that the respondents’ professional obligations and their self-understanding as 
psychiatrists sufficiently justifies overriding the patients’ wishes. Indeed, there is a 
predominant assumption that experts have the competence to balance the four main 
ethical principles (“autonomy,” “beneficence,” “non-maleficence,” and “justice”) in the 
best interest of the patient (Beauchamp & Childress, 2001; Kendall, 2014). 
Notwithstanding the underlying rationale, proceeding against the patients’ wishes, for 
example by coercive measures, in these cases is extremely problematic from both a legal 
and ethical point of view. 
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As highlighted above, the right to refuse medical treatment is at the core of 
personal autonomy. Yet, beneficent coercion remains highly prevalent in mental health 
institutions, and particularly for SPMI patients with a low probability of improvement 
and at risk of dying. In the next two sections, I discuss potential preconceptions regarding 
autonomy in SPMI patients and how these relate to patients with severe physical illness. 
Moreover, I reflect on the professional identity of psychiatrists and the deriving 
professional duties that may prevent clinicians from discussing end-of-life options with 
their patients. I argue that both aspects deserve close scrutiny in order to honor the 
principle of patient self-determination in the context of SPMI. 
Severe and Persistent Mental Illness and Autonomy 
As has been discussed in the introduction, preconceptions about the competence 
of SPMI patients to make valid end-of-life decisions have been raised particularly in the 
context of medical futility decisions in SEAN patients or access to (M)AID for patients 
with treatment-resistant depression. Although there is a general consensus in modern 
mental healthcare that some SPMI patients retain their competence to make far-reaching 
decisions, the main worry seems to be rooted in the complexity of distinguishing between 
competent and incompetent individuals. This process is inevitably error-prone and the 
consequences potentially far-reaching and irreversible. This risk of false positives for 
many opponents of (M)AID justifies an in-principle exclusion of SPMI patients 
(Schuklenk & van de Vathorst, 2015b).  
Interestingly, such concerns regarding capacity within end-of-life scenarios are 
less prevalent in the context of severely physically ill patients, despite evidence 
suggesting that decision-making capacity for those patients might not differ significantly 
from those of psychiatric patients: A comparative, cross sectional comparison between 
patients admitted to a psychiatric hospital and a medical in-patients at a general hospital 
rendered no differences in prevalence of incapacity (Owen et al., 2013). Moreover, there 
is evidence that decisional capacity in terminally physically ill patients might actually be 
severely impaired (Kolva, Rosenfeld, Brescia, & Comfort, 2014). Yet, this issue has not 
gained much attention up to this point. Additionally, in the context of decision-making 
for a certain intervention, concerns about capacity are typically less prominently 
discussed. Lapid et al. (2013), for example, conclude in their study that severely depressed 
patients can achieve high scores on the MacCAT-T, a clinical tool to assess patients’ 
capacities to make treatment decisions (Grisso, Appelbaum, & Hill-Fotouhi, 1997), 
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indicating that they likely had the capacity to decide about treatment with ECT (Lapid et 
al., 2003). Lima et al (2013) and Miyamoto, Jarskog, & Fleischhacker (2014) entirely 
refrain from discussing the potential risk of impaired decision-making capacity in their 
reviews on ECT therapy use in adolescents with SPMI (Lima et al., 2013; Miyamoto, 
Jarskog, & Fleischhacker, 2014). This phenomenon and the fact that the bars are per 
default set higher for decision-making capacity whenever decisions are made by mentally 
versus physically ill patients stands in need of further discussion. 
That said, it is important to stress that certainly, in many cases, clinicians are 
obliged to override an articulated patient wish. Patients with acute mania, psychosis, or 
suicidal intent obviously lack the capacity to make their own treatment decisions, and 
paternalistic intervention to protect them from harming themselves until their autonomy 
is restored, is not only justified, but also ethically desirable. When it comes to patients 
who have prolonged forms of SPMI, such as the patients described in the case vignettes, 
the presumption of permanently impaired capacity dissolving their autonomy is much 
more difficult to substantiate.  
A Brief Note on Professional Fallibility 
In this context, relatively little attention has been directed toward the potential 
fallibility of professional knowledge with regard to overriding patient wishes and 
involuntary treatment. Yet, considering clinical heterogeneity and high prognostic 
uncertainty associated with many psychiatric disorders, this seems all the more important. 
The interaction between the degree of uncertainty about a potential benefit of a treatment 
and the amount of harm done due to paternalistic measures is ethically highly relevant. 
As mentioned several times above, the more seriously and chronically ill an SPMI patient 
is, the less likely the benefit of an additional treatment. At the same time, due to the high 
stakes (life at risk), patients are more prone to receive the said treatment. To what extent 
an experimental treatment with a limited chance of success can ethically justify overriding 
patient autonomy based on the “best interest principle” requires further investigation. 
Professional Obligations Justifying Overriding Autonomy 
In the following section, I will now address two important professional obligations 
of psychiatrists: the goal of preserving life and the importance of maintaining hope. I 
reflect on how these two core obligations may hinder clinicians in dealing with difficult 
topics arising in their practice.  
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Preserving life: its special role in psychiatry. As mentioned in the beginning, 
suicide prevention is of high significance in psychiatry. There is a general understanding 
that suicide is preventable and that its completion is a failure of the mental health care 
system (Walter & Pridmore, 2012). In the context of the (M)AID debate, many 
psychiatrists have stressed the importance of protecting life (Kelly, 2017) and the 
incompatibility of (M)AID with the “physicians’ professional commitment to preserve 
life and promote health” and “our societal responsibility to prevent suicide and protect 
and care for people with mental illness” (Miller & Appelbaum, 2018). This general 
attitude is represented in the findings from our survey study, where a majority refused the 
concept of (M)AID for SPMI patients, despite accepting that SPMI can be terminal and 
that in some cases, additional (curative) interventions can be futile. 
There is little guidance on how clinicians can work towards suicide prevention 
and at the same time take the death wish of their (potentially competent) patients 
seriously. Yet, if psychiatric practice regarding suicidality remains highly restrictive, 
patients who are seriously considering ending their lives find themselves in the position 
of having to be not entirely truthful with their clinicians at a time when they most need 
emotional support (Yager, Ganzini, Nguyen, & Rapp, 2018). Here, palliative care 
approaches, rather than fostering hopelessness and implying “giving up on a patient,” 
would provide an opportunity for continuing compassionate care despite diverging 
objectives between patients and clinician. While general guidelines on the topic are 
lacking, some authors have given general recommendations on how to interact with 
patients with severe and chronic mental disorders and increased risk of death. Yager 
(2015), for example, believes that in the treatment of SEAN patients, it is important to 
maintain connection, relationship and interest, and to offer comfort care. He suggests to 
avoid judgmental or shaming questions and has no particular therapeutic intent or 
expectations towards the patient. Furthermore, he stresses that patients should have every 
chance, at every point in time, to ask for more help, such as active intervention. (Yager, 
2015). From both the original work conducted during this PhD project as well as abundant 
conversations with experienced clinicians on this topic, I conclude that such suggestions 
have relevance beyond the care for dying SEAN patients. Psychiatrists must be prepared 
to discuss the difficult topic of (M)AID if brought up by their patients. Responding to a 
(M)AID request, however, will always be challenging to the patient-doctor relationship. 
Yet, the treating clinician with an established relationship with the patient, is the 
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appropriate person to sensitively explore the request without taking it at face value. PC 
inspired principles such as connectedness, compassion, respect and dignity towards the 
suffering patients may guide such discussions and similarly ease the moral dilemma 
between protecting the patient’s life and respecting the patients (potentially autonomous) 
wish to die. I argue that being prepared to listen with empathy does not equal giving up, 
and that sufficient training is necessary for clinicians to develop this important skill. 
Maintaining hope: The last resort. The objection that a palliative terminology 
(including terms such as end-stage mental illness, futility, and palliative care) will put 
patients into a passive sick role and therefore minimize the patient’s motivation and will 
has been made (Jäger & Hoff, 2012). In line with this reasoning, assigning SPMI patients 
to later/end stages of a continuum would suggest hopelessness and ultimately reduce 
chances of (personal) recovery (Trauer, 2012). Trauer, in his critique of the staging model 
(including palliative models for later stages of the disorder), has objected: “The potential 
damage done to the expectations of patients (and their families) by them detecting, rightly 
or wrongly, that they have been placed into an ‘incurable’ category, would be most 
unfortunate and difficult to repair” (Trauer, 2012, p. 172) In a similar manner, policies 
aiming at harm reduction (e.g., in the context of alcohol or drug dependence) have been 
criticized as being recovery-hindering by helping patients to “self-harm more safely” 
(Pearce & Pickard, 2010). Yet, while hope certainly is an important ingredient in mental 
health care, it remains unclear what effect a (false) promotion of hope has on some SPMI 
patients with very low chances of recovery. Additionally, there is anecdotal evidence that 
while patients with little experience with mental healthcare prefer optimistic and 
confident psychiatrists, longer-term patients who may have experienced treatment 
failures do not share this preference (Priebe et al., 2017).  
Implications in Practice and Future Research Areas 
Summary of Ethical Considerations 
The disagreement between clinicians and scholars begins with the lack of 
consensus on the language used to describe the group of patients who are chronically ill 
and continuously experience symptoms that have a major negative impact on their life. A 
few years ago, the proposal to adopt the concept of medical futility in psychiatry has 
briefly sparked discussion among clinicians and ethicists. In this context,  
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clinicians and ethicists have stressed the potential risk of characterizing patients as 
incurably ill. Specifically, the consequences of categorizing them as palliative or within 
the end stages of a clinical staging model, some have argued, is harmful and diametrically 
opposed to the professional duties of psychiatrists: preserving life and maintaining hope. 
Others, including us, have argued that the current framework is ill suited to benefit the 
most severely and chronically mentally ill patients. In order to free necessary resources, 
a discussion must be launched about the needs of this (neglected) patient group and how 
they can be addressed by mental health care services. An option is the recognition of 
palliative care approaches as possibly transferable to mental health care services. 
Furthermore, I have discussed the reasons I believe contribute to the loud silence 
regarding death and dying within psychiatry. I argue that preconceptions regarding SPMI 
patients’ autonomy need to be further explored, particularly in view of decision-making 
in severely mentally versus physically ill patients. Furthermore, I discuss aspects relevant 
for the professional identity of psychiatrists, and conclude that the normative framework 
derived from (traditional) professional obligations of psychiatrists clashes with the 
acceptance that some patients reject intrusive interventions against medical advice, and 
that some of these patients may autonomously chose death over living with their SPMI. 
In view of recent developments regarding end-of-life options outside mental health care, 
I hold that psychiatrists must remain open towards discussing (M)AID with their patients. 
Future Research Topics 
 From the original research as well as the subsequent considerations regarding 
factors aggravating patient self-determination of SPMI patients, I now aim at suggesting 
areas of future research. 
 First, the needs of SPMI patients need to be better explored. Questions guiding 
qualitative studies may entail: Where have mental health services proven to be helpful for 
SPMI patients and what has been counterproductive? How are “difficult” topics such as 
irremediableness and death discussed in psychiatric care? Are there institutional barriers 
that prevent patients from getting the care they need in later stages of their disease?  
 Second, a deeper understanding of the framework guiding psychiatrists will be 
helpful in better addressing their concerns and fears regarding the topic of dying, 
autonomy and treatment refusal. A deeper understanding of these issues will be crucial in 
the development of training and guidelines on how to work with (potentially autonomous) 
SPMI patients considering (M)AID. 
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 Third, the usefulness of palliative approaches, focusing on a redirection of goals 
in line with clearly defined patient preferences and values, should be explored as a 
potential alternative in legislations where (M)AID is an option. It needs to be investigated 
how palliative principles could complement recovery-oriented, patient-centered practice 
without competing them. Furthermore, research should aim at further defining how 
palliative care as an integral part of mental health care could look like. Last but not least, 
it has to be explored whether the term palliative indeed is suitable in the context of mental 
health care, or whether a different terminology (e.g. supportive care, as I have previously 
suggested) are less contested and find better acceptance.  
Final Conclusion 
As has been demonstrated throughout this thesis, the clinical reality of unremitting mental 
illness and the social reality of end-of-life options outside the scope of mental health 
institutions for SPMI patients (i.e. [M]AID) requires that more traditional approaches to 
treatment, developed for earlier stages of mental illness, undergo a transformation to 
better fit the needs of those with SPMI. As has been stressed by ourselves and others, the 
worth of palliative approaches needs to be further explored in this context. Endorsing 
end-of-life discussions how we understand them does not equal abandoning patients (as 
has been implied by some scholars within the futility and [M]AID debate), but merely 
entails a redirection of goals of care in line with the patient’s own preferences and values. 
Whether severely mentally ill individuals are capable of deciding about the direction of 
their treatment, including decisions that potentially reduce remaining life expectancy, 
needs to be assessed on a case-to-case basis. Above all, it is essential for the treating team 
to appraise the highly specific and unique circumstances for each SPMI patient when 
making treatment decisions with the patient. 
  
ROLE OF PALLIATIVE CARE IN SPMI 94 
References 
American Academy of Hospice and Palliative Medicine. Statement on palliative 
sedation. (2013). Retrieved from http://aahpm.org/positions/palliative-sedation 
(Accessed on December 25, 2017). 
Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., 
Brookland, R. K., … Winchester, D. P. (2017). The Eighth Edition AJCC 
Cancer Staging Manual: Continuing to build a bridge from a population-based to 
a more “personalized” approach to cancer staging. CA: A Cancer Journal for 
Clinicians, 67(2), 93–99. https://doi.org/10.3322/caac.21388 
Andrade, C. (2017). Ketamine for depression, 4: In what dose, at what rate, by what 
route, for how long, and at what frequency? Journal of Clinical Psychiatry, 
78(7), 852–857. https://doi.org/10.4088/JCP.17f11738 
Anthony, W. A. (1993). Recovery from mental illness: The guiding vision of the mental 
health service system in the 1990s. Psychosocial Rehabilitation Journal, 16(4), 
11. 
Appelbaum, P. S. (2016). Physician-assisted death for patients with mental disorders—
reasons for concern. JAMA Psychiatry, 73(4), 325–326. 
https://doi.org/10.1001/jamapsychiatry.2015.2890 
Appelbaum, P. S. (2017). Who’s afraid of psychiatric genomics? American Journal of 
Bioethics, 17(4), 15–17. https://doi.org/10.1080/15265161.2017.1284937 
Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality rates in patients 
with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. 
Archives of General Psychiatry, 68(7), 724–731. 
https://doi.org/10.1001/archgenpsychiatry.2011.74 
ROLE OF PALLIATIVE CARE IN SPMI 95 
Arsenault-Lapierre, G., Kim, C., & Turecki, G. (2004). Psychiatric diagnoses in 3275 
suicides: A meta-analysis. BMC Psychiatry, 4(1), 37. 
https://doi.org/10.1186/1471-244X-4-37 
Baker, A. (2005). Palliative and end-of-life care in the serious and persistently mentally 
ill population. Journal of the American Psychiatric Nurses Association, 11(5), 
298–303. https://doi.org/10.1177/1078390305282209 
Battin, M. P. (2008). Terminal sedation: Pulling the sheet over our eyes. Hastings 
Center Report, 38(5), 27–30. https://doi.org/10.1353/hcr.0.0057 
Baweja, R., & Singareddy, R. (2013). Concomitant use of maintenance ECT and vagus 
nerve stimulation for more than 10 years in treatment-resistant depression. 
American Journal of Psychiatry, 170(9), 1059–1061. 
https://doi.org/10.1176/appi.ajp.2013.13010125 
Beauchamp, T. L. (2009). The philosophical basis of psychiatric ethics. In Psychiatric 
ethics (4th edition, pp. 25–48). Oxford: Oxford University Press. 
Beauchamp, T. L., & Childress, J. F. (2001). Principles of Biomedical Ethics. Oxford: 
Oxford University Press. 
Berghmans, R., Widdershoven, G., & Widdershoven-Heerding, I. (2013). Physician-
assisted suicide in psychiatry and loss of hope. International Journal of Law and 
Psychiatry, 36(5–6), 436–443. https://doi.org/10.1016/j.ijlp.2013.06.020 
Berk, M., Berk, L., Udina, M., Moylan, S., Stafford, L., Hallam, K., … McGorry, P. D. 
(2012). Palliative models of care for later stages of mental disorder: Maximizing 
recovery, maintaining hope, and building morale. Australian and New Zealand 
Journal of Psychiatry, 46(2), 92–99. https://doi.org/10.1177/0004867411432072 
ROLE OF PALLIATIVE CARE IN SPMI 96 
Berk, M., Singh, A., & Kapczinski, F. (2008). When illness does not get better: Do we 
need a palliative psychiatry? Acta Neuropsychiatrica, 20(3), 165–166. 
https://doi.org/10.1111/j.1601-5215.2008.00309.x 
Bolt, E. E., Snijdewind, M. C., Willems, D. L., Heide, A. van der, & Onwuteaka-
Philipsen, B. D. (2015). Can physicians conceive of performing euthanasia in 
case of psychiatric disease, dementia or being tired of living? Journal of Medical 
Ethics, 41(8), 592–598. https://doi.org/10.1136/medethics-2014-102150 
Boston, P., Bruce, A., & Schreiber, R. (2011). Existential suffering in the palliative care 
setting: An integrated literature review. Journal of Pain and Symptom 
Management, 41(3), 604–618. 
https://doi.org/10.1016/j.jpainsymman.2010.05.010 
Boyle, J. (2004). Medical ethics and double effect: The case of terminal sedation. 
Theoretical Medicine and Bioethics, 25(1), 51–60. 
https://doi.org/10.1023/B:META.0000025096.25317.22 
Brauer, S., Bolliger, C., & Strub, J.-D. (2015). Swiss physicians’ attitudes to assisted 
suicide: A qualitative and quantitative empirical study, 145, 1–8. 
https://doi.org/10.4414/smw.2015.14142 
Brenner, H. D., Dencker, S. J., Goldstein, M. J., Hubbard, J. W., Keegan, D. L., Kruger, 
G., … Midha, K. K. (1990). Defining treatment refractoriness in schizophrenia. 
Schizophrenia Bulletin, 16(4), 551–561. https://doi.org/10.1093/schbul/16.4.551 
Broeckaert, B. (2011). Palliative sedation, physician-assisted suicide, and euthanasia: 
“Same, same but different”? American Journal of Bioethics, 11(6), 62–64. 
https://doi.org/10.1080/15265161.2011.577518 
ROLE OF PALLIATIVE CARE IN SPMI 97 
Bruce, A., & Boston, P. (2011). Relieving existential suffering through palliative 
sedation: Discussion of an uneasy practice. Journal of Advanced Nursing, 
67(12), 2732–2740. https://doi.org/10.1111/j.1365-2648.2011.05711.x 
Bruni, T., & Weijer, C. (2015). A misunderstanding concerning futility. American 
Journal of Bioethics, 15(7), 59–60. 
https://doi.org/10.1080/15265161.2015.1039728 
Campbell, A. T., & Aulisio, M. P. (2012). The stigma of “mental” illness: End stage 
anorexia and treatment refusal. International Journal of Eating Disorders, 45(5), 
627–634. https://doi.org/10.1002/eat.22002 
Cassell, E. J. (1998). The nature of suffering and the goals of medicine. Loss, Grief & 
Care, 8(1–2), 129–142. 
Cassell, E. J., & Rich, B. A. (2010). Intractable end-of-life suffering and the ethics of 
palliative sedation. Pain Medicine, 11(3), 435–438. 
https://doi.org/10.1111/j.1526-4637.2009.00786.x 
Cherny, N. I., & Radbruch, L. (2009). European Association for Palliative Care (EAPC) 
recommended framework for the use of sedation in palliative care. Palliative 
Medicine, 23(7), 581–593. https://doi.org/10.1177/0269216309107024 
Chochinov, H. M., & Breitbart, W. (2009). Handbook of psychiatry in palliative 
medicine. Oxford University Press. 
Claessens, P., Menten, J., Schotsmans, P., & Broeckaert, B. (2008). Palliative sedation: 
A review of the research literature. Journal of Pain and Symptom Management, 
36(3), 310–333. https://doi.org/10.1016/j.jpainsymman.2007.10.004 
Clark, D. (2007). From margins to centre: A review of the history of palliative care in 
cancer. Lancet Oncology, 8(5), 430–438. https://doi.org/10.1016/S1470-
2045(07)70138-9 
ROLE OF PALLIATIVE CARE IN SPMI 98 
Colton, C. W., & Manderscheid, R. W. (2006). Congruencies in increased mortality 
rates, years of potential life lost, and causes of death among public mental health 
clients in eight states. Preventing Chronic Disease, 3(2). Retrieved from 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563985/ 
Conway, C. R., George, M. S., & Sackeim, H. A. (2016). Toward an evidence-based, 
operational definition of treatment-resistant depression: When enough is enough. 
JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2016.2586 
Cosci, F., & Fava, G. A. (2013). Staging of mental disorders: systematic review. 
 Psychotherapy and Psychosomatics, 82(1), 20-34. 
 https://doi.org/10.1159/000342243 
Cunningham, C. T., Quan, H., Hemmelgarn, B., Noseworthy, T., Beck, C. A., Dixon, 
E., … Jetté, N. (2015). Exploring physician specialist response rates to web-
based surveys. BMC Medical Research Methodology, 15(1), 32. 
https://doi.org/10.1186/s12874-015-0016-z 
Currow, D. C., Wheeler, J. L., Glare, P. A., Kaasa, S., & Abernethy, A. P. (2009). A 
framework for generalizability in palliative care. Journal of Pain and Symptom 
Management, 37(3), 373–386. 
https://doi.org/10.1016/j.jpainsymman.2008.03.020 
Dees, M. K., Vernooij-Dassen, M. J., Dekkers, W. J., Elwyn, G., Vissers, K. C., & van 
Weel, C. (2013). Perspectives of decision-making in requests for euthanasia: A 
qualitative research among patients, relatives and treating physicians in the 
Netherlands. Palliative Medicine, 27(1), 27–37. 
https://doi.org/10.1177/0269216312463259 
Delbeke, E. (2013). The legal permissibility of continuous deep sedation at the end of 
life: A comparison of laws and proposal. In Continuous sedation at the end of 
life. Ethical, clinical and legal perspectives (pp. 132–148). Cambridge: 
ROLE OF PALLIATIVE CARE IN SPMI 99 




Dembo, J. S. (2013). Are decisions made ‘in the throes’ of treatment-refractory mental 
illness truly invalid? American Journal of Bioethics, 13(3), 16–18. 
https://doi.org/10.1080/15265161.2012.760677 
Dierickx, S., Deliens, L., Cohen, J., & Chambaere, K. (2017). Euthanasia for people 
with psychiatric disorders or dementia in Belgium: Analysis of officially 
reported cases. BMC Psychiatry, 17. https://doi.org/10.1186/s12888-017-1369-0 
Dyer, O., White, C., & Rada, A. G. (2015). Assisted dying: Law and practice around the 
world. British Medical Journal, 351, h4481. https://doi.org/10.1136/bmj.h4481 
Elie, D., Marino, A., Torres-Platas, S. G., Noohi, S., Semeniuk, T., Segal, M., … Rej, S. 
(2017). End-of-life care preferences in patients with severe and persistent mental 
illness and chronic medical conditions: A comparative cross-sectional study. 
American Journal of Geriatric Psychiatry. 
https://doi.org/10.1016/j.jagp.2017.09.018 
Emanuel, E. J., Onwuteaka-Philipsen, B. D., Urwin, J. W., & Cohen, J. (2016). 
Attitudes and practices of euthanasia and physician-assisted suicide in the 
United States, Canada, and Europe. JAMA, 316(1), 79–90. 
https://doi.org/10.1001/jama.2016.8499 
Fischer, S., Bosshard, G., Faisst, K., Tschopp, A., Fischer, J., Bär, W., & Gutzwiller, F. 
(2006). Swiss doctors’ attitudes towards end-of-life decisions and their 
determinants: A comparison of three language regions. Swiss Medical Weekly, 
136(23–24), 370–376. https://doi.org/2006/23/smw-11260 
ROLE OF PALLIATIVE CARE IN SPMI 100 
Gamondi, C., Borasio, G. D., Oliver, P., Preston, N., & Sheila Payne. (2017). Responses 
to assisted suicide requests: An interview study with Swiss palliative care 
physicians. BMJ Supportive & Palliative Care, 0, 1–9. 
https://doi.org/10.1136/bmjspcare-2016-001291 
Geppert, C. M. A. (2014). Overcoming ethical dilemmas. In D. B. Cooper & J. Cooper 
(Eds.), Palliative care within mental health (1st ed., pp. 19–29). London: 
Radcliffe. 
Geppert, C. M. A. (2015). Futility in chronic anorexia nervosa: A concept whose time 
has not yet come. American Journal of Bioethics, 15(7), 34–43. 
https://doi.org/10.1080/15265161.2015.1039720 
Graeff, A. D., & Dean, M. (2007). Palliative sedation therapy in the last weeks of life: a 
literature review and recommendations for standards. Journal of Palliative 
Medicine, 10(1), 67–85. https://doi.org/10.1089/jpm.2006.0139 
Grisso, T., Appelbaum, P. S., & Hill-Fotouhi, C. (1997). The MacCAT-T: A clinical 
tool to assess patients’ capacities to make treatment decisions. Psychiatric 
Services, 48(11), 1415–1419. https://doi.org/10.1176/ps.48.11.1415 
Gurschick, L., Mayer, D. K., & Hanson, L. C. (2015). Palliative sedation: An analysis 
of international guidelines and position statements. American Journal of 
Hospice and Palliative Medicine, 32(6), 660–671. 
https://doi.org/10.1177/1049909114533002 
Hanratty, B., Hibbert, D., Mair, F., May, C., Ward, C., Corcoran, G., … Litva, A. 
(2006). Doctors’ understanding of palliative care. Palliative Medicine, 20(5), 
493–497. https://doi.org/10.1191/0269216306pm1162oa 
ROLE OF PALLIATIVE CARE IN SPMI 101 
Harding, L. (2005, December 19). Swiss hospital the first to allow assisted suicides. 
Retrieved February 12, 2018, from 
http://www.theguardian.com/society/2005/dec/19/health.medicineandhealth 
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., … 
Möller, H.-J. (2012). World Federation of Societies of Biological Psychiatry 
(WFSBP) guidelines for biological treatment of schizophrenia, part 1: Update 
2012 on the acute treatment of schizophrenia and the management of treatment 
resistance. World Journal of Biological Psychiatry, 13(5), 318–378. 
https://doi.org/10.3109/15622975.2012.696143 
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006). Acceptance 
and commitment therapy: Model, processes and outcomes. Behaviour Research 
and Therapy, 44(1), 1–25. https://doi.org/10.1016/j.brat.2005.06.006 
Hermann, H. (2015). Decision-making capacity: the enigmatic gatekeeper for patients’ 
right to self-determination. University of Zurich, Zurich. 
Hermann, H., Trachsel, M., & Biller-Andorno, N. (2015). Physicians’ personal values 
in determining medical decision-making capacity: A survey study. Journal of 
Medical Ethics, (9), 739–744. https://doi.org/10.1136/medethics-2014-102263 
Hewitt, J. (2013). Why are people with mental illness excluded from the rational suicide 
debate? International Journal of Law and Psychiatry, 36(5–6), 358–365. 
https://doi.org/10.1016/j.ijlp.2013.06.006 
Holahan, T., Carroll, T., Gonzalez, C., & Quill, T. (2013). Palliative sedation, 
consciousness and personhood. In Continuous sedation at the end of life. 
Ethical, clinical and legal perspectives (pp. 202–217). Cambridge: Cambridge 
University Press. 
ROLE OF PALLIATIVE CARE IN SPMI 102 
Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., 
Birnbaum, M. L., … Correll, C. U. (2016). Treatment-resistant schizophrenia: 
Treatment response and resistance in psychosis (TRRIP) working group 
consensus guidelines on diagnosis and terminology. American Journal of 
Psychiatry, 174(3), 216–229. https://doi.org/10.1176/appi.ajp.2016.16050503 
Huas, C., Caille, A., Godart, N., Foulon, C., Pham-Scottez, A., Divac, S., … Falissard, 
B. (2011). Factors predictive of ten-year mortality in severe anorexia nervosa 
patients. Acta Psychiatrica Scandinavica, 123(1), 62–70. 
https://doi.org/10.1111/j.1600-0447.2010.01627.x 
Hughes, M. T., & Smith, T. J. (2014). The growth of palliative care in the United States. 
Annual Review of Public Health, 35(1), 459–475. 
https://doi.org/10.1146/annurev-publhealth-032013-182406 
Hurst, S. A., Zellweger, U., Bosshard, G., & Bopp, M. (2018). Medical end-of-life 
practices in Swiss cultural regions: A death certificate study. BMC Medicine, 
16(1), 54. https://doi.org/10.1186/s12916-018-1043-5 
Ivbijaro, G. (2017). Excess mortality in severe mental disorder: The need for an 
integrated approach. World Psychiatry, 16(1), 48–49. 
https://doi.org/10.1002/wps.20382 
Jacobson, N., & Greenley, D. (2001). What Is recovery? A conceptual model and 
explication. Psychiatric Services, 52(4), 482–485. 
https://doi.org/10.1176/appi.ps.52.4.482 
Jäger, M., & Hoff, P. (2012). Recovery: Conceptual and ethical aspects. Current 
Opinion in Psychiatry, 25(6), 497–502. 
https://doi.org/10.1097/YCO.0b013e328359052f 
ROLE OF PALLIATIVE CARE IN SPMI 103 
Johansson, V., Garwicz, M., Kanje, M., Schouenborg, J., Tingström, A., & Görman, U. 
(2011). Authenticity, depression, and deep brain stimulation. Frontiers in 
Integrative Neuroscience, 5. https://doi.org/10.3389/fnint.2011.00021 
Kane, J. M., & Correll, C. U. (2016). The role of clozapine in treatment-resistant 
schizophrenia. JAMA Psychiatry, 73(3), 187–188. 
https://doi.org/10.1001/jamapsychiatry.2015.2966 
Katzman, D. K., Christensen, B., Young, A. R., & Zipursky, R. B. (2001). Starving the 
brain: Structural abnormalities and cognitive impairment in adolescents with 
anorexia nervosa. Seminars in Clinical Neuropsychiatry, 6(2), 146–152. 
https://doi.org/10.1053/scnp.2001.22263 
Keel, P. K., Dorer, D. J., Eddy, K. T., Franko, D., Charatan, D. L., & Herzog, D. B. 
(2003). Predictors of mortality in eating disorders. Archives of General 
Psychiatry, 60(2), 179. https://doi.org/10.1001/archpsyc.60.2.179 
Kelly, B. D. (2017). Invited commentary on … When unbearable suffering incites 
psychiatric patients to request euthanasia. British Journal of Psychiatry, 211(4), 
248–249. https://doi.org/10.1192/bjp.bp.117.199695 
Kendall, S. (2014). Anorexia nervosa: The diagnosis. Journal of Bioethical Inquiry, 
11(1), 31–40. https://doi.org/10.1007/s11673-013-9496-x 
Kennedy, J. L., Altar, C. A., Taylor, D. L., Degtiar, I., & Hornberger, J. C. (2014). The 
social and economic burden of treatment-resistant schizophrenia: A systematic 
literature review. International Clinical Psychopharmacology, 29(2), 63–76. 
https://doi.org/10.1097/YIC.0b013e32836508e6 
Khader, M. M. (2015). The use of palliative sedation for terminally ill patients: Review 
of the literature and an argumentative essay. Journal of Palliative Care & 
Medicine, 05(04). https://doi.org/10.4172/2165-7386.1000226 
ROLE OF PALLIATIVE CARE IN SPMI 104 
Kim, S., & Lemmens, T. (2016). Should assisted dying for psychiatric disorders be 
legalized in Canada? Canadian Medical Association Journal, 188(14), 337–339. 
https://doi.org/10.1503/cmaj.160365 
Kim, S. Y. H., Conwell, Y., & Caine, E. D. (2018). Suicide and physician-assisted death 
for persons with psychiatric disorders: How much overlap? JAMA Psychiatry, 
75(11), 1099–1100. https://doi.org/10.1001/jamapsychiatry.2018.2065 
Kim, Scott, Vries, R. G. D., & Peteet, J. R. (2016). Euthanasia and assisted suicide of 
patients with psychiatric disorders in the Netherlands 2011 to 2014. JAMA 
Psychiatry, 73(4), 362–368. https://doi.org/10.1001/jamapsychiatry.2015.2887 
Kolva, E., Rosenfeld, B., Brescia, R., & Comfort, C. (2014). Assessing decision-making 
capacity at end of life. General Hospital Psychiatry, 36(4), 392–397. 
https://doi.org/10.1016/j.genhosppsych.2014.02.013 
Kouwenhoven, P. S., Raijmakers, N. J., van Delden, J. J., Rietjens, J. A., Schermer, M. 
H., van Thiel, G. J., … van der Heide, A. (2013). Opinions of health care 
professionals and the public after eight years of euthanasia legislation in the 
Netherlands: A mixed methods approach. Palliative Medicine, 27(3), 273–280. 
https://doi.org/10.1177/0269216312448507 
Lapid, M. I., Rummans, T. A., Poole, K. L., Pankratz, V. S., Maurer, M. S., Rasmussen, 
K. G., … Appelbaum, P. S. (2003). Decisional capacity of severely depressed 
patients requiring electroconvulsive therapy. Journal of ECT, 19(2), 67–72. 
Lauber, C., Nordt, C., Braunschweig, C., & Rössler, W. (2006). Do mental health 
professionals stigmatize their patients? Acta Psychiatrica Scandinavica, 113, 
51–59. https://doi.org/10.1111/j.1600-0447.2005.00718.x 
ROLE OF PALLIATIVE CARE IN SPMI 105 
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014). Excess early mortality in 
schizophrenia. Annual Review of Clinical Psychology, 10(1), 425–448. 
https://doi.org/10.1146/annurev-clinpsy-032813-153657 
Levine, M. (2008). Sedation to unconsciousness in end-of-life care (CEJA Report 5-A-
08). American Medical Association Council on Ethical and Judicial Affairs 
(CEJA). Retrieved from http://www.ama - assn.org/resources/doc/code - 
medical - ethics/2201a.pdf 
Lima, N. N., Nascimento, V. B., Peixoto, J. A., Moreira, M. M., Neto, M. L., Almeida, 
J. C., … Reis, A. O. (2013). Electroconvulsive therapy use in adolescents: A 
systematic review. Annals of General Psychiatry, 12, 17. 
https://doi.org/10.1186/1744-859X-12-17 
Liu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., … Saxena, S. 
(2017). Excess mortality in persons with severe mental disorders: A multilevel 
intervention framework and priorities for clinical practice, policy and research 
agendas. World Psychiatry, 16(1), 30–40. https://doi.org/10.1002/wps.20384 
Lo, B., & Rubenfeld, G. (2005). Palliative sedation in dying patients: “We turn to It 
when everything else hasn’t worked.” JAMA, 294(14), 1810–1816. 
https://doi.org/10.1001/jama.294.14.1810 
Lopez, A., Yager, J., & Feinstein, R. E. (2009). Medical futility and psychiatry: 
Palliative care and hospice care as a last resort in the treatment of refractory 
anorexia nervosa. International Journal of Eating Disorders, 43(4), 372–377. 
https://doi.org/10.1002/eat.20701 
Materstvedt, L. J., & Bosshard, G. (2009). Deep and continuous palliative sedation 
(terminal sedation): clinical-ethical and philosophical aspects. Lancet Oncology, 
10(6), 622–627. https://doi.org/10.1016/S1470-2045(09)70032-4 
ROLE OF PALLIATIVE CARE IN SPMI 106 
McGorry, P. D. (2005). Early intervention in psychotic disorders: Beyond debate to 
solving problems. British Journal of Psychiatry, 187(S48), s108–s110. 
https://doi.org/10.1192/bjp.187.48.s108 
McGorry, P. D., Berk, M., Berk, L., & Goldstone, S. (2012). Commentary on ‘Palliative 
models of care for later stages of mental disorder: Maximising recovery, 
maintaining hope and building morale.’ Australian and New Zealand Journal of 
Psychiatry, 46(3), 276–278. https://doi.org/10.1177/0004867412438009 
McGorry, P. D., Hickie, I. B., Yung, A. R., Pantelis, C., & Jackson, H. J. (2006). 
Clinical staging of psychiatric disorders: A heuristic framework for choosing 
earlier, safer and more effective interventions. Australian and New Zealand 
Journal of Psychiatry, 40(8), 616–622. https://doi.org/10.1080/j.1440-
1614.2006.01860.x 
McGrath, P. D., Koilparampil, T., Koshy, C., & George, S. (2009). Learning from each 
other: Cross-cultural insights on palliative care in Indian and Australian regions. 
International Journal of Palliative Nursing, 15(10), 499-509 11p. 
McGrath, P. D., & Forrester, K. (2006). Ethico-legal issues in relation to end-of-life 
care and institutional mental health. Australian Health Review, 30(3), 286–297. 
https://doi.org/10.1071/ah060286 
McIntyre, A. (2011). Doctrine of double effect. In E. N. Zalta (Ed.), Stanford 
Encyclopedia of Philosophy. Retrieved from 
https://stanford.library.sydney.edu.au/entries/double-effect/ 
McKinney, C. (2015). Is resistance (n)ever futile? A response to “Futility in chronic 
anorexia nervosa: A concept whose time has not yet come” by Cynthia Geppert. 
American Journal of Bioethics, 15(7), 53–54. 
https://doi.org/10.1080/15265161.2015.1042991 
ROLE OF PALLIATIVE CARE IN SPMI 107 
Miller, F. G., & Appelbaum, P. S. (2018). Physician-assisted death for psychiatric 
patients—misguided public policy. New England Journal of Medicine, 378(10), 
883–885. https://doi.org/10.1056/NEJMp1709024 
Minkoff, K. (1987). Resistance of mental health professionals to working with the 
chronic mentally ill. New Directions for Mental Health Services, 1987(33), 3–
20. https://doi.org/10.1002/yd.23319873303 
Miyamoto, S., Jarskog, L. F., & Fleischhacker, W. W. (2014). New therapeutic 
approaches for treatment-resistant schizophrenia: A look to the future. Journal 
of Psychiatric Research, 58, 1–6. 
https://doi.org/10.1016/j.jpsychires.2014.07.001 
Morita, T. (2004). Palliative sedation to relieve psycho-existential suffering of 
terminally ill cancer patients. Journal of Pain and Symptom Management, 28(5), 
445–450. https://doi.org/10.1016/j.jpainsymman.2004.02.017 
Morrison, R. S., & Meier, D. E. (2004). Palliative care. New England Journal of 
Medicine, 350(25), 2582–2590. https://doi.org/10.1056/NEJMcp035232 
Muller-Busch, H. C., Andres, I., & Jehser, T. (2003). Sedation in palliative care–A 
critical analysis of 7 years experience. BMC Palliative Care, 2, 2. 
https://doi.org/10.1186/1472-684X-2-2 
Nock, M. K., Hwang, I., Sampson, N. A., & Kessler, R. C. (2010). Mental disorders, 
comorbidity and suicidal behavior: Results from the national comorbidity survey 
replication. Molecular Psychiatry, 15(8), 868–876. 
https://doi.org/10.1038/mp.2009.29 
Okai, D., Owen, G., Mcguire, H., Singh, S., Churchill, R., & Hotopf, M. (2007). Mental 
capacity in psychiatric patients: Systematic review. British Journal of 
Psychiatry, 191, 291–297. https://doi.org/10.1192/bjp.bp.106.035162 
ROLE OF PALLIATIVE CARE IN SPMI 108 
Olfson, M., Gerhard, T., Huang, C., Crystal, S., & Stroup, T. S. (2015). Premature 
mortality among adults with schizophrenia in the United States. JAMA 
Psychiatry, 72(12), 1172–1181. 
https://doi.org/10.1001/jamapsychiatry.2015.1737 
Olié E, & Courtet P. (2016). The controversial issue of euthanasia in patients with 
psychiatric illness. JAMA, 316(6), 656–657. 
https://doi.org/10.1001/jama.2016.9883 
O’Neill, J., Crowther, T., & Sampson, G. (1994). Anorexia nervosa: Palliative care of 
terminal psychiatric disease. American Journal of Hospice and Palliative 
Medicine, 11(6), 36–38. https://doi.org/10.1177/104990919401100609 
Owen, G. S., Szmukler, G., Richardson, G., David, A. S., Raymont, V., Freyenhagen, 
F., … Hotopf, M. (2013). Decision-making capacity for treatment in psychiatric 
and medical in-patients: Cross-sectional, comparative study. British Journal of 
Psychiatry, 203(6), 461–467. https://doi.org/10.1192/bjp.bp.112.123976 
Pastrana, T., Jünger, S., Ostgathe, C., Elsner, F., & Radbruch, L. (2008). A matter of 
definition–Key elements identified in a discourse analysis of definitions of 
palliative care. Palliative Medicine, 22(3), 222–232. 
https://doi.org/10.1177/0269216308089803 
Payne, S., Sheldon, F., Jarrett, N., Smith, P., Davis, C. L., Turner, P., & George, S. 
(2002). Differences in understanding of specialist palliative care amongst service 
providers and commissioners in South London. Palliative Medicine, 16(5), 395–
402. https://doi.org/10.1191/0269216302pm572oa 
Pearce, S., & Pickard, H. (2010). Finding the will to recover: Philosophical perspectives 
on agency and the sick role. Journal of Medical Ethics, 36(12), 831–833. 
https://doi.org/10.1136/jme.2010.035865 
ROLE OF PALLIATIVE CARE IN SPMI 109 
Pies, R. W. (2015). Anorexia nervosa, “futility,” and category errors. American Journal 
of Bioethics, 15(7), 44–46. https://doi.org/10.1080/15265161.2015.1039734 
Priebe, S., Ramjaun, G., Strappelli, N., Arcidiacono, E., Aguglia, E., & Greenberg, L. 
(2017). Do patients prefer optimistic or cautious psychiatrists? An experimental 
study with new and long-term patients. BMC Psychiatry, 17(1), 26. 
https://doi.org/10.1186/s12888-016-1182-1 




Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., … Jones, 
P. B. (2015). Mortality in schizophrenia and other psychoses: A 10-year follow-
up of the ӔSOP first-episode cohort. Schizophrenia Bulletin, 41(3), 664–673. 
https://doi.org/10.1093/schbul/sbu138 
Rietjens, J., van Tol, D., Schermer, M., & van der Heide, A. (2009). Judgement of 
suffering in the case of a euthanasia request in The Netherlands. Journal of 
Medical Ethics, 35(8), 502–507. https://doi.org/10.1136/jme.2008.028779 
Roberts, G., & Wolfson, P. (2004). The rediscovery of recovery: Open to all. Advances 
in Psychiatric Treatment, 10(1), 37–48. https://doi.org/10.1192/apt.10.1.37 
Rousseau, S., Turner, S., Chochinov, H. M., Enns, M. W., & Sareen, J. (2017). A 
national survey of Canadian psychiatrists’ attitudes toward medical assistance in 
death. Canadian Journal of Psychiatry, 62(11), 787–794. 
https://doi.org/10.1177/0706743717711174 
Ruhé, H. G., van Rooijen, G., Spijker, J., Peeters, F. P. M. L., & Schene, A. H. (2012). 
Staging methods for treatment resistant depression. A systematic review. 
ROLE OF PALLIATIVE CARE IN SPMI 110 
Journal of Affective Disorders, 137(1), 35–45. 
https://doi.org/10.1016/j.jad.2011.02.020 
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., 
Warden, D., … Fava, M. (2006). Acute and longer-term outcomes in depressed 
outpatients requiring one or several treatment steps: A STAR*D report. 
American Journal of Psychiatry, 163(11), 1905–1917. 
https://doi.org/10.1176/ajp.2006.163.11.1905 
Sachs, G. A., Shega, J. W., & Cox-Hayley, D. (2004). Barriers to excellent end-of-life 
care for patients with dementia. Journal of General Internal Medicine, 19(10), 
1057–1063. https://doi.org/10.1111/j.1525-1497.2004.30329.x 
Saunders, C. (2001). The evolution of palliative care. Journal of the Royal Society of 
Medicine, 94(9), 430–432. 
Schildmann, E., & Schildmann, J. (2014). Palliative sedation therapy: A systematic 
literature review and critical appraisal of available guidance on indication and 
decision making. Journal of Palliative Medicine, 17(5), 601–611. 
https://doi.org/10.1089/jpm.2013.0511 
Schneiderman, L. J. (1990). Medical futility: Its meaning and ethical implications. 
Annals of Internal Medicine, 112(12), 949. https://doi.org/10.7326/0003-4819-
112-12-949 
Schuklenk, U. (2015). The ethical case against assisted euthanasia has not been made. 
The Journal of Thoracic and Cardiovascular Surgery, 149(6), 1685–1686. 
https://doi.org/10.1016/j.jtcvs.2015.02.010 
Schuklenk, U., & van de Vathorst, S. (2015a). Treatment-resistant major depressive 
disorder and assisted dying. Journal of Medical Ethics, 41(8), 577–583. 
https://doi.org/10.1136/medethics-2014-102458 
ROLE OF PALLIATIVE CARE IN SPMI 111 
Schuklenk, U., & van de Vathorst, S. van de. (2015b). Treatment-resistant major 
depressive disorder and assisted dying: Response to comments. Journal of 
Medical Ethics, 41(8), 589–591. https://doi.org/10.1136/medethics-2015-102966 
Scott, J., Leboyer, M., Hickie, I., Berk, M., Kapczinski, F., Frank, E., … McGorry, P. 
(2013). Clinical staging in psychiatry: A cross-cutting model of diagnosis with 
heuristic and practical value. British Journal of Psychiatry, 202(4), 243–245. 
https://doi.org/10.1192/bjp.bp.112.110858 
Shalev, D., Brewster, K., Arbuckle, M. R., & Levenson, J. A. (2017). A staggered edge: 
End-of-life care in patients with severe mental illness. General Hospital 
Psychiatry, 44, 1–3. https://doi.org/10.1016/j.genhosppsych.2016.10.004 
Simpson, A. I. (2018). Medical assistance in dying and mental health: A legal, ethical, 
and clinical analysis. Canadian Journal of Psychiatry, 63(2), 80–84. 
https://doi.org/10.1177/0706743717746662 
Sjöstrand, M., & Helgesson, G. (2008). Coercive treatment and autonomy in psychiatry. 
Bioethics, 22(2), 113–120. https://doi.org/10.1111/j.1467-8519.2007.00610.x 
Sommer, B. R., & Raj, K. S. (2017). Refractory depression and the right to terminate 
active treatment. In R. E. McCue & M. Balasubramaniam (Eds.), Rational 
Suicide in the Elderly: Clinical, Ethical, and Sociocultural Aspects (pp. 45–61). 
Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-
32672-6_4 
Steck, N., Junker, C., & Zwahlen, M. (2018). Increase in assisted suicide in 
Switzerland: Did the socioeconomic predictors change? Results from the Swiss 
National Cohort. BMJ Open, 8(4), e020992. https://doi.org/10.1136/bmjopen-
2017-020992 
ROLE OF PALLIATIVE CARE IN SPMI 112 
Steinhausen, H.-C. (2002). The outcome of anorexia nervosa in the 20th century. 
American Journal of Psychiatry, 159(8), 1284–1293. 
https://doi.org/10.1176/appi.ajp.159.8.1284 
Sterckx, S., Raus, K., & Mortier, F. (2013). Continuous sedation at the end of life: 
Ethical, clinical and legal perspectives. Cambridge University Press. 
Strober, M. (2004). Managing the chronic, treatment-resistant patient with anorexia 
nervosa. International Journal of Eating Disorders, 36(3), 245–255. 
https://doi.org/10.1002/eat.20054 
Swiss Academy of Medical Sciences (SAMS). (2018). Management of dying and death. 
Retrieved from https://www.samw.ch/en/Ethics/Ethics-in-end-of-life-
care/Guidelines-management-dying-death.html 
Trachsel, M., Hodel, M. A., Irwin, S. A., Hoff, P., Biller-Andorno, N., & Riese, F. 
(n.d.). Acceptability of palliative care approaches for patients with severe and 
persistent mental illness: A survey of psychiatrists in Switzerland. Accepted. 
Trachsel, M., Irwin, S. A., Biller-Andorno, N., Hoff, P., & Riese, F. (2016a). Palliative 
psychiatry for severe and persistent mental illness. Lancet Psychiatry, 3(3), 200. 
https://doi.org/10.1016/S2215-0366(16)00005-5 
Trachsel, M., Irwin, S. A., Biller-Andorno, N., Hoff, P., & Riese, F. (2016b). Palliative 
psychiatry for severe persistent mental illness as a new approach to psychiatry? 
Definition, scope, benefits, and risks. BMC Psychiatry, 16, 260. 
https://doi.org/10.1186/s12888-016-0970-y 
Trachsel, M., Wild, V., Biller-Andorno, N., & Krones, T. (2015). Compulsory treatment 
in chronic anorexia nervosa by all means? Searching for a middle ground 
between a curative and a palliative approach. American Journal of Bioethics, 
15(7), 55–56. https://doi.org/10.1080/15265161.2015.1039730 
ROLE OF PALLIATIVE CARE IN SPMI 113 
Trauer, T. (2012). Palliative models of care for later stages of mental disorder: 
Maximising recovery, maintaining hope and building morale. Australian and 
New Zealand Journal of Psychiatry, 46(2), 170–172. 
https://doi.org/10.1177/0004867411435287 
Tuffs, A. (2007). Swiss hospitals admit to allowing assisted suicide on their wards. 
British Medical Journal, 335(7629), zie. 
https://doi.org/10.1136/bmj.39405.470498.94 
Van Deijck, R. H., Hasselaar, J. G., Krijnsen, P. J., Gloudemans, A. J., Verhagen, S. C., 
Vissers, K. C., & Koopmans, R. T. (2015). The practice of continuous palliative 
sedation in long-term care for frail patients with existential suffering. Journal of 
Palliative Care, 31(3), 141–149. 
Van Os, J., & Guloksuz, S. (2017). A critique of the “ultra-high risk” and “transition” 
paradigm. World Psychiatry, 16(2), 200–206. https://doi.org/10.1002/wps.20423 
Van Tol, D., Rietjens, J., & van der Heide, A. (2010). Judgment of unbearable suffering 
and willingness to grant a euthanasia request by Dutch general practitioners. 
Health Policy, 97(2), 166–172. https://doi.org/10.1016/j.healthpol.2010.04.007 
Vandenberghe, J. (2018). Physician-assisted suicide and psychiatric illness. New 
England Journal of Medicine, 378(10), 885–887. 
https://doi.org/10.1056/NEJMp1714496 
Veterans Health Administration National Ethics Committee. (2007). The ethics of 
palliative sedation as a therapy of last resort. American Journal of Hospice and 
Palliative Medicine®, 23(6), 483–491. 
https://doi.org/10.1177/1049909106294883 
Vögeli, D. (2018, October 26). Suizidhilfe: Ärztekammer erteilt neuen Regeln eine 
Abfuhr. Neue Zürcher Zeitung. Retrieved from 
ROLE OF PALLIATIVE CARE IN SPMI 114 
https://www.nzz.ch/schweiz/suizidhilfe-aerztekammer-erteilt-neuen-regeln-eine-
abfuhr-ld.1431311 
Walker, E. R., McGee, R. E., & Druss, B. G. (2015). Mortality in mental disorders and 
global disease burden implications: A systematic review and meta-analysis. 
JAMA Psychiatry, 72(4), 334–341. 
https://doi.org/10.1001/jamapsychiatry.2014.2502 
Walter, G., & Pridmore, S. (2012). Suicide is preventable, sometimes. Australasian 
Psychiatry, 20(4), 271–273. https://doi.org/10.1177/1039856212449880 
Wang, D. W. L. (2015). Mental Capacity Act, anorexia nervosa and the choice between 
life-prolonging treatment and palliative Care: A NHS foundation trust v Ms X. 
Modern Law Review, 78(5), 871–882. https://doi.org/10.1111/1468-2230.12147 
Weide, M. C. J. der, Onwuteaka-Philipsen, B. D., & Wal, G. van der. (2005). Granted, 
undecided, withdrawn, and refused requests for euthanasia and physician-
assisted suicide. Archives of Internal Medicine, 165(15), 1698–1704. 
https://doi.org/10.1001/archinte.165.15.1698 
White, N., Kupeli, N., Vickerstaff, V., & Stone, P. (2017). How accurate is the 
“Surprise Question” at identifying patients at the end of life? A systematic 
review and meta-analysis. BMC Medicine, 15(1), 139. 
https://doi.org/10.1186/s12916-017-0907-4 
Woods, A., Willison, K., Kington, C., & Gavin, A. (2008). Palliative care for people 
with severe persistent mental illness: A review of the literature. Canadian 
Journal of Psychiatry, 53(11), 725–736. 
https://doi.org/10.1177/070674370805301104 
World Health Organization (WHO) 2014. (2014). WHO definition of palliative care. 
Retrieved from www.who.int/cancer/palliative/definition/en/ 
ROLE OF PALLIATIVE CARE IN SPMI 115 
Yager, J. (2015). The futility of arguing about medical futility in anorexia nervosa: The 
question is how would you handle highly specific circumstances? American 
Journal of Bioethics, 15(7), 47–50. 
https://doi.org/10.1080/15265161.2015.1039724 
Yager, J., Ganzini, L., Nguyen, D. H., & Rapp, E. K. (2018). Working with decisionally 
capable patients who are determined to end their own lives. Journal of Clinical 
Psychiatry, 79(4), 0–0. https://doi.org/10.4088/JCP.17r11767 
Ziegler, S. J. (2009). Collaborated death: An exploration of the Swiss model of assisted 
suicide for its potential to enhance oversight and demedicalize the dying 
process. Journal of Law, Medicine & Ethics, 37(2), 318–330. 
https://doi.org/10.1111/j.1748-720X.2009.00375.x 
Ziegler, S. J., & Bosshard, G. (2007). Role of non-governmental organisations in 
physician assisted suicide. British Medical Journal, 334(7588), 295–298. 
https://doi.org/10.1136/bmj.39100.417072.BE 
Zipfel, S., Löwe, B., Reas, D. L., Deter, H.-C., & Herzog, W. (2000). Long-term 
prognosis in anorexia nervosa: Lessons from a 21-year follow-up study. Lancet, 
355(9205), 721–722. https://doi.org/10.1016/S0140-6736(99)05363-5 
  
ROLE OF PALLIATIVE CARE IN SPMI 116 
Curriculum Vitae 
 
Martina Andrea Hodel 




1996-2002 Primary Education, Primary School Einigen, Switzerland 
2002-2005 Primary Education, Secondary School Längenstein, Spiez, 
Switzerland 
2005-2008 Gymnasium Thun-Schadau, Switzerland 
2008-2012 Bachelor of Science in Psychology (BSc), University of Bern, 
Bern, Switzerland  
2013-2015  Master of Science in Psychology (MSc), Universities Humboldt 
(Berlin, Germany) and Zurich, Switzerland 
2016-2019   Doctoral Program in Biomedical Ethics (PhD), Institute of  




01/2014-12/2014   Teaching Assistant for the seminar “Basic Psychological Skills 
for undergraduate students, Psychological Institute, University 
of Zurich 
2015  Clinical internship at the Centre of Eating Disorders and 
Adipositas in Zurich, Switzerland 
01/2015-12/2015  Research Assistant for conduction of a real-time fMRI study 
investigating brain-psychopathology of cocaine-addicted 
patients, Addictive Disorders Research Group, Psychiatric 
Hospital, University of Zurich 
02/2017-07/2018 Clinical Psychologist for psychological assessment of military 
candidates, Department of Defense, Civil Protection and Sport 
(DPPS) of Switzerland 
02/2016-02/2019 Doctoral Researcher on palliative care for patients with severe 
and persistent mental illness, Advisor: Manuel Trachsel, 
Institute of Biomedical Ethics and History of Medicine, 
University of Zurich 
12/2017-Present  Research Assistant for “Database of Individual Patient 
Experiences (DIPEX)”, Institute of Biomedical Ethics and 
History of Medicine, University of Zurich 
